{
  "topic_id": "mpx1016",
  "ingest_source": "gold",
  "candidates": [
    {
      "nct_id": "NCT06585488",
      "title": "A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification",
      "brief_title": "A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Metastatic Solid Tumors",
        "Advanced Non-squamous Non-small-cell Lung Cancer",
        "Advanced Colorectal Cancer"
      ],
      "interventions": [
        "BGB-53038",
        "Tislelizumab",
        "Cetuximab"
      ],
      "sponsor": "BeiGene",
      "enrollment": 514,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='KRAS Wild-Type NSCLC'",
        "cond='Wild Type NSCLC'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06427941",
      "title": "A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors",
      "brief_title": "A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Metastatic Hepatocellular Carcinoma",
        "Local Advanced Hepatocellular Carcinoma",
        "Alpha-fetoprotein (AFP)-Producing Gastric Cancer"
      ],
      "interventions": [
        "BGB-B2033",
        "Tislelizumab",
        "Bevacizumab"
      ],
      "sponsor": "BeOne Medicines",
      "enrollment": 140,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07376707",
      "title": "A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors",
      "brief_title": "A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "CRC (Colorectal Cancer)",
        "Melanoma (Skin Cancer)",
        "HCC - Hepatocellular Carcinoma"
      ],
      "interventions": [
        "TGI-5"
      ],
      "sponsor": "Hefei TG ImmunoPharma Co., Ltd.",
      "enrollment": 194,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04903873",
      "title": "A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors",
      "brief_title": "A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Solid Tumor",
        "Renal Cell Cancer Metastatic",
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "EU101"
      ],
      "sponsor": "Eutilex",
      "enrollment": 110,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05266846",
      "title": "Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK",
      "brief_title": "Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "ALK Gene Mutation",
        "Lung Adenocarcinoma",
        "Immunotherapy"
      ],
      "interventions": [
        "Pembrolizumab injection"
      ],
      "sponsor": "Hunan Province Tumor Hospital",
      "enrollment": 78,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='NSCLC'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Lung Cancer'",
        "cond='Advanced NSCLC'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06382129",
      "title": "A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer",
      "brief_title": "A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "BL-B01D1",
        "Docetaxel"
      ],
      "sponsor": "Sichuan Baili Pharmaceutical Co., Ltd.",
      "enrollment": 680,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='EGFR Wild-Type NSCLC'",
        "cond='Wild Type NSCLC'",
        "cond='Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06066138",
      "title": "A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing",
      "brief_title": "A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Locally Advanced Alveolar Soft Part Sarcoma",
        "Metastatic Alveolar Soft Part Sarcoma",
        "Locally Advanced Non Small Cell Lung Cancer"
      ],
      "interventions": [
        "Atezolizumab"
      ],
      "sponsor": "National Cancer Institute (NCI)",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07094204",
      "title": "A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors",
      "brief_title": "A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Solid Tumor",
        "Non-Small-Cell Lung Cancer",
        "Pancreatic Ductal Adenocarcinoma"
      ],
      "interventions": [
        "ASP5834",
        "panitumumab"
      ],
      "sponsor": "Astellas Pharma Inc",
      "enrollment": 364,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06710132",
      "title": "Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)",
      "brief_title": "Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Solid Tumors",
        "Gastric Cancer",
        "Non-Small Cell Lung Cancer (NSCLC)"
      ],
      "interventions": [
        "M9140"
      ],
      "sponsor": "EMD Serono Research & Development Institute, Inc.",
      "enrollment": 250,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05877599",
      "title": "A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation",
      "brief_title": "A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer",
        "Head and Neck Squamous Cell Carcinoma",
        "Colorectal Carcinoma"
      ],
      "interventions": [
        "Autologous, engineered T Cells targeting TP53 R175H"
      ],
      "sponsor": "AstraZeneca",
      "enrollment": 46,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06108479",
      "title": "Study of DF6215 in Patients with Advanced Solid Tumors",
      "brief_title": "Study of DF6215 in Patients with Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Solid Tumor, Adult",
        "Solid Tumor Cancer"
      ],
      "interventions": [
        "DF6215",
        "pembrolizumab",
        "KEYTRUDA®"
      ],
      "sponsor": "Dragonfly Therapeutics",
      "enrollment": 255,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07348211",
      "title": "First in Human Study of SIM0610 in Solid Tumors",
      "brief_title": "First in Human Study of SIM0610 in Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced Solid Tumours",
        "Non-Small Cell Lung Cancer",
        "Colorectal Cancer"
      ],
      "interventions": [
        "SIM0610 for Injection",
        "SIM0610 for Injection"
      ],
      "sponsor": "Jiangsu Simcere Pharmaceutical Co., Ltd.",
      "enrollment": 260,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT03556228",
      "title": "VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma",
      "brief_title": "VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Head and Neck Carcinoma",
        "Adenoid Cystic Carcinoma",
        "Lung Cancer"
      ],
      "interventions": [
        "VMD-928 100 mg Tablet",
        "VMD-928 Tablet and Pembrolizumab (200 mg)"
      ],
      "sponsor": "VM Oncology, LLC",
      "enrollment": 242,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05469022",
      "title": "Neoadjuvant Lazertinib Therapy in EGFR-Mutation Positive Lung Adenocarcinoma Detected by BALF Liquid Biopsy",
      "brief_title": "Neoadjuvant Lazertinib Therapy in EGFR-Mutation Positive Lung Adenocarcinoma Detected by BALF Liquid Biopsy",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer"
      ],
      "interventions": [
        "Neoadjuvant lazertinib"
      ],
      "sponsor": "Konkuk University Medical Center",
      "enrollment": 40,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05473156",
      "title": "A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies",
      "brief_title": "A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Locally Advanced or Metastatic Solid Tumors",
        "Non Small Cell Lung Cancer (NSCLC)",
        "Head and Neck Squamous Cell Carcinoma (HNSCC)"
      ],
      "interventions": [
        "AP203",
        "AP203"
      ],
      "sponsor": "AP Biosciences Inc.",
      "enrollment": 168,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05841472",
      "title": "Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer",
      "brief_title": "Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non Squamous Non Small Cell Lung Cancer"
      ],
      "interventions": [
        "Camrelizumab (SHR-1210), Pemetrexed, and Carboplatin"
      ],
      "sponsor": "CrystalGenomics, Inc.",
      "enrollment": 60,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05937906",
      "title": "Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %.",
      "brief_title": "Clinical Trial Evaluating the Safety and Efficacy of Chemoimmunotherapy Plus Short Course of Mek Inhibitor in First Line of Treatment of Metastatic Non Squamous Non Small Cell Lung Adenocarcinoma With PDL1 < 50 %.",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "Phase I - Mirdametinib - Level 1",
        "Phase II - Mirdametinib",
        "Phase I - Mirdametinib - Level 2",
        "Phase I - Mirdametinib - Level 3"
      ],
      "sponsor": "Centre Georges Francois Leclerc",
      "enrollment": 24,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06151574",
      "title": "Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment",
      "brief_title": "Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Lung Cancer, Non-squamous, Non-small Cell"
      ],
      "interventions": [
        "zongertinib",
        "pembrolizumab",
        "cisplatin",
        "carboplatin"
      ],
      "sponsor": "Boehringer Ingelheim",
      "enrollment": 416,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06475300",
      "title": "A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors",
      "brief_title": "A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer",
        "Nasopharyngeal Carcinoma",
        "Solid Tumor"
      ],
      "interventions": [
        "BL-B01D1",
        "PD-1 Monoclonal Antibody"
      ],
      "sponsor": "Sichuan Baili Pharmaceutical Co., Ltd.",
      "enrollment": 570,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06618287",
      "title": "A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors",
      "brief_title": "A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Lung Cancer",
        "Breast Cancer"
      ],
      "interventions": [
        "BMS-986507",
        "Osimertinib",
        "Pembrolizumab",
        "Nivolumab"
      ],
      "sponsor": "Bristol-Myers Squibb",
      "enrollment": 416,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='EGFR Wild-Type NSCLC'",
        "cond='Wild Type NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06671379",
      "title": "A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLC",
      "brief_title": "A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "SHR-A2009 monotherapy",
        "platinum-based dual-agent chemotherapy"
      ],
      "sponsor": "Suzhou Suncadia Biopharmaceuticals Co., Ltd.",
      "enrollment": 500,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06940401",
      "title": "JS111 in Patients With Advanced NSCLC Harboring EGFR Mutations",
      "brief_title": "JS111 in Patients With Advanced NSCLC Harboring EGFR Mutations",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "NSCLC"
      ],
      "interventions": [
        "JS111 capsules (AP-L1898)"
      ],
      "sponsor": "Suzhou Junjing BioSciences Co., Ltd.",
      "enrollment": 42,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07014202",
      "title": "Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy",
      "brief_title": "Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "Immunotherapy (with or without chemotherapy) maintenance therapy combined with radiotherapy",
        "Immunotherapy (with or without chemotherapy) maintenance therapy"
      ],
      "sponsor": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences",
      "enrollment": 224,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Advanced NSCLC'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07017829",
      "title": "GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer",
      "brief_title": "GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Advanced Lung Non-Small Cell Carcinoma",
        "Metastatic Lung Non-Small Cell Carcinoma",
        "Stage III Lung Cancer AJCC v8"
      ],
      "interventions": [
        "Anti-CFH Monoclonal Antibody GT103",
        "Biopsy Procedure",
        "Biospecimen Collection",
        "Computed Tomography"
      ],
      "sponsor": "Roswell Park Cancer Institute",
      "enrollment": 28,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07115043",
      "title": "A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors",
      "brief_title": "A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Melanoma",
        "Non-small Cell Lung Cancer",
        "Squamous Cell Carcinoma (Skin)"
      ],
      "interventions": [
        "AZD6750",
        "rilvegostomig"
      ],
      "sponsor": "AstraZeneca",
      "enrollment": 60,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07172802",
      "title": "A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors",
      "brief_title": "A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced Solid Tumor",
        "Metastatic Solid Tumor",
        "Non-small Cell Lung Cancer (NSCLC)"
      ],
      "interventions": [
        "GI-108"
      ],
      "sponsor": "GI Innovation, Inc.",
      "enrollment": 76,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07222566",
      "title": "A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer",
      "brief_title": "A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Advanced Non-Small Cell Lung Cancer",
        "Non-Small Cell Lung Cancer",
        "Carcinoma, Non-Small-Cell Lung"
      ],
      "interventions": [
        "PF-08634404",
        "Pembrolizumab",
        "Chemotherapy Regimen 1",
        "Chemotherapy Regimen 2"
      ],
      "sponsor": "Pfizer",
      "enrollment": 1410,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07397338",
      "title": "Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors",
      "brief_title": "Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced Solid Tumors",
        "Metastatic Solid Tumors",
        "Non-small Cell Lung Cancer (NSCLC)"
      ],
      "interventions": [
        "Daraxonrasib",
        "Elironrasib",
        "Zoldonrasib",
        "Ivonescimab"
      ],
      "sponsor": "Revolution Medicines, Inc.",
      "enrollment": 370,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07410494",
      "title": "Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors",
      "brief_title": "Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Cancer",
        "Breast Cancer",
        "Non-Small Cell Lung Cancer (NSCLC)"
      ],
      "interventions": [
        "EB-SELECT Single-Target CAR-NK Cells",
        "Dual-Target Antigen-Selected CAR-NK"
      ],
      "sponsor": "Essen Biotech",
      "enrollment": 85,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04149691",
      "title": "Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies",
      "brief_title": "Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Gastric Cancer",
        "Bladder Cancer",
        "Squamous Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "CPL304110"
      ],
      "sponsor": "Celon Pharma SA",
      "enrollment": 42,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05245500",
      "title": "Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion",
      "brief_title": "Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Mesothelioma",
        "Non Small Cell Lung Cancer",
        "Malignant Peripheral Nerve Sheath Tumors"
      ],
      "interventions": [
        "MRTX1719"
      ],
      "sponsor": "Bristol-Myers Squibb",
      "enrollment": 336,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06444815",
      "title": "A Study of VET3-TGI in Patients With Solid Tumors",
      "brief_title": "A Study of VET3-TGI in Patients With Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Solid Tumor, Adult",
        "Microsatellite Stable Colorectal Cancer",
        "Head and Neck Squamous Cell Carcinoma"
      ],
      "interventions": [
        "VET3-TGI",
        "Pembrolizumab"
      ],
      "sponsor": "KaliVir Immunotherapeutics",
      "enrollment": 60,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06910657",
      "title": "IDOV-Immune for Advanced Solid Tumors",
      "brief_title": "IDOV-Immune for Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Colorectal Cancer",
        "Pancreatic Cancer",
        "Melanoma"
      ],
      "interventions": [
        "IDOV-Immune (oncolytic vaccinia virus)"
      ],
      "sponsor": "ViroMissile, Inc.",
      "enrollment": 78,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07056556",
      "title": "A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors",
      "brief_title": "A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer",
        "Solid Tumor"
      ],
      "interventions": [
        "BL-M09D1"
      ],
      "sponsor": "Sichuan Baili Pharmaceutical Co., Ltd.",
      "enrollment": 31,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04566432",
      "title": "Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients",
      "brief_title": "Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Neoplasms",
        "Lung Cancer, Nonsmall Cell",
        "Adenocarcinoma of Lung"
      ],
      "interventions": [
        "Observation"
      ],
      "sponsor": "Geneplus-Beijing Co. Ltd.",
      "enrollment": 250,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05550961",
      "title": "APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch",
      "brief_title": "APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "NSCLC",
        "Cancer",
        "Lung Cancer"
      ],
      "interventions": [],
      "sponsor": "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano",
      "enrollment": 1200,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT03175224",
      "title": "APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors",
      "brief_title": "APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Solid Tumors",
        "Advanced Cancer",
        "Renal Cancer"
      ],
      "interventions": [
        "APL-101 Oral Capsules"
      ],
      "sponsor": "Apollomics Inc.",
      "enrollment": 497,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04777084",
      "title": "The Efficacy and Safety of the Bispecific Anti-PD-1/PD-L1 Antibody IBI318 Combined with Lenvatinib in NSCLC.",
      "brief_title": "The Efficacy and Safety of the Bispecific Anti-PD-1/PD-L1 Antibody IBI318 Combined with Lenvatinib in NSCLC.",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "IBI318"
      ],
      "sponsor": "Hunan Province Tumor Hospital",
      "enrollment": 120,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04787042",
      "title": "Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067",
      "brief_title": "Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Cancer",
        "Solid Tumor",
        "Melanoma"
      ],
      "interventions": [
        "ST-067",
        "Obinutuzumab 25 MG/1 ML Intravenous Solution [GAZYVA]",
        "pembrolizumab"
      ],
      "sponsor": "Simcha IL-18, Inc.",
      "enrollment": 316,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05271916",
      "title": "First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutations",
      "brief_title": "First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutations",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer (NSCLC)"
      ],
      "interventions": [
        "Dacomitinib+Anlotinib",
        "Dacomitinib"
      ],
      "sponsor": "Shanghai Chest Hospital",
      "enrollment": 140,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05382728",
      "title": "Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)",
      "brief_title": "Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "NSCLC",
        "EGFR Activating Mutation"
      ],
      "interventions": [
        "TY-9591",
        "placebo Osimertinib",
        "Osimertinib",
        "placebo TY-9591"
      ],
      "sponsor": "TYK Medicines, Inc",
      "enrollment": 680,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05589818",
      "title": "Pembrolizumab for Advanced NSCLC and PS 2-3",
      "brief_title": "Pembrolizumab for Advanced NSCLC and PS 2-3",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer (NSCLC)"
      ],
      "interventions": [
        "Pembrolizumab"
      ],
      "sponsor": "Icahn School of Medicine at Mount Sinai",
      "enrollment": 45,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05865730",
      "title": "A Study of Oncobax®-AK in Patients With Advanced Solid Tumors",
      "brief_title": "A Study of Oncobax®-AK in Patients With Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Carcinoma, Renal Cell",
        "Carcinoma, Non-Small-Cell Lung"
      ],
      "interventions": [
        "Live Bacterial Product - Akkermansia muciniphila"
      ],
      "sponsor": "EverImmune",
      "enrollment": 122,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05887492",
      "title": "Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors",
      "brief_title": "Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer",
        "Solid Tumors, Adult",
        "Lung Cancer"
      ],
      "interventions": [
        "TNG260",
        "Pembrolizumab"
      ],
      "sponsor": "Tango Therapeutics, Inc.",
      "enrollment": 126,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='KRAS Wild-Type NSCLC'",
        "cond='Wild Type NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06047379",
      "title": "Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis",
      "brief_title": "Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Diffuse Astrocytoma, IDH-Mutant",
        "Glioblastoma, IDH-wildtype",
        "Brain Metastases, Adult"
      ],
      "interventions": [
        "NEO212 Oral Capsule",
        "Ipilimumab",
        "Pembrolizumab",
        "Nivolumab"
      ],
      "sponsor": "Neonc Technologies, Inc.",
      "enrollment": 134,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Wild Type NSCLC'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06102057",
      "title": "PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC",
      "brief_title": "PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Stage III Non-small Cell Lung Cancer",
        "Locally Advanced",
        "Unresectable"
      ],
      "interventions": [
        "standard Radiotherapy",
        "Chemotherapy",
        "Immunotherapy",
        "Experimental Radiotherapy"
      ],
      "sponsor": "TheraOp",
      "enrollment": 110,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06296745",
      "title": "Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib.",
      "brief_title": "Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib.",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Leptomeningeal Metastasis"
      ],
      "interventions": [
        "Pemetrexed"
      ],
      "sponsor": "Guangzhou Medical University",
      "enrollment": 36,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06303505",
      "title": "FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC",
      "brief_title": "FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Ovarian Cancer",
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "TUB-040"
      ],
      "sponsor": "Tubulis GmbH",
      "enrollment": 200,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06440954",
      "title": "Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases",
      "brief_title": "Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "Intrathecal pemetrexed"
      ],
      "sponsor": "Hunan Province Tumor Hospital",
      "enrollment": 220,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06492421",
      "title": "Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.",
      "brief_title": "Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Lung Cancer",
        "Surgery",
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "ipilimumab, pembrolizumab, durvalumab, idarubicin, bevacizumab"
      ],
      "sponsor": "Second Affiliated Hospital of Guangzhou Medical University",
      "enrollment": 90,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06500455",
      "title": "Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain",
      "brief_title": "Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Anatomic Stage IV Breast Cancer AJCC v8",
        "Metastatic Breast Carcinoma",
        "Metastatic Digestive System Carcinoma"
      ],
      "interventions": [
        "Computed Tomography",
        "Fractionated Stereotactic Radiation Therapy",
        "Magnetic Resonance Imaging",
        "Stereotactic Radiosurgery"
      ],
      "sponsor": "NRG Oncology",
      "enrollment": 269,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06532799",
      "title": "TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer",
      "brief_title": "TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Stomach Cancer",
        "Stomach Cancer Recurrent",
        "Stomach Cancer, Adenocarcinoma"
      ],
      "interventions": [
        "Tumor Infiltrating Lymphocytes (TIL)",
        "Cyclophosphamid",
        "Fludarabine",
        "Interleukin-2"
      ],
      "sponsor": "Essen Biotech",
      "enrollment": 75,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06644768",
      "title": "A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations",
      "brief_title": "A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer",
        "Lung Cancer"
      ],
      "interventions": [
        "valemetostat tosylate",
        "pembrolizumab"
      ],
      "sponsor": "Daiichi Sankyo",
      "enrollment": 137,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06772623",
      "title": "Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations",
      "brief_title": "Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Non Small Cell Lung Carcinoma"
      ],
      "interventions": [
        "Telisotuzumab Adizutecan",
        "Budigalimab",
        "Pembrolizumab",
        "Pembrolizumab"
      ],
      "sponsor": "AbbVie",
      "enrollment": 252,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06917573",
      "title": "PALACE: Cemiplimab Trial According to ctDNA Levels",
      "brief_title": "PALACE: Cemiplimab Trial According to ctDNA Levels",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer Metastatic",
        "Lung Diseases",
        "Stage IV Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Cemiplimab",
        "Carboplatin",
        "Paclitaxel"
      ],
      "sponsor": "Fundación GECP",
      "enrollment": 63,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06969027",
      "title": "JS207Combined With Chemotherapy in First-line Treatment of Advanced NSCLC",
      "brief_title": "JS207Combined With Chemotherapy in First-line Treatment of Advanced NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "JS207",
        "Pemetrexed injection",
        "Platinum",
        "Paclitaxel"
      ],
      "sponsor": "Shanghai Junshi Bioscience Co., Ltd.",
      "enrollment": 84,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07098338",
      "title": "A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)",
      "brief_title": "A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "Rilvegostomig",
        "Ramucirumab",
        "Dato-DXd"
      ],
      "sponsor": "AstraZeneca",
      "enrollment": 278,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07148128",
      "title": "Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.",
      "brief_title": "Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma",
        "Advanced or Metastatic KRAS-mutant Tumor in Colorectal Cancer",
        "Advanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer"
      ],
      "interventions": [
        "WEF-001"
      ],
      "sponsor": "Auricula Biosciences Inc.",
      "enrollment": 110,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT07169994",
      "title": "A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors",
      "brief_title": "A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced Solid Tumors",
        "Breast Cancer",
        "Non Small Cell Lung Cancer"
      ],
      "interventions": [
        "YL202 for injection; Toripalimab injection",
        "YL202 for injection; Furmonertinib Mesilate Tablets"
      ],
      "sponsor": "MediLink Therapeutics (Suzhou) Co., Ltd.",
      "enrollment": 414,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT03740256",
      "title": "Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors",
      "brief_title": "Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Bladder Cancer",
        "Head and Neck Squamous Cell Carcinoma",
        "Cancer of the Salivary Gland"
      ],
      "interventions": [
        "CAdVEC"
      ],
      "sponsor": "Baylor College of Medicine",
      "enrollment": 45,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT03991819",
      "title": "Study of Binimetinib in Combination With Pembrolizumab in Advanced Non-Small Cell Lung Cancer",
      "brief_title": "Study of Binimetinib in Combination With Pembrolizumab in Advanced Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Non-small Cell Carcinoma"
      ],
      "interventions": [
        "Binimetinib",
        "Pembrolizumab"
      ],
      "sponsor": "University Health Network, Toronto",
      "enrollment": 40,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04886804",
      "title": "Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)",
      "brief_title": "Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Neoplasm Metastasis",
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "zongertinib"
      ],
      "sponsor": "Boehringer Ingelheim",
      "enrollment": 554,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05136846",
      "title": "Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer",
      "brief_title": "Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Locally Advanced Lung Non-Small Cell Carcinoma",
        "Stage II Lung Cancer AJCC v8",
        "Stage IIA Lung Cancer AJCC v8"
      ],
      "interventions": [
        "Carboplatin",
        "Durvalumab",
        "Paclitaxel",
        "Papaverine"
      ],
      "sponsor": "Ohio State University Comprehensive Cancer Center",
      "enrollment": 28,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05452005",
      "title": "Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer",
      "brief_title": "Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Lung Cancer",
        "Lung Cancer Metastatic",
        "Brain Metastases"
      ],
      "interventions": [
        "[18F]-αvβ6-BP"
      ],
      "sponsor": "University of California, Davis",
      "enrollment": 20,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06040541",
      "title": "Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors",
      "brief_title": "Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer (NSCLC)",
        "Colorectal Cancer (CRC)",
        "Pancreatic Ductal Adenocarcinoma (PDAC)"
      ],
      "interventions": [
        "RMC-9805",
        "RMC-6236"
      ],
      "sponsor": "Revolution Medicines, Inc.",
      "enrollment": 604,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06218914",
      "title": "Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors",
      "brief_title": "Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer",
        "Colorectal Carcinoma",
        "Pancreatic Ductal Adenocarcinoma"
      ],
      "interventions": [
        "NT-112: Autologous, engineered T Cells targeting KRAS G12D",
        "AZD0240: Autologous, engineered T Cells targeting KRAS G12D"
      ],
      "sponsor": "AstraZeneca",
      "enrollment": 24,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06687941",
      "title": "A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors",
      "brief_title": "A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Neoplasms",
        "Carcinoma, Hepatocellular",
        "Carcinoma, Non-Small-Cell Lung"
      ],
      "interventions": [
        "AST-201"
      ],
      "sponsor": "Aptamer Sciences, Inc.",
      "enrollment": 70,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06778863",
      "title": "A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation",
      "brief_title": "A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced Solid Tumor",
        "Unresectable Solid Tumor",
        "Metastatic Solid Tumor"
      ],
      "interventions": [
        "CLSP-1025"
      ],
      "sponsor": "Clasp Therapeutics, Inc.",
      "enrollment": 90,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06805825",
      "title": "A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit",
      "brief_title": "A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Gastrointestinal Stromal Tumors",
        "Small-cell Lung Cancer",
        "Adenoid Cystic Carcinoma"
      ],
      "interventions": [
        "NN3201"
      ],
      "sponsor": "Novelty Nobility, Inc.",
      "enrollment": 67,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT07300150",
      "title": "A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors",
      "brief_title": "A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Colorectal Cancer",
        "Pancreatic Cancer",
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "PT0511",
        "Cetuximab"
      ],
      "sponsor": "PAQ Therapeutics, Inc.",
      "enrollment": 195,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT00900419",
      "title": "Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers",
      "brief_title": "Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Esophageal Cancer",
        "Head and Neck Cancer",
        "Lung Cancer"
      ],
      "interventions": [
        "immunohistochemistry staining method",
        "laboratory biomarker analysis",
        "sputum cytology",
        "biopsy"
      ],
      "sponsor": "University of Colorado, Denver",
      "enrollment": 700,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT02596490",
      "title": "Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners",
      "brief_title": "Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Cancer"
      ],
      "interventions": [
        "Questionnaires",
        "Meditation and Discussion Sessions",
        "Cancer-Related Discussion Program"
      ],
      "sponsor": "M.D. Anderson Cancer Center",
      "enrollment": 300,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04401059",
      "title": "Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study",
      "brief_title": "Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Prospective Study",
      "status": "RECRUITING",
      "phase": [
        "PHASE4"
      ],
      "conditions": [
        "Carcinoma",
        "Non-Small-Cell Lung Cancer",
        "Adenocarcinoma"
      ],
      "interventions": [
        "Elemene plus first or third generation EGFR-TKIs",
        "First or third generation EGFR-TKIs"
      ],
      "sponsor": "Tian Xie",
      "enrollment": 744,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04973293",
      "title": "Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer",
      "brief_title": "Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Neoplasm Malignant"
      ],
      "interventions": [
        "sintilimab",
        "bevacizumab"
      ],
      "sponsor": "Ruijin Hospital",
      "enrollment": 20,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Advanced NSCLC'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05965557",
      "title": "Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer",
      "brief_title": "Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Cancer"
      ],
      "interventions": [],
      "sponsor": "Geneplus-Beijing Co. Ltd.",
      "enrollment": 100,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06056115",
      "title": "Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic",
      "brief_title": "Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Adenocarcinoma"
      ],
      "interventions": [
        "Tislelizumab,Platinum"
      ],
      "sponsor": "Hebei Medical University Fourth Hospital",
      "enrollment": 20,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06232265",
      "title": "An Observational Study on Predicting the Efficacy of Immunotherapy for NSCLC Based on LIRAscore",
      "brief_title": "An Observational Study on Predicting the Efficacy of Immunotherapy for NSCLC Based on LIRAscore",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [],
      "sponsor": "Nanfang Hospital, Southern Medical University",
      "enrollment": 108,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06272864",
      "title": "BostonGene and Exigent Genomic INsight Study",
      "brief_title": "BostonGene and Exigent Genomic INsight Study",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Breast Cancer",
        "Non-small Cell Lung Cancer",
        "Melanoma"
      ],
      "interventions": [],
      "sponsor": "BostonGene",
      "enrollment": 400,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06358222",
      "title": "Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan",
      "brief_title": "Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Carcinoma",
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Blood ctDNA + methylation + PET-CT and Postoperative pathology",
        "MRD+ methylation (or combined with PET-CT) and Invasive mediastinoscopy /EBUS-TBNA",
        "Intraoperative lymph node dissection"
      ],
      "sponsor": "Shanghai Chest Hospital",
      "enrollment": 200,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07164885",
      "title": "RAPART in Locally Advanced Non-small Cell Lung Cancer Patients",
      "brief_title": "RAPART in Locally Advanced Non-small Cell Lung Cancer Patients",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Locally Advanced Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Radiosensitivity-Assisted Personalized Adaptive Radiotherapy Technology（RAPART)）",
        "Conventional radiotherapy"
      ],
      "sponsor": "Capital Medical University",
      "enrollment": 911,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07224464",
      "title": "The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.",
      "brief_title": "The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Metastatic Solid Tumors",
        "Stage 4 Cancer"
      ],
      "interventions": [
        "The Sarah Nanotechnology System - intended to deliver thermal energy to malignant cells for the purpose of thermal destruction of these cells in patients with advanced metastatic solid tumors."
      ],
      "sponsor": "New Phase Ltd.",
      "enrollment": 9,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT03412877",
      "title": "Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer",
      "brief_title": "Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Endocrine Tumors",
        "Non-Small Cell Lung Cancer",
        "Ovarian Cancer"
      ],
      "interventions": [
        "Cyclophosphamide",
        "Fludarabine",
        "Aldesleukin",
        "Individual Patient TCR-Transduced PBL"
      ],
      "sponsor": "National Cancer Institute (NCI)",
      "enrollment": 285,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04339218",
      "title": "Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma",
      "brief_title": "Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Lung Adenocarcinoma",
        "Cryotherapy Effect"
      ],
      "interventions": [
        "Cryoablation",
        "Pembrolizumab",
        "Pemetrexed",
        "Carboplatin"
      ],
      "sponsor": "Institut Bergonié",
      "enrollment": 214,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04585750",
      "title": "The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)",
      "brief_title": "The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced Solid Tumor",
        "Advanced Malignant Neoplasm",
        "Metastatic Cancer"
      ],
      "interventions": [
        "rezatapopt",
        "pembrolizumab"
      ],
      "sponsor": "PMV Pharmaceuticals, Inc",
      "enrollment": 300,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 Positive Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04853342",
      "title": "To Assess the Efficacy and Safety of Furmonertinib Versus Placebo, in Patients With Epidermal Growth Factor Receptor Mutation Positive Stage II-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy",
      "brief_title": "To Assess the Efficacy and Safety of Furmonertinib Versus Placebo, in Patients With Epidermal Growth Factor Receptor Mutation Positive Stage II-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Non-small Cell Lung Carcinoma"
      ],
      "interventions": [
        "Drug: Furmonertinib 80 mg",
        "Furmonertinib 80 mg placebo"
      ],
      "sponsor": "Allist Pharmaceuticals, Inc.",
      "enrollment": 318,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04969315",
      "title": "TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors",
      "brief_title": "TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Renal Cell Cancer",
        "Castrate Resistant Prostate Cancer",
        "Non Small Cell Lung Cancer"
      ],
      "interventions": [
        "TT-10",
        "TT-4"
      ],
      "sponsor": "Portage Biotech",
      "enrollment": 90,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05024214",
      "title": "Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors",
      "brief_title": "Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Solid Tumors",
        "Non-small Cell Lung Cancer",
        "Renal Cell Carcinoma"
      ],
      "interventions": [
        "Lenvatinib + Envafolimab",
        "Sunitinib"
      ],
      "sponsor": "3D Medicines (Sichuan) Co., Ltd.",
      "enrollment": 170,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05078047",
      "title": "Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO",
      "brief_title": "Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Lung Cancer Metastatic",
        "Renal Cell Carcinoma",
        "Head and Neck Cancer"
      ],
      "interventions": [
        "Reduced dose intensity of IO"
      ],
      "sponsor": "UNICANCER",
      "enrollment": 646,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05384626",
      "title": "A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)",
      "brief_title": "A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Locally Advanced Solid Tumor",
        "Metastatic Solid Tumor"
      ],
      "interventions": [
        "Neladalkib (NVL-655)"
      ],
      "sponsor": "Nuvalent Inc.",
      "enrollment": 840,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05431270",
      "title": "Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 MAb, Administered Alone and in Combination with a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)",
      "brief_title": "Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 MAb, Administered Alone and in Combination with a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer",
        "Pancreatic Ductal Adenocarcinoma"
      ],
      "interventions": [
        "Mavrostobart (PT199)",
        "Tislelizumab",
        "Gemcitabine + nab-Paclitaxel",
        "Docetaxel"
      ],
      "sponsor": "Phanes Therapeutics",
      "enrollment": 40,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Wild Type NSCLC'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05501665",
      "title": "Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer",
      "brief_title": "Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Lung Non-Small Cell Carcinoma",
        "Stage IV Lung Cancer AJCC v8",
        "Stage III Lung Cancer"
      ],
      "interventions": [
        "Biospecimen Collection",
        "Carboplatin",
        "Computed Tomography",
        "Fludeoxyglucose F-18"
      ],
      "sponsor": "Vanderbilt-Ingram Cancer Center",
      "enrollment": 25,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05503667",
      "title": "Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma",
      "brief_title": "Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Lung Adenocarcinoma Stage III",
        "Lung Adenocarcinoma Stage IV",
        "EGFR Gene Mutation"
      ],
      "interventions": [
        "Furmonertinib",
        "Bevacizumab"
      ],
      "sponsor": "Shanghai Pulmonary Hospital, Shanghai, China",
      "enrollment": 96,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Stage IVA Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05579366",
      "title": "Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)",
      "brief_title": "Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "High Grade Epithelial Ovarian Cancer",
        "High Grade Serous Ovarian Cancer",
        "Primary Peritoneal Carcinoma"
      ],
      "interventions": [
        "Rina-S",
        "Carboplatin",
        "Bevacizumab",
        "Pembrolizumab"
      ],
      "sponsor": "Genmab",
      "enrollment": 764,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05669430",
      "title": "A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies",
      "brief_title": "A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Solid Tumor, Adult",
        "Refractory Cancer",
        "Endometrial Carcinoma (EC)"
      ],
      "interventions": [
        "GV20-0251",
        "GV20-0251",
        "GV20-0251 and Pembrolizumab [KEYTRUDA®]",
        "GV20-0251 and Pembrolizumab [KEYTRUDA®]"
      ],
      "sponsor": "GV20 Therapeutics",
      "enrollment": 365,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05768178",
      "title": "DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.",
      "brief_title": "DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.",
      "status": "RECRUITING",
      "phase": [
        "PHASE2",
        "PHASE3"
      ],
      "conditions": [
        "Haematological Malignancy",
        "Melanoma",
        "Thyroid Cancer, Papillary"
      ],
      "interventions": [
        "Vemurafenib",
        "Cobimetinib"
      ],
      "sponsor": "Cancer Research UK",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Non-Small Cell Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05933265",
      "title": "Study of LP-184 in Patients With Advanced Solid Tumors",
      "brief_title": "Study of LP-184 in Patients With Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced Solid Tumor",
        "Metastatic Solid Tumor",
        "GBM"
      ],
      "interventions": [
        "LP-184",
        "Spironolactone",
        "Olaparib"
      ],
      "sponsor": "Lantern Pharma Inc.",
      "enrollment": 175,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05941507",
      "title": "A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors",
      "brief_title": "A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced Solid Tumors"
      ],
      "interventions": [
        "LCB84",
        "Anti-PD-1 monoclonal antibody"
      ],
      "sponsor": "LigaChem Biosciences, Inc.",
      "enrollment": 300,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06032052",
      "title": "Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients",
      "brief_title": "Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Elderly Patients",
        "Metastatic Lung Cancer"
      ],
      "interventions": [
        "Single drug chemotherapy plus immunotherapy"
      ],
      "sponsor": "Hubei Cancer Hospital",
      "enrollment": 49,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06051695",
      "title": "A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression",
      "brief_title": "A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Solid Tumor, Adult",
        "Colorectal Cancer",
        "NSCLC"
      ],
      "interventions": [
        "A2B694",
        "A2B543",
        "xT CDx with HLA-LOH Assay"
      ],
      "sponsor": "A2 Biotherapeutics Inc.",
      "enrollment": 474,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06141226",
      "title": "Phase II Clinical Trial to Evaluate the Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Capsule and Chemotherapy in the Treatment of Immunoresistant Advanced Non-small Cell Lung Cancer",
      "brief_title": "Phase II Clinical Trial to Evaluate the Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Capsule and Chemotherapy in the Treatment of Immunoresistant Advanced Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-small-cell Lung Cancer"
      ],
      "interventions": [
        "TQB2450 +Anlotinib+Docetaxel",
        "TQB2450 +Androtinib Placebo+Docetaxel"
      ],
      "sponsor": "Tianjin Medical University Cancer Institute and Hospital",
      "enrollment": 148,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06265285",
      "title": "Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program",
      "brief_title": "Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Advanced Esophageal Squamous Cell Carcinoma",
        "Advanced Renal Cell Carcinoma",
        "Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8"
      ],
      "interventions": [
        "Home Health Encounter",
        "Nivolumab",
        "Patient Monitoring",
        "Questionnaire Administration"
      ],
      "sponsor": "Mayo Clinic",
      "enrollment": 50,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06362369",
      "title": "A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy",
      "brief_title": "A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced Cancer",
        "Advanced Solid Tumor",
        "Melanoma"
      ],
      "interventions": [
        "Alintegimod",
        "Ipilimumab",
        "Nivolumab"
      ],
      "sponsor": "7 Hills Pharma, LLC",
      "enrollment": 126,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06417008",
      "title": "A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer",
      "brief_title": "A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2",
        "PHASE3"
      ],
      "conditions": [
        "Non-Squamous Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "HS-20117",
        "Aumolertinib"
      ],
      "sponsor": "Hansoh BioMedical R&D Company",
      "enrollment": 1080,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06472388",
      "title": "Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors",
      "brief_title": "Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Neuroendocrine Tumors",
        "Progression",
        "Neuroendocrine Tumor Grade 1"
      ],
      "interventions": [
        "Everolimus 5 MG"
      ],
      "sponsor": "AC Camargo Cancer Center",
      "enrollment": 100,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06516887",
      "title": "Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma",
      "brief_title": "Study of Bemcentinib Plus Pacritinib In Patients With Advanced Lung Adenocarcinoma",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced Lung Adenocarcinoma"
      ],
      "interventions": [
        "bemcentinib",
        "pacritinib"
      ],
      "sponsor": "The University of Texas Health Science Center at San Antonio",
      "enrollment": 44,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06617416",
      "title": "A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC",
      "brief_title": "A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "NSCLC (Non-small Cell Lung Cancer)"
      ],
      "interventions": [
        "Cadonilimab (AK104)",
        "Sugemalimab"
      ],
      "sponsor": "Akeso",
      "enrollment": 560,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06731907",
      "title": "A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)",
      "brief_title": "A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Pembrolizumab",
        "Carboplatin",
        "Paclitaxel",
        "Nab-paclitaxel"
      ],
      "sponsor": "Merck Sharp & Dohme LLC",
      "enrollment": 90,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06734182",
      "title": "Neoadjuvant Envafolimab Plus Disitamab Vedotin and Carboplatin in Resectable HER2-Mutant Non-Small-Cell Lung Cancer",
      "brief_title": "Neoadjuvant Envafolimab Plus Disitamab Vedotin and Carboplatin in Resectable HER2-Mutant Non-Small-Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Envafolimab injections+intravenous Disitamab Vedotin+carboplatin"
      ],
      "sponsor": "Guangdong Provincial People's Hospital",
      "enrollment": 25,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06859684",
      "title": "Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)",
      "brief_title": "Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Intrahepatic Cholangiocarcinoma (Icc)",
        "HAIC",
        "Durvalumab"
      ],
      "interventions": [
        "Durvalumab",
        "hepatic arterial infusion chemotherapy (HAIC)",
        "Lenvatinib"
      ],
      "sponsor": "West China Hospital",
      "enrollment": 25,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06922591",
      "title": "Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients",
      "brief_title": "Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "PDAC",
        "PDAC - Pancreatic Ductal Adenocarcinoma",
        "NSCLC"
      ],
      "interventions": [
        "TNG462",
        "RMC-9805",
        "RMC-6236",
        "mFOLFIRINOX"
      ],
      "sponsor": "Tango Therapeutics, Inc.",
      "enrollment": 183,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06943521",
      "title": "A Study of MT-4561 in Patients With Various Advanced Solid Tumors",
      "brief_title": "A Study of MT-4561 in Patients With Various Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Head and Neck Squamous Cell Carcinoma (HNSCC)",
        "Non-small Cell Lung Cancer (NSCLC)",
        "Esophageal Cancer"
      ],
      "interventions": [
        "MT-4561"
      ],
      "sponsor": "Tanabe Pharma America, Inc.",
      "enrollment": 27,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07016126",
      "title": "D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC",
      "brief_title": "D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "NSCLC (Non-small Cell Lung Cancer)"
      ],
      "interventions": [
        "D-BACE in combination with chemotherapy and karelizumab"
      ],
      "sponsor": "Guangdong Provincial People's Hospital",
      "enrollment": 70,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07070518",
      "title": "Study of GV20-0251 in Participants With Solid Tumor Malignancies",
      "brief_title": "Study of GV20-0251 in Participants With Solid Tumor Malignancies",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Solid Tumor Cancer",
        "Adult Refractory Cancer",
        "Endometrial Carcinoma (EC)"
      ],
      "interventions": [
        "GV20-0251"
      ],
      "sponsor": "GV20 Therapeutics",
      "enrollment": 350,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT07133425",
      "title": "A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer",
      "brief_title": "A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer",
        "ICI-refractory"
      ],
      "interventions": [
        "SAR445877"
      ],
      "sponsor": "M.D. Anderson Cancer Center",
      "enrollment": 29,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07207278",
      "title": "Multi Omics Molecular Characteristics and Immunophenotyping of Lung Signet Ring Cell Carcinoma",
      "brief_title": "Multi Omics Molecular Characteristics and Immunophenotyping of Lung Signet Ring Cell Carcinoma",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Signet Ring Cell Carcinoma of the Lung"
      ],
      "interventions": [
        "Patients with specific TIME subtype and ALK fusion mutations (confirmed via RNA-seq and OncoKB annotation) will receive tyrosine kinase inhibitors (TKIs, e.g., alectinib or crizotinib) as first-line"
      ],
      "sponsor": "First People's Hospital of Hangzhou",
      "enrollment": 39,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Signet Ring Cell Carcinoma'",
        "cond='Signet Ring Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07219576",
      "title": "Retifanlimab and Ruxolitinib In Solid Malignancies",
      "brief_title": "Retifanlimab and Ruxolitinib In Solid Malignancies",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Non Small Cell Lung Carcinoma",
        "Renal Cell Carcinoma"
      ],
      "interventions": [
        "Ruxolitinib",
        "Retifanlimab"
      ],
      "sponsor": "University of California, San Diego",
      "enrollment": 40,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04119024",
      "title": "Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors",
      "brief_title": "Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Metastatic Malignant Solid Neoplasm",
        "Metastatic Melanoma",
        "Pathologic Stage IIIC Cutaneous Melanoma AJCC v8"
      ],
      "interventions": [
        "Biopsy",
        "Biospecimen Collection",
        "Computed Tomography",
        "Cyclophosphamide"
      ],
      "sponsor": "Anusha Kalbasi",
      "enrollment": 18,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT04485013",
      "title": "TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers",
      "brief_title": "TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Cancer"
      ],
      "interventions": [
        "TTX-080",
        "TTX-080",
        "pembrolizumab",
        "cetuximab"
      ],
      "sponsor": "Tizona Therapeutics, Inc",
      "enrollment": 240,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT04999761",
      "title": "AB122 Platform Study",
      "brief_title": "AB122 Platform Study",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced or Metastatic Solid Tumor",
        "Pancreatic Ductal Adenocarcinoma",
        "Colorectal Cancer"
      ],
      "interventions": [
        "AB122",
        "AB122",
        "TAS-116",
        "AB122"
      ],
      "sponsor": "Taiho Pharmaceutical Co., Ltd.",
      "enrollment": 917,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05176483",
      "title": "Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors",
      "brief_title": "Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Renal Cell Carcinoma (RCC)",
        "Metastatic Castration-Resistant Prostate Cancer (mCRPC)",
        "Urothelial Carcinoma (UC)"
      ],
      "interventions": [
        "Zanzalintinib",
        "Nivolumab",
        "Ipilimumab",
        "Nivolumab"
      ],
      "sponsor": "Exelixis",
      "enrollment": 1314,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05208762",
      "title": "A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors",
      "brief_title": "A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Carcinoma, Non-Small-Cell Lung",
        "Squamous Cell Carcinoma of the Head and Neck",
        "Esophageal Squamous Cell Carcinoma"
      ],
      "interventions": [
        "PF-08046054",
        "pembrolizumab"
      ],
      "sponsor": "Seagen, a wholly owned subsidiary of Pfizer",
      "enrollment": 714,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05538130",
      "title": "A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors",
      "brief_title": "A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Melanoma",
        "Glioma",
        "Thyroid Cancer"
      ],
      "interventions": [
        "PF-07799544",
        "PF-07799933"
      ],
      "sponsor": "Pfizer",
      "enrollment": 124,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05783622",
      "title": "Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies",
      "brief_title": "Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer",
        "Renal Cell Carcinoma",
        "Squamous Cell Carcinoma of the Head and Neck"
      ],
      "interventions": [
        "JANX008"
      ],
      "sponsor": "Janux Therapeutics",
      "enrollment": 130,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06126406",
      "title": "Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors",
      "brief_title": "Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Gastric Cancer",
        "Colon Cancer",
        "Rectal Cancer"
      ],
      "interventions": [
        "CEA-targeted CAR-T cells",
        "CEA-targeted CAR-T cells"
      ],
      "sponsor": "Chongqing Precision Biotech Co., Ltd",
      "enrollment": 60,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06150664",
      "title": "A Phase 1 of CTX-8371 in Patients With Advanced Malignancies",
      "brief_title": "A Phase 1 of CTX-8371 in Patients With Advanced Malignancies",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer",
        "Triple Negative Breast Cancer",
        "Hodgkin Lymphoma"
      ],
      "interventions": [
        "CTX-8371"
      ],
      "sponsor": "Compass Therapeutics",
      "enrollment": 73,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06266299",
      "title": "A Study of KK2269 in Adult Participants With Solid Tumors",
      "brief_title": "A Study of KK2269 in Adult Participants With Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced Solid Tumor",
        "Metastatic Solid Tumor",
        "Gastric Adenocarcinoma"
      ],
      "interventions": [
        "KK2269",
        "Docetaxel"
      ],
      "sponsor": "Kyowa Kirin Co., Ltd.",
      "enrollment": 101,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06393400",
      "title": "CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC)",
      "brief_title": "CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC)",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Unresectable or Metastatic Advanced Pancreatic Ductal Adenocarcinoma"
      ],
      "interventions": [
        "Fecal Microbiota Transplantation",
        "PEG3350",
        "Gemcitabine",
        "nab-Paclitaxel"
      ],
      "sponsor": "John Lenehan",
      "enrollment": 20,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06484816",
      "title": "TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies",
      "brief_title": "TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer",
        "Advanced Solid Tumor",
        "Hematologic Malignancy"
      ],
      "interventions": [
        "TGRX-1942"
      ],
      "sponsor": "Shenzhen TargetRx, Inc.",
      "enrollment": 90,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06508307",
      "title": "A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors",
      "brief_title": "A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Sarcoma",
        "Cervical Cancer",
        "Colon Cancer"
      ],
      "interventions": [
        "A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patients With Advanced Solid Tumors"
      ],
      "sponsor": "GONGCHU Biotechnology Co., Ltd",
      "enrollment": 21,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06577987",
      "title": "Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies",
      "brief_title": "Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced Solid Tumor",
        "Metastatic Solid Tumor",
        "Refractory Solid Tumor"
      ],
      "interventions": [
        "CID-078 Monotherapy"
      ],
      "sponsor": "Circle Pharma",
      "enrollment": 220,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06767514",
      "title": "Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1",
      "brief_title": "Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "Ivonescimab Injection",
        "Pembrolizumab Injection"
      ],
      "sponsor": "Summit Therapeutics",
      "enrollment": 780,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 High Lung Cancer'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06917079",
      "title": "BBO-11818 in Adult Subjects With KRAS Mutant Cancer",
      "brief_title": "BBO-11818 in Adult Subjects With KRAS Mutant Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer",
        "NSCLC",
        "PDAC - Pancreatic Ductal Adenocarcinoma"
      ],
      "interventions": [
        "BBO-11818",
        "Pembrolizumab",
        "Platinum chemotherapy (cisplatin or carboplatin)",
        "Pemetrexed"
      ],
      "sponsor": "TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)",
      "enrollment": 387,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT07020117",
      "title": "A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors",
      "brief_title": "A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Urothelial Carcinoma Bladder",
        "Triple Negative Breast Cancer (TNBC)",
        "Hormone Receptor Positive Breast Adenocarcinoma"
      ],
      "interventions": [
        "[225Ac]Ac-AKY-1189 (therapeutic)",
        "[64Cu]Cu-AKY-1189 (imaging)"
      ],
      "sponsor": "Aktis Oncology, Inc.",
      "enrollment": 150,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT07334119",
      "title": "Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors",
      "brief_title": "Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "HER2-Expressing Solid Tumors"
      ],
      "interventions": [
        "MT-304",
        "MT-304 + Nivolumab"
      ],
      "sponsor": "Myeloid Therapeutics",
      "enrollment": 60,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT02146170",
      "title": "Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors",
      "brief_title": "Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Non-Small Cell Lung Cancer",
        "Small Cell Lung Cancer",
        "Extrapulmonary Small Cell Cancer"
      ],
      "interventions": [],
      "sponsor": "National Cancer Institute (NCI)",
      "enrollment": 2000,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT03958240",
      "title": "Deciphering Mechanisms Underlying Cancer Immunogenicity",
      "brief_title": "Deciphering Mechanisms Underlying Cancer Immunogenicity",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Head and Neck Cancer",
        "Ovarian Cancer",
        "Cervical Cancer"
      ],
      "interventions": [
        "Blood samples, tumor biopsy specimens and ascites samples will be collected."
      ],
      "sponsor": "Institut Claudius Regaud",
      "enrollment": 1100,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04314401",
      "title": "National Cancer Institute \"Cancer Moonshot Biobank\"",
      "brief_title": "National Cancer Institute \"Cancer Moonshot Biobank\"",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Acute Myeloid Leukemia",
        "Anatomic Stage III Breast Cancer AJCC v8",
        "Anatomic Stage IV Breast Cancer AJCC v8"
      ],
      "interventions": [
        "Biospecimen Collection",
        "Computed Tomography",
        "Magnetic Resonance Imaging",
        "Medical Chart Review"
      ],
      "sponsor": "National Cancer Institute (NCI)",
      "enrollment": 1600,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04631770",
      "title": "Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLC",
      "brief_title": "Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLC",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Neoplasms",
        "Lymph Node Excision"
      ],
      "interventions": [
        "Systemic mediastinal lymph node dissection",
        "Spared mediastinal lymph node dissection"
      ],
      "sponsor": "Tianjin Medical University Cancer Institute and Hospital",
      "enrollment": 1362,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04926584",
      "title": "Prospective Trial of Induction Immunotherapy in Locally Advanced or Oligometastatic NSCLC Without a Primary Curative Option",
      "brief_title": "Prospective Trial of Induction Immunotherapy in Locally Advanced or Oligometastatic NSCLC Without a Primary Curative Option",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Carcinoma, Non-Small-Cell Lung"
      ],
      "interventions": [
        "induction therapy"
      ],
      "sponsor": "Klinikum Esslingen",
      "enrollment": 50,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05461430",
      "title": "Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)",
      "brief_title": "Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Pleural Effusion, Malignant",
        "Ascites, Malignant",
        "Carcinoma"
      ],
      "interventions": [],
      "sponsor": "Travera Inc",
      "enrollment": 200,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05502523",
      "title": "The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer",
      "brief_title": "The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Non-Small Cell Carcinoma",
        "Stage I Lung Cancer AJCC v8",
        "Stage II Lung Cancer AJCC v8"
      ],
      "interventions": [
        "Pulmonary Artery-First Surgical Technique",
        "Biospecimen Collection"
      ],
      "sponsor": "Thomas Jefferson University",
      "enrollment": 100,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05703269",
      "title": "Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy",
      "brief_title": "Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "NSCLC",
        "Renal Cell Carcinoma",
        "Breast Carcinoma"
      ],
      "interventions": [
        "single fraction stereotactic radiosurgery (SSRS)",
        "fractionated stereotactic radiosurgery (FSRS)"
      ],
      "sponsor": "Wake Forest University Health Sciences",
      "enrollment": 244,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06122064",
      "title": "A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer",
      "brief_title": "A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Non-Small Cell Carcinoma",
        "Stage II Lung Cancer AJCC v8",
        "Stage III Lung Cancer AJCC v8"
      ],
      "interventions": [
        "Best Practice",
        "Communication Intervention",
        "Electronic Health Record Review",
        "Survey Administration"
      ],
      "sponsor": "Mayo Clinic",
      "enrollment": 100,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06250829",
      "title": "Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer",
      "brief_title": "Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Non-small Cell Lung Cancer Stage IB (Resectable)",
        "Non-small Cell Lung Cancer Stage II (Resectable)",
        "Non-small Cell Lung Cancer Stage ⅢA (Resectable)"
      ],
      "interventions": [
        "Observational"
      ],
      "sponsor": "London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's",
      "enrollment": 60,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06349642",
      "title": "Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform",
      "brief_title": "Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Early Stage Triple-Negative Breast Carcinoma",
        "Metastatic Bladder Urothelial Carcinoma",
        "Metastatic Cervical Carcinoma"
      ],
      "interventions": [
        "Biospecimen Collection",
        "Tissue Collection"
      ],
      "sponsor": "Mayo Clinic",
      "enrollment": 324,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06513663",
      "title": "Exercise as Maintenance Therapy in Advanced Lung Cancer",
      "brief_title": "Exercise as Maintenance Therapy in Advanced Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Cancer",
        "Non Small Cell Lung Cancer",
        "Metastatic Lung Cancer"
      ],
      "interventions": [
        "Exercise Intervention"
      ],
      "sponsor": "Indiana University",
      "enrollment": 100,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06555588",
      "title": "Engage Psychosocial Intervention for Cancer Symptoms",
      "brief_title": "Engage Psychosocial Intervention for Cancer Symptoms",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Advanced Breast Cancer",
        "Advanced Prostate Cancer",
        "Advanced Lung Cancer"
      ],
      "interventions": [
        "ENGAGE",
        "Supportive Care"
      ],
      "sponsor": "Duke University",
      "enrollment": 190,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06716437",
      "title": "Prehabilitation for Patients Undergoing Lung Cancer Surgery",
      "brief_title": "Prehabilitation for Patients Undergoing Lung Cancer Surgery",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Cancer (NSCLC)"
      ],
      "interventions": [
        "Prehabilitation"
      ],
      "sponsor": "University of Melbourne",
      "enrollment": 25,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06843707",
      "title": "Establishing a Longitudinal Cohort Study of Lung Cancer Using Tissue and Peripheral Blood Metabolomics.",
      "brief_title": "Establishing a Longitudinal Cohort Study of Lung Cancer Using Tissue and Peripheral Blood Metabolomics.",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Cancer",
        "Lung",
        "Lung Cancer (NSCLC)"
      ],
      "interventions": [
        "Monitoring serum metabolites in lung cancer patients using tissue and peripheral blood samples."
      ],
      "sponsor": "The First Affiliated Hospital of Guangzhou Medical University",
      "enrollment": 2500,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07039994",
      "title": "Early Palliative Care in Patients With Advanced Lung Cancer Using an e-Health Ecosystem",
      "brief_title": "Early Palliative Care in Patients With Advanced Lung Cancer Using an e-Health Ecosystem",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "Standard intervention",
        "E-health intervention"
      ],
      "sponsor": "Jesús González",
      "enrollment": 200,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07057102",
      "title": "Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer",
      "brief_title": "Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Non Small Cell Lung Cancer"
      ],
      "interventions": [],
      "sponsor": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences",
      "enrollment": 40,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07188480",
      "title": "The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients",
      "brief_title": "The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer NSCLC"
      ],
      "interventions": [
        "bronchial lavage for NGS analysis"
      ],
      "sponsor": "IRCCS Azienda Ospedaliero-Universitaria di Bologna",
      "enrollment": 10,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07325864",
      "title": "Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site",
      "brief_title": "Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "NSCLC",
        "Lung Cancer (Diagnosis)"
      ],
      "interventions": [],
      "sponsor": "European Institute of Oncology",
      "enrollment": 25,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT01804686",
      "title": "A Long-term Extension Study of PCI-32765 (Ibrutinib)",
      "brief_title": "A Long-term Extension Study of PCI-32765 (Ibrutinib)",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Chronic Lymphocytic Leukemia",
        "Small Lymphocytic Lymphoma",
        "Mantle Cell Lymphoma"
      ],
      "interventions": [
        "Ibrutinib"
      ],
      "sponsor": "Janssen Research & Development, LLC",
      "enrollment": 700,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT02133196",
      "title": "T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer",
      "brief_title": "T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Advanced Non-Small Cell Lung Cancer",
        "Squamous Cell Carcinoma",
        "Advanced NSCLC"
      ],
      "interventions": [
        "Aldesleukin",
        "Fludarabine",
        "Cyclophosphamide",
        "Young TIL"
      ],
      "sponsor": "National Cancer Institute (NCI)",
      "enrollment": 85,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT03476681",
      "title": "Study of NEO-201 in Solid Tumors Expansion Cohorts",
      "brief_title": "Study of NEO-201 in Solid Tumors Expansion Cohorts",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer",
        "Head and Neck Squamous Cell Carcinoma",
        "Cervical Cancer"
      ],
      "interventions": [
        "NEO-201 in combination with pembrolizumab"
      ],
      "sponsor": "Precision Biologics, Inc",
      "enrollment": 121,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT03924466",
      "title": "Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients",
      "brief_title": "Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Metastatic Breast Carcinoma",
        "Locally Advanced Breast Cancer",
        "Cancer of Pancreas"
      ],
      "interventions": [
        "68GaNOTA-Anti-HER2 VHH1"
      ],
      "sponsor": "Universitair Ziekenhuis Brussel",
      "enrollment": 55,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT04370587",
      "title": "A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors",
      "brief_title": "A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Solid Tumor",
        "Melanoma",
        "HNSCC"
      ],
      "interventions": [
        "T3011",
        "T3011 + pembrolizumab"
      ],
      "sponsor": "ImmVira Pharma Co. Ltd",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04686682",
      "title": "A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors",
      "brief_title": "A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "NSCLC",
        "SCLC",
        "CRPC"
      ],
      "interventions": [
        "JAB-8263",
        "JAB-8263"
      ],
      "sponsor": "Jacobio Pharmaceuticals Co., Ltd.",
      "enrollment": 152,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04771520",
      "title": "Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors",
      "brief_title": "Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Anatomic Stage IV Breast Cancer AJCC v8",
        "Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8",
        "Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8"
      ],
      "interventions": [
        "Avapritinib"
      ],
      "sponsor": "M.D. Anderson Cancer Center",
      "enrollment": 50,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Stage IVA Lung Cancer'",
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT04895709",
      "title": "A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors",
      "brief_title": "A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Cervical Cancer",
        "Gastric/Gastroesophageal Junction Adenocarcinoma",
        "Microsatellite Stable Colorectal Cancer"
      ],
      "interventions": [
        "BMS-986340",
        "BMS-936558-01",
        "Docetaxel"
      ],
      "sponsor": "Bristol-Myers Squibb",
      "enrollment": 949,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT04928846",
      "title": "A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)",
      "brief_title": "A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer"
      ],
      "interventions": [
        "Telisotuzumab Vedotin",
        "Docetaxel"
      ],
      "sponsor": "AbbVie",
      "enrollment": 698,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='EGFR Wild-Type NSCLC'",
        "cond='Wild Type NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05086692",
      "title": "A Beta-only IL-2 ImmunoTherapY Study",
      "brief_title": "A Beta-only IL-2 ImmunoTherapY Study",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced Solid Tumor",
        "Unresectable Solid Tumor",
        "Clear Cell Renal Cell Carcinoma"
      ],
      "interventions": [
        "MDNA11",
        "Pembrolizumab (KEYTRUDA®)"
      ],
      "sponsor": "Medicenna Therapeutics, Inc.",
      "enrollment": 115,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05208944",
      "title": "THIO Sequenced With Cemiplimab in Advanced NSCLC",
      "brief_title": "THIO Sequenced With Cemiplimab in Advanced NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Carcinoma, Non-Small-Cell Lung"
      ],
      "interventions": [
        "6-Thio-2'-Deoxyguanosine",
        "Cemiplimab"
      ],
      "sponsor": "Maia Biotechnology",
      "enrollment": 227,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05269381",
      "title": "Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors",
      "brief_title": "Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Anatomic Stage III Breast Cancer AJCC v8",
        "Anatomic Stage IIIA Breast Cancer AJCC v8",
        "Anatomic Stage IIIB Breast Cancer AJCC v8"
      ],
      "interventions": [
        "Cyclophosphamide",
        "Neoantigen Peptide Vaccine",
        "Pembrolizumab",
        "Sargramostim"
      ],
      "sponsor": "Mayo Clinic",
      "enrollment": 36,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Stage IVA Lung Cancer'",
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05276726",
      "title": "A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1",
      "brief_title": "A Study of JAB-21822 in Advanced or Metastatic NSCLC With KRAS p.G12C and STK11 Co-mutation and Wild-type KEAP1",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "JAB 21822"
      ],
      "sponsor": "Allist Pharmaceuticals, Inc.",
      "enrollment": 104,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='KRAS Wild-Type NSCLC'",
        "cond='Wild Type NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05288205",
      "title": "Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation",
      "brief_title": "Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "KRAS P.G12C",
        "Non-small Cell Lung Cancer",
        "Colorectal Cancer"
      ],
      "interventions": [
        "JAB-21822",
        "JAB-3312"
      ],
      "sponsor": "Allist Pharmaceuticals, Inc.",
      "enrollment": 240,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05456256",
      "title": "A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma",
      "brief_title": "A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Adenocarcinoma of Lung",
        "Carcinoma, Non-Small-Cell Lung"
      ],
      "interventions": [
        "LP-300",
        "Pemetrexed",
        "Carboplatin"
      ],
      "sponsor": "Lantern Pharma Inc.",
      "enrollment": 90,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05631249",
      "title": "Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C",
      "brief_title": "Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "KRAS P.G12C",
        "Non Small Cell Lung Cancer"
      ],
      "interventions": [
        "Sotorasib 120Mg Tab"
      ],
      "sponsor": "Gustave Roussy, Cancer Campus, Grand Paris",
      "enrollment": 40,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05652686",
      "title": "A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)",
      "brief_title": "A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Small Cell Lung Cancer (SCLC)",
        "Large Cell Neuroendocrine Cancer (LCNEC)",
        "Neuroendocrine Prostate Cancer (NEPC)"
      ],
      "interventions": [
        "Peluntamig (PT217)",
        "Carboplatin + Etoposide",
        "Paclitaxel.",
        "Atezolizumab"
      ],
      "sponsor": "Phanes Therapeutics",
      "enrollment": 203,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT05706129",
      "title": "A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors",
      "brief_title": "A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Clear Cell Renal Cell Cancer (ccRCC)",
        "Pancreatic Ductal Adenocarcinoma (PDAC)",
        "Colorectal Cancer (CRC)"
      ],
      "interventions": [
        "[68Ga]Ga-DPI-4452",
        "[177Lu]Lu-DPI-4452"
      ],
      "sponsor": "ITM Oncologics GmbH",
      "enrollment": 270,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05765877",
      "title": "Neoadjuvant WX-0593 in Resectable ALK-positive or ROS1-positive Non-small Cell Lung Cancer",
      "brief_title": "Neoadjuvant WX-0593 in Resectable ALK-positive or ROS1-positive Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer(NSCLC)"
      ],
      "interventions": [
        "WX-0593 Tablets"
      ],
      "sponsor": "Pingping Song",
      "enrollment": 26,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05777278",
      "title": "Savolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET Overexpression",
      "brief_title": "Savolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET Overexpression",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Savolitinib",
        "Docetaxel"
      ],
      "sponsor": "The First Affiliated Hospital of Guangzhou Medical University",
      "enrollment": 29,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='EGFR Wild-Type NSCLC'",
        "cond='Wild Type NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05910827",
      "title": "Study of an Anti-HER3 Antibody, HMBD-001, With Docetaxel +/- Cetuximab in Advanced Squamous Non-small Cell Lung Cancers, and HMBD-001 + Cetuximab in Advanced Squamous Cell Cancers",
      "brief_title": "Study of an Anti-HER3 Antibody, HMBD-001, With Docetaxel +/- Cetuximab in Advanced Squamous Non-small Cell Lung Cancers, and HMBD-001 + Cetuximab in Advanced Squamous Cell Cancers",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced or Metastatic Squamous Non-Small Cell Lung Cancer",
        "Advanced Head and Neck Squamous Cell Carcinoma",
        "Advanced Esophageal Squamous Cell Carcinoma"
      ],
      "interventions": [
        "HMBD-001",
        "Docetaxel",
        "Cetuximab"
      ],
      "sponsor": "Hummingbird Bioscience",
      "enrollment": 98,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06015724",
      "title": "Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer",
      "brief_title": "Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Pancreatic Ductal Adenocarcinoma",
        "Refractory Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "Daratumumab",
        "KRAS vaccine",
        "Nivolumab"
      ],
      "sponsor": "Georgetown University",
      "enrollment": 54,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT06031181",
      "title": "Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)",
      "brief_title": "Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Lung Adenocarcinoma",
        "Frozen Section",
        "Sublobar Resection"
      ],
      "interventions": [
        "Sublobar Resection"
      ],
      "sponsor": "Fudan University",
      "enrollment": 390,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT06041776",
      "title": "Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations",
      "brief_title": "Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer",
        "EGFR Sensitive Mutation",
        "Adjuvant Therapy"
      ],
      "interventions": [
        "Befotertinib + Icotinib placebo",
        "Icotinib + Befotertinib placebo"
      ],
      "sponsor": "Betta Pharmaceuticals Co., Ltd.",
      "enrollment": 570,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06107686",
      "title": "A Study of YL202 in Selected Patients With Advanced Solid Tumors",
      "brief_title": "A Study of YL202 in Selected Patients With Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "NSCLC",
        "Breast Cancer",
        "HNSCC"
      ],
      "interventions": [
        "YL202 should be intravenously infused"
      ],
      "sponsor": "MediLink Therapeutics (Suzhou) Co., Ltd.",
      "enrollment": 200,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06281678",
      "title": "A Study of IBI363 in Subjects with Advanced Solid Malignancies",
      "brief_title": "A Study of IBI363 in Subjects with Advanced Solid Malignancies",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Melanoma",
        "Non-small Cell Lung Cancer",
        "Colorectal Cancer"
      ],
      "interventions": [
        "IBI363"
      ],
      "sponsor": "Innovent Biologics (Suzhou) Co. Ltd.",
      "enrollment": 178,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06283719",
      "title": "Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer",
      "brief_title": "Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Small Cell Lung Cancer",
        "Neuroendocrine Cancer"
      ],
      "interventions": [
        "ZG006"
      ],
      "sponsor": "Suzhou Zelgen Biopharmaceuticals Co.,Ltd",
      "enrollment": 265,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06345729",
      "title": "A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)",
      "brief_title": "A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Calderasib",
        "Placebo",
        "Pembrolizumab"
      ],
      "sponsor": "Merck Sharp & Dohme LLC",
      "enrollment": 600,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06394674",
      "title": "High-dose Furmonertinib in the Treatment in Patients With Advanced, Metastatic NSCLC With Progressed After First- or Second-line Treatment With Osimertinib",
      "brief_title": "High-dose Furmonertinib in the Treatment in Patients With Advanced, Metastatic NSCLC With Progressed After First- or Second-line Treatment With Osimertinib",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "Furmonertinib"
      ],
      "sponsor": "Changhai Hospital",
      "enrollment": 84,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06440057",
      "title": "Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma.",
      "brief_title": "Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma.",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Neuroendocrine Carcinoma"
      ],
      "interventions": [
        "ZG006"
      ],
      "sponsor": "Suzhou Zelgen Biopharmaceuticals Co.,Ltd",
      "enrollment": 78,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06495125",
      "title": "Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer",
      "brief_title": "Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Advanced Lung Adenocarcinoma",
        "Refractory Lung Adenocarcinoma",
        "Stage III Lung Cancer AJCC v8"
      ],
      "interventions": [
        "Avutometinib",
        "Biopsy",
        "Biospecimen Collection",
        "Computed Tomography"
      ],
      "sponsor": "Emory University",
      "enrollment": 50,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06528847",
      "title": "Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma",
      "brief_title": "Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "Benmelstobart"
      ],
      "sponsor": "Shanghai Pulmonary Hospital, Shanghai, China",
      "enrollment": 62,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06568939",
      "title": "A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)",
      "brief_title": "A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "Telisotuzumab Vedotin"
      ],
      "sponsor": "AbbVie",
      "enrollment": 150,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='EGFR Wild-Type NSCLC'",
        "cond='Wild Type NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06581419",
      "title": "A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors",
      "brief_title": "A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced Malignant Neoplasm",
        "Advanced or Metastatic Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "IAP0971"
      ],
      "sponsor": "SUNHO（China）BioPharmaceutical CO., Ltd.",
      "enrollment": 78,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06686771",
      "title": "Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer",
      "brief_title": "Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "SBRT",
        "Second-line standard of care therapy"
      ],
      "sponsor": "Canadian Cancer Trials Group",
      "enrollment": 320,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06718309",
      "title": "Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC",
      "brief_title": "Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "Chemotherapy",
        "Immunotherapy",
        "Radical resection of lung cancer",
        "SBRT"
      ],
      "sponsor": "First People's Hospital of Hangzhou",
      "enrollment": 40,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced NSCLC'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06749886",
      "title": "An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line Setting",
      "brief_title": "An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line Setting",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Lung Cancer"
      ],
      "interventions": [
        "Denosumab",
        "tislelizumab",
        "Docetaxel"
      ],
      "sponsor": "Shanghai Pulmonary Hospital, Shanghai, China",
      "enrollment": 22,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='ALK Negative NSCLC'",
        "cond='ROS1 Negative NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06777316",
      "title": "A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors",
      "brief_title": "A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Intrahepatic Cholangiocarcinoma (Icc)",
        "Cholangiocarcinoma",
        "Other Solid Tumors, Adult"
      ],
      "interventions": [
        "CGT4859"
      ],
      "sponsor": "Cogent Biosciences, Inc.",
      "enrollment": 110,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06780098",
      "title": "Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)",
      "brief_title": "Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Lung Neoplasm"
      ],
      "interventions": [
        "R-DXD",
        "I-DXD",
        "Docetaxel"
      ],
      "sponsor": "Merck Sharp & Dohme LLC",
      "enrollment": 144,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06810544",
      "title": "Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss",
      "brief_title": "Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer",
        "Glioma Glioblastoma Multiforme",
        "Glioma, Malignant"
      ],
      "interventions": [
        "TNG456",
        "abemaciclib"
      ],
      "sponsor": "Tango Therapeutics, Inc.",
      "enrollment": 191,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT06814496",
      "title": "Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors",
      "brief_title": "Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Melanoma",
        "Medullary Thyroid Cancer",
        "Sinonasal Undifferentiated Carcinoma"
      ],
      "interventions": [
        "Tarlatamab",
        "Concurrent Radiation Therapy",
        "Sequential Radiation therapy"
      ],
      "sponsor": "University of Arizona",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT06877299",
      "title": "Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer",
      "brief_title": "Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Lung Cancer",
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Low-Dose Radiation(LDRT) + Stereotactic body radiotherapy (SBRT)"
      ],
      "sponsor": "Sichuan University",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06881784",
      "title": "Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)",
      "brief_title": "Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "NSCLC (Non-small Cell Lung Cancer)",
        "Non-Small Cell Lung Cancer",
        "NSCLC"
      ],
      "interventions": [
        "daraxonrasib",
        "docetaxel"
      ],
      "sponsor": "Revolution Medicines, Inc.",
      "enrollment": 420,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06899126",
      "title": "Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer",
      "brief_title": "Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Trastuzumab Deruxtecan",
        "pembrolizumab",
        "Pemetrexed",
        "Chemotherapy"
      ],
      "sponsor": "Daiichi Sankyo",
      "enrollment": 686,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06908304",
      "title": "A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC",
      "brief_title": "A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Carcinoma, Non-Small -Cell Lung"
      ],
      "interventions": [
        "6-Thio-2'-Deoxyguanosine",
        "Cemiplimab",
        "Docetaxel",
        "Vinorelbine"
      ],
      "sponsor": "Maia Biotechnology",
      "enrollment": 300,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06923761",
      "title": "EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)",
      "brief_title": "EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced Solid Malignancy"
      ],
      "interventions": [
        "Module 1 (GRWD5769 on its own as monotherapy)",
        "Module 2 (GRWD5769 in combination with cemiplimab, administered IV)"
      ],
      "sponsor": "Grey Wolf Therapeutics",
      "enrollment": 300,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06937905",
      "title": "Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs)",
      "brief_title": "Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs)",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Neuroendocrine Carcinoma"
      ],
      "interventions": [
        "Standard of Care Chemotherapy",
        "Tarlatamab"
      ],
      "sponsor": "Intergroupe Francophone de Cancerologie Thoracique",
      "enrollment": 129,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06953089",
      "title": "DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors",
      "brief_title": "DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Solid Tumors"
      ],
      "interventions": [
        "DB-1311/BNT324",
        "BNT327",
        "DB-1305/BNT325"
      ],
      "sponsor": "DualityBio Inc.",
      "enrollment": 492,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06962865",
      "title": "A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC",
      "brief_title": "A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "RC108",
        "Furmonertinib Mesilate Tablets Monotherapy"
      ],
      "sponsor": "RemeGen Co., Ltd.",
      "enrollment": 80,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06974604",
      "title": "Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM",
      "brief_title": "Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Breast Neoplasms",
        "Lung Neoplasms"
      ],
      "interventions": [
        "Dexamethasone oral"
      ],
      "sponsor": "Brown University",
      "enrollment": 60,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07038096",
      "title": "ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma",
      "brief_title": "ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Small Cell Lung Cancer",
        "Neuroendocrine Carcinoma"
      ],
      "interventions": [
        "ZG006",
        "ZG005"
      ],
      "sponsor": "Suzhou Zelgen Biopharmaceuticals Co.,Ltd",
      "enrollment": 350,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT07058519",
      "title": "A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC",
      "brief_title": "A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)"
      ],
      "interventions": [
        "Osimertinib-based adaptive treatment",
        "Osimertinib 80 MG"
      ],
      "sponsor": "Shanghai Chest Hospital",
      "enrollment": 250,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07223047",
      "title": "A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies",
      "brief_title": "A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced Solid Malignancies",
        "Non-small Cell Lung Cancer (NSCLC)",
        "Colorectal Cancer (CRC)"
      ],
      "interventions": [
        "BMS-986523",
        "Gemcitabine",
        "Nab-Paclitaxel",
        "Cetuximab"
      ],
      "sponsor": "Bristol-Myers Squibb",
      "enrollment": 252,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT07264647",
      "title": "Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)",
      "brief_title": "Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Stage III NSCLC"
      ],
      "interventions": [
        "Tislelizumab",
        "surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines",
        "Chemoradiotherapy"
      ],
      "sponsor": "Fondazione Ricerca Traslazionale",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 Positive Lung Cancer'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT03198546",
      "title": "GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression",
      "brief_title": "GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Hepatocellular Carcinoma",
        "Immunotherapy",
        "CAR"
      ],
      "interventions": [
        "GPC3 and/or TGFβ targeting CAR-T cells"
      ],
      "sponsor": "Second Affiliated Hospital of Guangzhou Medical University",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04084067",
      "title": "Indocyanine Green (ICG) Guided Tumor Resection",
      "brief_title": "Indocyanine Green (ICG) Guided Tumor Resection",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Neoplastic Disease",
        "Solid Tumor"
      ],
      "interventions": [
        "Indocyanine Green"
      ],
      "sponsor": "St. Jude Children's Research Hospital",
      "enrollment": 230,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT04762199",
      "title": "MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer",
      "brief_title": "MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced Lung Non-Small Cell Carcinoma",
        "Metastatic Lung Non-Small Cell Carcinoma",
        "Stage IV Lung Cancer AJCC v8"
      ],
      "interventions": [
        "Flt3/MerTK Inhibitor MRX-2843",
        "Osimertinib"
      ],
      "sponsor": "Emory University",
      "enrollment": 69,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Stage IVA Lung Cancer'",
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04777994",
      "title": "Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors",
      "brief_title": "Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced Solid Tumor Cancer"
      ],
      "interventions": [
        "ABBV-CLS-484",
        "Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor (TKI)",
        "Programmed Cell Death-1 (PD-1) Inhibitor"
      ],
      "sponsor": "Calico Life Sciences LLC",
      "enrollment": 248,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05076760",
      "title": "MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors",
      "brief_title": "MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Solid Tumor",
        "Advanced Cancer",
        "Metastatic Cancer"
      ],
      "interventions": [
        "MEM-288 Intratumoral Injection",
        "Nivolumab",
        "Docetaxel"
      ],
      "sponsor": "Memgen, Inc.",
      "enrollment": 40,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05277051",
      "title": "First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors",
      "brief_title": "First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Neoplasms"
      ],
      "interventions": [
        "Remzistotug",
        "Dostarlimab",
        "Belrestotug",
        "Nelistotug"
      ],
      "sponsor": "GlaxoSmithKline",
      "enrollment": 158,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05764954",
      "title": "A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma",
      "brief_title": "A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Adenocarcinoma of Lung"
      ],
      "interventions": [
        "NovoTTF-200T System"
      ],
      "sponsor": "Memorial Sloan Kettering Cancer Center",
      "enrollment": 25,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT05873686",
      "title": "A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers",
      "brief_title": "A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced Solid Tumor",
        "NSCLC (Non-small Cell Lung Cancer)",
        "Renal Cancer"
      ],
      "interventions": [
        "NXP900"
      ],
      "sponsor": "Nuvectis Pharma, Inc.",
      "enrollment": 140,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06010862",
      "title": "Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors",
      "brief_title": "Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Gastric Cancer",
        "Colon Cancer",
        "Pancreas Cancer"
      ],
      "interventions": [
        "CEA CAR-T cells",
        "CEA CAR-T cells"
      ],
      "sponsor": "Chongqing Precision Biotech Co., Ltd",
      "enrollment": 36,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06026410",
      "title": "KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors",
      "brief_title": "KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Solid Tumors With HRAS Alterations",
        "Non Small Cell Lung Cancer (NSCLC)",
        "Colorectal Cancer (CRC)"
      ],
      "interventions": [
        "Darlifarnib",
        "Cabozantinib",
        "Adagrasib"
      ],
      "sponsor": "Kura Oncology, Inc.",
      "enrollment": 300,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06050980",
      "title": "Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation",
      "brief_title": "Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "NSCLC"
      ],
      "interventions": [
        "HSK40118"
      ],
      "sponsor": "Haisco Pharmaceutical Group Co., Ltd.",
      "enrollment": 220,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06147037",
      "title": "A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours",
      "brief_title": "A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced Solid Tumor",
        "Metastatic Colorectal Carcinoma",
        "Head and Neck Squamous Cell Carcinoma"
      ],
      "interventions": [
        "FPI-2053",
        "[111In]-FPI-2107",
        "[225Ac]-FPI-2068"
      ],
      "sponsor": "AstraZeneca",
      "enrollment": 70,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06179160",
      "title": "A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation",
      "brief_title": "A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Solid Tumors"
      ],
      "interventions": [
        "INCB161734",
        "Cetuximab",
        "Retifanlimab",
        "GEMNabP"
      ],
      "sponsor": "Incyte Corporation",
      "enrollment": 710,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06238479",
      "title": "A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors",
      "brief_title": "A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Metastatic Solid Tumor",
        "Recurrent Solid Tumor",
        "Advanced Solid Tumor"
      ],
      "interventions": [
        "LY4101174"
      ],
      "sponsor": "Eli Lilly and Company",
      "enrollment": 490,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06242470",
      "title": "A Study of MGC026 in Participants With Advanced Solid Tumors",
      "brief_title": "A Study of MGC026 in Participants With Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced Solid Tumor",
        "Advanced Cancer",
        "Metastatic Cancer"
      ],
      "interventions": [
        "MGC026 Dose Escalation",
        "MGC026 Dose for Expansion"
      ],
      "sponsor": "MacroGenics",
      "enrollment": 250,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06343402",
      "title": "Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer",
      "brief_title": "Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer",
        "Metastatic Non-Small Cell Lung Cancer",
        "NSCLC"
      ],
      "interventions": [
        "BBO-8520",
        "Pembrolizumab"
      ],
      "sponsor": "TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)",
      "enrollment": 250,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06357533",
      "title": "Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations",
      "brief_title": "Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "Datopotamab Deruxtecan",
        "Rilvegostomig",
        "Pembrolizumab"
      ],
      "sponsor": "AstraZeneca",
      "enrollment": 675,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 High Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06451497",
      "title": "Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors",
      "brief_title": "Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer",
        "Esophageal Cancer",
        "Head and Neck Squamous Cell Carcinoma"
      ],
      "interventions": [
        "ZM008"
      ],
      "sponsor": "Zumutor Biologics Inc.",
      "enrollment": 33,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06758401",
      "title": "This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.",
      "brief_title": "This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer",
        "Carcinoma, Non-Small-Cell Lung",
        "Carcinoma, Non-Small-Cell Lung (NSCLC)"
      ],
      "interventions": [
        "Sigvotatug Vedotin",
        "Pembrolizumab"
      ],
      "sponsor": "Pfizer",
      "enrollment": 714,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 High Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06946927",
      "title": "A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation",
      "brief_title": "A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "NSCLC (Advanced Non-small Cell Lung Cancer)"
      ],
      "interventions": [
        "JMKX001899",
        "IN10018",
        "Chemotherapy: Pemetrexed",
        "Carboplatin"
      ],
      "sponsor": "Jemincare",
      "enrollment": 72,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07046923",
      "title": "A Study of LY4175408 in Participants With Advanced Cancer",
      "brief_title": "A Study of LY4175408 in Participants With Advanced Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Carcinoma, Non-Small-Cell Lung",
        "Small Cell Lung Carcinoma",
        "Endometrial Neoplasms"
      ],
      "interventions": [
        "LY4175408"
      ],
      "sponsor": "Eli Lilly and Company",
      "enrollment": 240,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Non-Small Cell Lung Cancer'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07218003",
      "title": "A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4",
      "brief_title": "A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer",
        "Cervical Cancer",
        "Head and Neck Squamous Cell Cancer"
      ],
      "interventions": [
        "RNDO-564",
        "Pembrolizumab"
      ],
      "sponsor": "Rondo Therapeutics",
      "enrollment": 149,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT07229313",
      "title": "A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors",
      "brief_title": "A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advance Solid Tumors"
      ],
      "interventions": [
        "KIVU-107"
      ],
      "sponsor": "Kivu Bioscience Inc.",
      "enrollment": 76,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT07275073",
      "title": "JMT106 Injection in the Treatment of Advanced Solid Tumors",
      "brief_title": "JMT106 Injection in the Treatment of Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced Solid Tumor",
        "Lung Squamous Cell Carcinoma",
        "Hepatocellular Carcinoma"
      ],
      "interventions": [
        "JMT106 Injection"
      ],
      "sponsor": "Shanghai JMT-Bio Inc.",
      "enrollment": 200,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT07349537",
      "title": "Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors",
      "brief_title": "Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer (NSCLC)",
        "Colorectal Cancer (CRC)",
        "Pancreatic Adenocarcinoma"
      ],
      "interventions": [
        "RMC-5127",
        "daraxonrasib",
        "cetuximab"
      ],
      "sponsor": "Revolution Medicines, Inc.",
      "enrollment": 574,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT07390838",
      "title": "A Study of SH009 Injection in Patients With Advanced Solid Tumors.",
      "brief_title": "A Study of SH009 Injection in Patients With Advanced Solid Tumors.",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Liver Cancer (Locally Advanced or Metastatic)",
        "Lung Cancer (NSCLC)",
        "Head and Neck Cancer Squamous Cell Carcinoma"
      ],
      "interventions": [
        "SH009"
      ],
      "sponsor": "Nanjing Sanhome Pharmaceutical, Co., Ltd.",
      "enrollment": 150,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT00471978",
      "title": "DNA Analysis of Blood and Tissue from Patients with Lung Cancer",
      "brief_title": "DNA Analysis of Blood and Tissue from Patients with Lung Cancer",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Cancer"
      ],
      "interventions": [],
      "sponsor": "Massachusetts General Hospital",
      "enrollment": null,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04981119",
      "title": "Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing",
      "brief_title": "Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Solid Tumor, Adult",
        "Colorectal Cancer",
        "Non Small Cell Lung Cancer"
      ],
      "interventions": [
        "Apheresis",
        "Next Generation Sequencing (NGS)",
        "Long Range NGS HLA typing"
      ],
      "sponsor": "A2 Biotherapeutics Inc.",
      "enrollment": 200,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05172739",
      "title": "Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLC",
      "brief_title": "Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE4"
      ],
      "conditions": [
        "Systemic Inflammatory Response Syndrome",
        "Postoperative Pain, Acute",
        "Postoperative Pain, Chronic"
      ],
      "interventions": [
        "Opioid-Based Anesthesia-Analgesia Strategy",
        "Opioid-free Anesthesia-Analgesia Strategy"
      ],
      "sponsor": "University of Crete",
      "enrollment": 70,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05830812",
      "title": "Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma",
      "brief_title": "Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Adenocarcinoma, Stage I"
      ],
      "interventions": [
        "Invasiveness diagnosis"
      ],
      "sponsor": "Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",
      "enrollment": 3000,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT05838053",
      "title": "Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm",
      "brief_title": "Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Adenocarcinoma"
      ],
      "interventions": [
        "Lobectomy with systemic lymph node dissection",
        "Segmentectomy with systemic lymph node dissection"
      ],
      "sponsor": "Shanghai Pulmonary Hospital, Shanghai, China",
      "enrollment": 446,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT06073431",
      "title": "LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia",
      "brief_title": "LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Advanced Colorectal Carcinoma",
        "Advanced Lung Non-Small Cell Carcinoma",
        "Advanced Pancreatic Adenocarcinoma"
      ],
      "interventions": [
        "Biospecimen Collection",
        "Computed Tomography",
        "Electronic Health Record Review",
        "Medical Device Usage and Evaluation"
      ],
      "sponsor": "University of Rochester",
      "enrollment": 800,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06305962",
      "title": "177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors",
      "brief_title": "177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "EARLY_PHASE1"
      ],
      "conditions": [
        "PDL1 Gene Mutation",
        "Non Small Cell Lung Cancer",
        "Small Cell Lung Cancer ( SCLC )"
      ],
      "interventions": [
        "177Lu-RAD204"
      ],
      "sponsor": "Radiopharm Theranostics, Ltd",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 High Lung Cancer'",
        "cond='PD-L1 Positive Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06598839",
      "title": "Immuno-effect of Tα1 for Stage I NSCLC",
      "brief_title": "Immuno-effect of Tα1 for Stage I NSCLC",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer"
      ],
      "interventions": [
        "Thymosin Alpha1"
      ],
      "sponsor": "Yousheng Mao",
      "enrollment": 40,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06639191",
      "title": "[177Lu]Lu-AKIR001 First-in-human Study",
      "brief_title": "[177Lu]Lu-AKIR001 First-in-human Study",
      "status": "RECRUITING",
      "phase": [
        "EARLY_PHASE1"
      ],
      "conditions": [
        "Thyroid Gland Anaplastic Carcinoma",
        "Poorly Differentiated Thyroid Carcinoma",
        "Cancer Head and Neck"
      ],
      "interventions": [
        "[177Lu]Lu-AKIR001"
      ],
      "sponsor": "Karolinska University Hospital",
      "enrollment": 15,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06646471",
      "title": "PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies",
      "brief_title": "PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies",
      "status": "RECRUITING",
      "phase": [
        "PHASE4"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer",
        "Lung Cancer"
      ],
      "interventions": [
        "Bio-bank repository",
        "Quality of Life (QoL)",
        "G-Code"
      ],
      "sponsor": "GFPC Investigation",
      "enrollment": 500,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06737107",
      "title": "Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung Cancer",
      "brief_title": "Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung Cancer",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Early Stage Lung Cancer (I and II)",
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [],
      "sponsor": "Scientific Institute San Raffaele",
      "enrollment": 472,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06745830",
      "title": "Lymph Node Pathologic Grading Strategy",
      "brief_title": "Lymph Node Pathologic Grading Strategy",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Adenocarcinoma"
      ],
      "interventions": [
        "No intervention"
      ],
      "sponsor": "Fudan University",
      "enrollment": 2998,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT06796816",
      "title": "Bioimpedance Analysis in Perioperative Assessment in Thoracic Surgery",
      "brief_title": "Bioimpedance Analysis in Perioperative Assessment in Thoracic Surgery",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Resection",
        "Adenocarcinoma of Lung"
      ],
      "interventions": [
        "Bioelectrical Impedance Vector Analysis (BIVA)"
      ],
      "sponsor": "Azienda USL Reggio Emilia - IRCCS",
      "enrollment": 1000,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT06853678",
      "title": "Second-line Immunotherapy for ES-SCLC",
      "brief_title": "Second-line Immunotherapy for ES-SCLC",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Extensive Stage Small Cell Lung Cancer (ES-SCLC)"
      ],
      "interventions": [
        "Adebrelimab",
        "Selinexor",
        "Nab-paclitaxel"
      ],
      "sponsor": "Tianjin Medical University Cancer Institute and Hospital",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07028489",
      "title": "Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer",
      "brief_title": "Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Non Small Cell Lung Cancer"
      ],
      "interventions": [],
      "sponsor": "N-Power Medicine",
      "enrollment": 130,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'",
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07079150",
      "title": "Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study",
      "brief_title": "Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Hepatitis B, Chronic (CHB)",
        "Hepatitis B",
        "Hepatitis B Virus (HBV)"
      ],
      "interventions": [
        "Peg IFN-α-2b"
      ],
      "sponsor": "First Affiliated Hospital Xi'an Jiaotong University",
      "enrollment": 1500,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT07171190",
      "title": "Targeted Abdominal CT in Conjunction With Lung Cancer Screening",
      "brief_title": "Targeted Abdominal CT in Conjunction With Lung Cancer Screening",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Renal Cell Carcinoma (Kidney Cancer)",
        "Kidney Cancers",
        "AAA - Abdominal Aortic Aneurysm"
      ],
      "interventions": [
        "Lung Cancer Screening Invitation Intervention",
        "Abdominal scan intervention"
      ],
      "sponsor": "University of Cambridge",
      "enrollment": 6272,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07257471",
      "title": "Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy",
      "brief_title": "Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Cancer (NSCLC)"
      ],
      "interventions": [],
      "sponsor": "Beijing Haidian Hospital",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'",
        "cond='Non-Small Cell Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07359586",
      "title": "Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia",
      "brief_title": "Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Gastric Cancer",
        "Hepatic Carcinoma",
        "Pulmonary Carcinoma"
      ],
      "interventions": [],
      "sponsor": "Zhejiang University",
      "enrollment": 1200,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'",
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07423169",
      "title": "Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer",
      "brief_title": "Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Adenocarcinoma",
        "Bulky Tumors",
        "Unresectable Cancer"
      ],
      "interventions": [
        "Partial Tumor Irradiation"
      ],
      "sponsor": "Karl Landsteiner University of Health Sciences",
      "enrollment": 10,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'",
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT03351842",
      "title": "Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%",
      "brief_title": "Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Chemotherapy, Adjuvant",
        "Lung Adenocarcinoma, Stage I",
        "Treatment"
      ],
      "interventions": [
        "cis Platinum/Carboplatin, Pemetrexed Disodium",
        "Undergo surgery"
      ],
      "sponsor": "Shanghai Pulmonary Hospital, Shanghai, China",
      "enrollment": 460,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT03394365",
      "title": "A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy",
      "brief_title": "A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)",
        "Solid Organ Transplant Complications",
        "Lymphoproliferative Disorders"
      ],
      "interventions": [
        "tabelecleucel"
      ],
      "sponsor": "Pierre Fabre Medicament",
      "enrollment": 115,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT03582124",
      "title": "Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery",
      "brief_title": "Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Lung Carcinoma",
        "Metastatic Malignant Neoplasm in the Lung",
        "Stage IV Lung Cancer AJCC v8"
      ],
      "interventions": [
        "Near-Infrared Fluorescence Imaging",
        "Panitumumab-IRDye800",
        "Pharmacokinetic Study",
        "Therapeutic Conventional Surgery"
      ],
      "sponsor": "Stanford University",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Stage IVA Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT03755739",
      "title": "Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors",
      "brief_title": "Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE2",
        "PHASE3"
      ],
      "conditions": [
        "Hepatocarcinoma",
        "Lung Cancer",
        "Melanoma"
      ],
      "interventions": [
        "Checkpoint inhibitor (CPI) such as Pembrolizumab plus chemotherapy"
      ],
      "sponsor": "Second Affiliated Hospital of Guangzhou Medical University",
      "enrollment": 200,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT03851445",
      "title": "Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer",
      "brief_title": "Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2",
        "PHASE3"
      ],
      "conditions": [
        "Previously Treated Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "Screening Platform"
      ],
      "sponsor": "SWOG Cancer Research Network",
      "enrollment": 10000,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04105270",
      "title": "RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial",
      "brief_title": "RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Adenocarcinoma of Lung",
        "Lung Cancer"
      ],
      "interventions": [
        "Oral Restorative Microbiota Therapy (RMT) Capsules",
        "Durvalumab 1500 mg IV",
        "Cisplatin/pemetrexed or Carboplatin/pemetrexed",
        "Placebo"
      ],
      "sponsor": "Masonic Cancer Center, University of Minnesota",
      "enrollment": 82,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT04267848",
      "title": "Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])",
      "brief_title": "Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Lung Non-Small Cell Carcinoma",
        "Lung Non-Small Cell Squamous Carcinoma",
        "Lung Non-Squamous Non-Small Cell Carcinoma"
      ],
      "interventions": [
        "Biospecimen Collection",
        "Carboplatin",
        "Cisplatin",
        "Computed Tomography"
      ],
      "sponsor": "National Cancer Institute (NCI)",
      "enrollment": 1210,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04273061",
      "title": "Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity",
      "brief_title": "Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Breast Cancer",
        "Lung Cancer",
        "Gastrointestinal Cancer"
      ],
      "interventions": [
        "Atezolizumab"
      ],
      "sponsor": "British Columbia Cancer Agency",
      "enrollment": 200,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04322617",
      "title": "Anlotinib Plus Immune Checkpoint Inhibitors for Lung Cancer",
      "brief_title": "Anlotinib Plus Immune Checkpoint Inhibitors for Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2",
        "PHASE3"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Anlotinib plus the same Immune Checkpoint Inhibitors.",
        "Anlotinib plus the new Immune Checkpoint Inhibitors.",
        "Anlotinib"
      ],
      "sponsor": "Hunan Province Tumor Hospital",
      "enrollment": 1200,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04400539",
      "title": "The IMmunotherapy Pleural 5-ALA PDT",
      "brief_title": "The IMmunotherapy Pleural 5-ALA PDT",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Mesotheliomas Pleural",
        "Malignant Pleural Mesothelioma"
      ],
      "interventions": [
        "intrapleural photodynamic therapy with videothoracoscopy",
        "Nivolumab Injection"
      ],
      "sponsor": "University Hospital, Lille",
      "enrollment": 20,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04402788",
      "title": "Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial",
      "brief_title": "Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial",
      "status": "RECRUITING",
      "phase": [
        "PHASE2",
        "PHASE3"
      ],
      "conditions": [
        "Extensive Stage Lung Small Cell Carcinoma"
      ],
      "interventions": [
        "Atezolizumab",
        "Biospecimen Collection",
        "Computed Tomography",
        "Magnetic Resonance Imaging"
      ],
      "sponsor": "National Cancer Institute (NCI)",
      "enrollment": 138,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04410796",
      "title": "Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers",
      "brief_title": "Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Metastatic Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Osimertinib",
        "Carboplatin",
        "Pemetrexed"
      ],
      "sponsor": "Memorial Sloan Kettering Cancer Center",
      "enrollment": 571,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04563338",
      "title": "An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)",
      "brief_title": "An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Hepatocellular Carcinoma",
        "Non-small Cell Lung Cancer Metastatic",
        "Liver Metastases"
      ],
      "interventions": [
        "Atezolizumab",
        "Bevacizumab"
      ],
      "sponsor": "University Health Network, Toronto",
      "enrollment": 36,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT04665206",
      "title": "Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors",
      "brief_title": "Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Solid Tumor, Adult",
        "Mesothelioma",
        "NSCLC"
      ],
      "interventions": [
        "VT3989",
        "Nivolumab & Ipilimumab",
        "Osimertinib"
      ],
      "sponsor": "Vivace Therapeutics, Inc",
      "enrollment": 336,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04728724",
      "title": "Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung Cancer",
      "brief_title": "Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer Stage III"
      ],
      "interventions": [
        "Sintilimab",
        "Chemotherapy"
      ],
      "sponsor": "Shanghai Pulmonary Hospital, Shanghai, China",
      "enrollment": 100,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04919382",
      "title": "Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer",
      "brief_title": "Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Extensive Stage Lung Small Cell Carcinoma",
        "Metastatic Lung Small Cell Carcinoma",
        "Recurrent Lung Small Cell Carcinoma"
      ],
      "interventions": [
        "Atezolizumab",
        "Temozolomide"
      ],
      "sponsor": "Dwight Owen",
      "enrollment": 56,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Stage IVA Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04952480",
      "title": "Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer",
      "brief_title": "Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Small Cell Lung Cancer"
      ],
      "interventions": [
        "Dose-escalated adaptive radiotherapy",
        "Chemotherapy"
      ],
      "sponsor": "AHS Cancer Control Alberta",
      "enrollment": 31,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04977453",
      "title": "GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors",
      "brief_title": "GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced Solid Tumor",
        "Metastatic Solid Tumor",
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "GI-101",
        "Pembrolizumab (KEYTRUDA®)",
        "Lenvatinib",
        "Local Radiotherapy"
      ],
      "sponsor": "GI Innovation, Inc.",
      "enrollment": 430,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT04996017",
      "title": "Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)",
      "brief_title": "Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Mesotheliomas Pleural"
      ],
      "interventions": [
        "Atezolizumab 1200 mg in 20 ML Injection",
        "Placebo"
      ],
      "sponsor": "Gruppo Oncologico Italiano di Ricerca Clinica",
      "enrollment": 162,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05004974",
      "title": "Sintilimab With Pemigatinib in Patients With PD-L1-positive and FGFR Mutated Advanced Non-small Cell Lung Cancer",
      "brief_title": "Sintilimab With Pemigatinib in Patients With PD-L1-positive and FGFR Mutated Advanced Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Advanced Non Small Cell Lung Cancer"
      ],
      "interventions": [
        "Sintilimab",
        "Pemigatinib"
      ],
      "sponsor": "The Fourth Affiliated Hospital of Zhejiang University School of Medicine",
      "enrollment": 20,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 Positive Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05085028",
      "title": "A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)",
      "brief_title": "A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Lung Cancer, Nonsmall Cell"
      ],
      "interventions": [
        "Pembrolizumab 25 MG/ML [Keytruda]"
      ],
      "sponsor": "Imperial College London",
      "enrollment": 1750,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05215340",
      "title": "Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations",
      "brief_title": "Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Metastatic Non Small Cell Lung Cancer"
      ],
      "interventions": [
        "Datopotamab Deruxtecan",
        "Pembrolizumab"
      ],
      "sponsor": "Daiichi Sankyo",
      "enrollment": 740,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 High Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05255302",
      "title": "De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction",
      "brief_title": "De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction",
      "status": "RECRUITING",
      "phase": [
        "PHASE2",
        "PHASE3"
      ],
      "conditions": [
        "Metastatic NSCLC"
      ],
      "interventions": [
        "Pembrolizumab before randomization",
        "Chemotherapy",
        "Pemetrexed",
        "Pembrolizumab after randomization"
      ],
      "sponsor": "Intergroupe Francophone de Cancerologie Thoracique",
      "enrollment": 1360,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05261399",
      "title": "Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment",
      "brief_title": "Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Carcinoma",
        "Non-Small-Cell Lung"
      ],
      "interventions": [
        "Savolitinib",
        "Osimertinib",
        "Pemetrexed",
        "Cisplatin"
      ],
      "sponsor": "AstraZeneca",
      "enrollment": 324,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05267626",
      "title": "Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer",
      "brief_title": "Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced Solid Tumor",
        "Metastatic Cancer",
        "Cutaneous Melanoma"
      ],
      "interventions": [
        "AU-007",
        "Aldesleukin",
        "Avelumab",
        "Nivolumab"
      ],
      "sponsor": "Aulos Bioscience, Inc.",
      "enrollment": 159,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05318027",
      "title": "ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy",
      "brief_title": "ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Lung Cancer",
        "Gastrointestinal Cancer",
        "Head and Neck Cancer"
      ],
      "interventions": [
        "ChatBot"
      ],
      "sponsor": "Abramson Cancer Center at Penn Medicine",
      "enrollment": 70,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05334277",
      "title": "Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA",
      "brief_title": "Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Furmonertinib",
        "Furmonertinib",
        "Furmonertinib/Pemetrexed/Carboplatin",
        "Furmonertinib/Pemetrexed/Carboplatin/Bevacizumab"
      ],
      "sponsor": "Sun Yat-sen University",
      "enrollment": 280,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05344209",
      "title": "Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer",
      "brief_title": "Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Oncology",
        "NSCLC Stage IV",
        "NSCLC, Stage III"
      ],
      "interventions": [
        "UV1",
        "Sagramostim",
        "Anti-PD-1/PD-L1 treatment"
      ],
      "sponsor": "Vestre Viken Hospital Trust",
      "enrollment": 138,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05358548",
      "title": "ATATcH Alternating Treatment Plans for Advanced Cancer",
      "brief_title": "ATATcH Alternating Treatment Plans for Advanced Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Head and Neck Cancer",
        "Lung Cancer"
      ],
      "interventions": [
        "Paclitaxel",
        "Pemetrexed",
        "5Fluorouracil",
        "Carboplatin"
      ],
      "sponsor": "Rutgers, The State University of New Jersey",
      "enrollment": 150,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05379985",
      "title": "Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS",
      "brief_title": "Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer (NSCLC)",
        "Colorectal Cancer (CRC)",
        "Pancreatic Ductal Adenocarcinoma (PDAC)"
      ],
      "interventions": [
        "RMC-6236"
      ],
      "sponsor": "Revolution Medicines, Inc.",
      "enrollment": 754,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05416775",
      "title": "Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer",
      "brief_title": "Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "SHR-8068；Adebrelimab",
        "SHR-8068；adebrelimab and platinum-based chemotherapy",
        "Adebrelimab；platinum-based chemotherapy"
      ],
      "sponsor": "Suzhou Suncadia Biopharmaceuticals Co., Ltd.",
      "enrollment": 168,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05502913",
      "title": "Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer",
      "brief_title": "Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Metastatic Lung Cancer"
      ],
      "interventions": [
        "Antibiotics",
        "FMT (Fecal Microbiota Transplantation)"
      ],
      "sponsor": "Soroka University Medical Center",
      "enrollment": 80,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05522660",
      "title": "Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer",
      "brief_title": "Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer",
        "Melanoma"
      ],
      "interventions": [
        "Stereotactic radiosurgery",
        "Immune checkpoint inhibitor"
      ],
      "sponsor": "ETOP IBCSG Partners Foundation",
      "enrollment": 180,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05558904",
      "title": "An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer",
      "brief_title": "An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Lung Adenocarcinoma"
      ],
      "interventions": [
        "Alpha-methyl-4-deoxy-4-[(18)F]fluoro-D-glucopyranoside",
        "Computed Tomography",
        "Laboratory Biomarker Analysis",
        "Positron Emission Tomography"
      ],
      "sponsor": "Jonsson Comprehensive Cancer Center",
      "enrollment": 60,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT05592626",
      "title": "A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors",
      "brief_title": "A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced Solid Tumors",
        "Genital Neoplasm, Female",
        "Urogenital Neoplasms"
      ],
      "interventions": [
        "STAR0602"
      ],
      "sponsor": "Marengo Therapeutics, Inc.",
      "enrollment": 365,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05609578",
      "title": "Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation",
      "brief_title": "Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Advanced NSCLC",
        "Metastatic Lung Cancer"
      ],
      "interventions": [
        "Adagrasib oral dose of 400 mg twice daily tablets",
        "Pembrolizumab",
        "Chemotherapy: Pemetrexed",
        "Cisplatin/Carboplatin"
      ],
      "sponsor": "Mirati Therapeutics Inc.",
      "enrollment": 90,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05642572",
      "title": "Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)",
      "brief_title": "Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Recurrent Lung Non-Small Cell Carcinoma",
        "Stage IV Lung Cancer AJCC v8"
      ],
      "interventions": [
        "Biospecimen Collection",
        "Capmatinib",
        "Computed Tomography",
        "Magnetic Resonance Imaging"
      ],
      "sponsor": "SWOG Cancer Research Network",
      "enrollment": 66,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05669846",
      "title": "Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC",
      "brief_title": "Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer"
      ],
      "interventions": [
        "Healthy Donor Fecal Microbiota Transplant (hdFMT)",
        "Pembrolizumab"
      ],
      "sponsor": "Diwakar Davar",
      "enrollment": 26,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 Positive Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05684276",
      "title": "DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors",
      "brief_title": "DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "NSCLC",
        "Pancoast Tumor"
      ],
      "interventions": [
        "Carboplatin",
        "Paclitaxel",
        "Nivolumab"
      ],
      "sponsor": "Fundación GECP",
      "enrollment": 22,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05717803",
      "title": "Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)",
      "brief_title": "Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Segmentectomy",
        "Lung Adenocarcinoma"
      ],
      "interventions": [
        "Segmentectomy"
      ],
      "sponsor": "Fudan University",
      "enrollment": 307,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT05718323",
      "title": "Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC",
      "brief_title": "Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "SCLC,Extensive Stage",
        "SLFN11-positive"
      ],
      "interventions": [
        "Niraparib"
      ],
      "sponsor": "ETOP IBCSG Partners Foundation",
      "enrollment": 44,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 Positive Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05726383",
      "title": "Iscador® P (Mistletoe) Immunotherapy for Recurrent Osteogenic Sarcoma",
      "brief_title": "Iscador® P (Mistletoe) Immunotherapy for Recurrent Osteogenic Sarcoma",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Osteogenic Sarcoma Recurrent"
      ],
      "interventions": [
        "Iscador*P"
      ],
      "sponsor": "Hackensack Meridian Health",
      "enrollment": 32,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05751798",
      "title": "Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas",
      "brief_title": "Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Solid Advanced Tumor",
        "Lymphoma",
        "NSCLC (Non-small Cell Lung Cancer)"
      ],
      "interventions": [
        "Part A: OSE-279 100mg",
        "Part A: OSE-279 300mg",
        "Part A: OSE-279 600mg",
        "Part B: OSE-279 600 mg and OSE2101"
      ],
      "sponsor": "OSE Immunotherapeutics",
      "enrollment": 41,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 Positive Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05765084",
      "title": "Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma",
      "brief_title": "Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Malignant Pleural Mesothelioma"
      ],
      "interventions": [
        "Dendritic cell vaccination",
        "Atezolizumab",
        "Platinum/pemetrexed based chemotherapy"
      ],
      "sponsor": "University Hospital, Antwerp",
      "enrollment": 15,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05798845",
      "title": "The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer",
      "brief_title": "The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "NSCLC"
      ],
      "interventions": [
        "SBRT+LDRT",
        "Toripalimab",
        "Chemotherapy drug",
        "Toripalimab"
      ],
      "sponsor": "Shanghai Chest Hospital",
      "enrollment": 124,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05825443",
      "title": "Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients",
      "brief_title": "Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Immunotherapy",
        "Chemotherapy"
      ],
      "interventions": [
        "Camrelizumab"
      ],
      "sponsor": "Nanfang Hospital, Southern Medical University",
      "enrollment": 57,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05830058",
      "title": "Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma",
      "brief_title": "Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Lung Non-Small Cell Carcinoma",
        "Malignant Solid Neoplasm",
        "Melanoma"
      ],
      "interventions": [
        "Biospecimen Collection",
        "Computed Tomography",
        "Positron Emission Tomography",
        "Questionnaire Administration"
      ],
      "sponsor": "City of Hope Medical Center",
      "enrollment": 32,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT05837052",
      "title": "A Phase II Trial to Evaluate the Efficiency and Safety of Serplulimab Plus Chemotherapy as Conversion Therapy in NSCLC",
      "brief_title": "A Phase II Trial to Evaluate the Efficiency and Safety of Serplulimab Plus Chemotherapy as Conversion Therapy in NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Unresectable Lung Non-Small Cell Carcinoma"
      ],
      "interventions": [
        "serplulimab plus chemotherapy as conversion treatment"
      ],
      "sponsor": "Zhejiang University",
      "enrollment": 49,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Stage IVA Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05914116",
      "title": "A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors",
      "brief_title": "A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced Solid Tumors"
      ],
      "interventions": [
        "DB-1311",
        "Lopinavir and Ritonavir Tablets",
        "itraconazole",
        "Enzalutamide"
      ],
      "sponsor": "DualityBio Inc.",
      "enrollment": 862,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05920356",
      "title": "A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)",
      "brief_title": "A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer (NSCLC)"
      ],
      "interventions": [
        "Sotorasib",
        "Pembrolizumab"
      ],
      "sponsor": "Amgen",
      "enrollment": 750,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 Positive Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05978284",
      "title": "Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma",
      "brief_title": "Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Small Cell Lung Cancer",
        "Neuroendocrine Carcinoma"
      ],
      "interventions": [
        "ZG006"
      ],
      "sponsor": "Suzhou Zelgen Biopharmaceuticals Co.,Ltd",
      "enrollment": 54,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT06031246",
      "title": "Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)",
      "brief_title": "Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Lung Adenocarcinoma",
        "Lymph Node Metastasis"
      ],
      "interventions": [
        "Selective Lymph Node Dissection"
      ],
      "sponsor": "Fudan University",
      "enrollment": 634,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06095505",
      "title": "A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer",
      "brief_title": "A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Small Cell Lung Cancer"
      ],
      "interventions": [
        "Alisertib"
      ],
      "sponsor": "Puma Biotechnology, Inc.",
      "enrollment": 80,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06096844",
      "title": "Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial",
      "brief_title": "Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Advanced Lung Non-Small Cell Carcinoma",
        "Stage IIIB Lung Cancer AJCC v8",
        "Stage IIIC Lung Cancer AJCC v8"
      ],
      "interventions": [
        "Carboplatin",
        "Computed Tomography",
        "Magnetic Resonance Imaging",
        "Nab-paclitaxel"
      ],
      "sponsor": "National Cancer Institute (NCI)",
      "enrollment": 304,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06119581",
      "title": "A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer",
      "brief_title": "A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Carcinoma, Non-Small-Cell Lung",
        "Neoplasm Metastasis"
      ],
      "interventions": [
        "LY3537982",
        "Pembrolizumab",
        "Placebo",
        "Cisplatin"
      ],
      "sponsor": "Eli Lilly and Company",
      "enrollment": 1016,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 Positive Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06121505",
      "title": "Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer",
      "brief_title": "Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Lung Squamous Cell Carcinoma"
      ],
      "interventions": [
        "low-dose radiation therapy and stereotactic body radiation therapy",
        "chemotherapy",
        "Sintilimab"
      ],
      "sponsor": "Sichuan University",
      "enrollment": 114,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06199895",
      "title": "Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer",
      "brief_title": "Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Pancreatic Adenocarcinoma",
        "Cholangiocarcinoma",
        "Lung Cancer"
      ],
      "interventions": [
        "Paclitaxel Polymeric Micelles for Injection"
      ],
      "sponsor": "Liu Huang",
      "enrollment": 25,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT06203210",
      "title": "A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer",
      "brief_title": "A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Small Cell Lung Cancer"
      ],
      "interventions": [
        "Ifinatamab deruxtecan",
        "Topotecan",
        "Amrubicin",
        "Lurbinectedin"
      ],
      "sponsor": "Daiichi Sankyo",
      "enrollment": 540,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06216301",
      "title": "LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC",
      "brief_title": "LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Metastatic Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "NovoTTF-200T",
        "Pembrolizumab",
        "Platinum based chemotherapy"
      ],
      "sponsor": "NovoCure GmbH",
      "enrollment": 734,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06223711",
      "title": "Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC",
      "brief_title": "Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Extensive-stage Small-cell Lung Cancer"
      ],
      "interventions": [
        "Thoracic Radiochemotherapy",
        "durvalumab",
        "Stereotactic radiotherapy of further tumor locations",
        "Chemotherapy"
      ],
      "sponsor": "Universität des Saarlandes",
      "enrollment": 43,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06228066",
      "title": "Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)",
      "brief_title": "Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Small Cell Carcinoma of the Bladder",
        "High Grade Neuroendocrine Tumors of the Urinary Tract"
      ],
      "interventions": [
        "Lurbinectedin",
        "Avelumab"
      ],
      "sponsor": "National Cancer Institute (NCI)",
      "enrollment": 45,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 High Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06241807",
      "title": "Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC",
      "brief_title": "Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "IMMUNOTHERAPY",
        "Neoadjuvant Therapy",
        "Resectable Lung Non-Small Cell Carcinoma"
      ],
      "interventions": [
        "Camrelizumab Plus Chemotherapy"
      ],
      "sponsor": "Shandong Cancer Hospital and Institute",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06247605",
      "title": "A Phase IIII Study of AL8326 in Small Cell Lung Cancer",
      "brief_title": "A Phase IIII Study of AL8326 in Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Small Cell Lung Carcinoma"
      ],
      "interventions": [
        "AL8326 tablets",
        "placebo"
      ],
      "sponsor": "Advenchen Laboratories Nanjing Ltd.",
      "enrollment": 243,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06248606",
      "title": "Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases",
      "brief_title": "Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer",
        "NSCLC",
        "KRAS G12C"
      ],
      "interventions": [
        "Adagrasib",
        "Stereotactic Radiosurgery"
      ],
      "sponsor": "Ryan Gentzler, MD",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06269211",
      "title": "Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive Expression",
      "brief_title": "Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive Expression",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Carcinoma, Non-Small-Cell Lung"
      ],
      "interventions": [
        "Toripalimab"
      ],
      "sponsor": "Ruijin Hospital",
      "enrollment": 29,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 Positive Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06371586",
      "title": "Neo-Sequence 2：NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGC",
      "brief_title": "Neo-Sequence 2：NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGC",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Gastric Cancer",
        "Diffuse Type Carcinoma"
      ],
      "interventions": [
        "Albumin paclitaxel+SOX+BEV+ PD-1 monoclonal antibody therapy"
      ],
      "sponsor": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences",
      "enrollment": 67,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Signet Ring Cell Carcinoma'"
      ]
    },
    {
      "nct_id": "NCT06412471",
      "title": "A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC Patients",
      "brief_title": "A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC Patients",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "First-line Advanced NSCLC Patients"
      ],
      "interventions": [
        "SSGJ-707",
        "carboplatin",
        "Pemetrexed",
        "paclitaxel"
      ],
      "sponsor": "Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.",
      "enrollment": 235,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06448312",
      "title": "A Study of SKB264 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer",
      "brief_title": "A Study of SKB264 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "SKB264",
        "Pembrolizumab"
      ],
      "sponsor": "Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.",
      "enrollment": 406,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 Positive Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06448572",
      "title": "EXL01 in Combination With Nivolumab for Advanced NSCLC Refractory to Immunotherapy.",
      "brief_title": "EXL01 in Combination With Nivolumab for Advanced NSCLC Refractory to Immunotherapy.",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "EXL01"
      ],
      "sponsor": "University Hospital, Lille",
      "enrollment": 21,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06472245",
      "title": "Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor",
      "brief_title": "Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Patients With Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "OSE2101",
        "Docetaxel",
        "NGS HLAA2 assay"
      ],
      "sponsor": "OSE Immunotherapeutics",
      "enrollment": 363,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06477523",
      "title": "Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC",
      "brief_title": "Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "SCLC, Extensive Stage"
      ],
      "interventions": [
        "AK104",
        "Etoposide",
        "Carboplatin",
        "low-dose radiotherapy"
      ],
      "sponsor": "Sichuan University",
      "enrollment": 57,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06478108",
      "title": "Interventional Software for Multi-immunotherapy of Solid Tumors",
      "brief_title": "Interventional Software for Multi-immunotherapy of Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE2",
        "PHASE3"
      ],
      "conditions": [
        "Lung Cancer",
        "Liver Cancer",
        "Solid Tumor, Adult"
      ],
      "interventions": [
        "IRSW-MIM"
      ],
      "sponsor": "Second Affiliated Hospital of Guangzhou Medical University",
      "enrollment": 60,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06483347",
      "title": "Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT",
      "brief_title": "Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Lung Cancer",
        "Inoperable Disease"
      ],
      "interventions": [
        "ipilimumab+pembrolizumab or ipilimumab+durvalumab, idarubicin, bevacizumab"
      ],
      "sponsor": "Second Affiliated Hospital of Guangzhou Medical University",
      "enrollment": 90,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06487221",
      "title": "Avutometinib and Defactinib in Diffuse Gastric Cancer",
      "brief_title": "Avutometinib and Defactinib in Diffuse Gastric Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Gastric Cancer",
        "Stomach Cancer"
      ],
      "interventions": [
        "Avutometinib",
        "Defactinib"
      ],
      "sponsor": "Ryan H. Moy, MD, PhD",
      "enrollment": 27,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Signet Ring Cell Carcinoma'"
      ]
    },
    {
      "nct_id": "NCT06498635",
      "title": "Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial",
      "brief_title": "Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Lung Non-Small Cell Carcinoma",
        "Stage II Lung Cancer AJCC v8",
        "Stage IIIA Lung Cancer AJCC v8"
      ],
      "interventions": [
        "Biospecimen Collection",
        "Computed Tomography",
        "Durvalumab",
        "Patient Observation"
      ],
      "sponsor": "National Cancer Institute (NCI)",
      "enrollment": 306,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06500481",
      "title": "Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial",
      "brief_title": "Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Anatomic Stage IV Breast Cancer AJCC v8",
        "Metastatic Breast Carcinoma",
        "Metastatic Lung Non-Small Cell Carcinoma"
      ],
      "interventions": [
        "Biospecimen Collection",
        "Computed Tomography",
        "Involved-Field Radiation Therapy",
        "Lumbar Puncture"
      ],
      "sponsor": "NRG Oncology",
      "enrollment": 115,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06518057",
      "title": "Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer",
      "brief_title": "Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Anatomic Stage IV Breast Cancer AJCC v8",
        "Metastatic Breast Carcinoma",
        "Metastatic Lung Non-Small Cell Carcinoma"
      ],
      "interventions": [
        "Biospecimen Collection",
        "Computed Tomography",
        "Electronic Health Record Review",
        "Lumbar Puncture"
      ],
      "sponsor": "University of Washington",
      "enrollment": 22,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06527898",
      "title": "Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer",
      "brief_title": "Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Small-cell Lung Cancer"
      ],
      "interventions": [
        "hypofractionated radiotherapy with immunotherapy"
      ],
      "sponsor": "Anhui Provincial Hospital",
      "enrollment": 45,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06545747",
      "title": "Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRI",
      "brief_title": "Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRI",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "DCE-MRI based split-course hypo-RT",
        "CT based split-course hypo-RT",
        "Concurrent chemotherapy",
        "Consolidative immunotherapy"
      ],
      "sponsor": "Sun Yat-sen University",
      "enrollment": 490,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06562920",
      "title": "Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer",
      "brief_title": "Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer"
      ],
      "interventions": [
        "adebrelimab and chemotherapy"
      ],
      "sponsor": "Zhejiang Cancer Hospital",
      "enrollment": 20,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06563388",
      "title": "Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial",
      "brief_title": "Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Oligometastasis",
        "Lung Cancer",
        "Colo-rectal Cancer"
      ],
      "interventions": [
        "Stereotactic Ablative Radiotherapy",
        "Best Practice"
      ],
      "sponsor": "Roswell Park Cancer Institute",
      "enrollment": 800,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06579196",
      "title": "Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1",
      "brief_title": "Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed Advanced NSCLC and Positive PD-L1",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Trabedersen",
        "Pembrolizumab"
      ],
      "sponsor": "University of Nebraska",
      "enrollment": 45,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 Positive Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06582771",
      "title": "A Study of Sotorasib in People With Non-Small Cell Lung Cancer",
      "brief_title": "A Study of Sotorasib in People With Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non Small Lung Cancer"
      ],
      "interventions": [
        "Sotorasib"
      ],
      "sponsor": "Memorial Sloan Kettering Cancer Center",
      "enrollment": 39,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06586697",
      "title": "First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy",
      "brief_title": "First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Extensive-stage Small-cell Lung Cancer"
      ],
      "interventions": [
        "Thoracic Radiotherapy"
      ],
      "sponsor": "Henan Cancer Hospital",
      "enrollment": 47,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06632262",
      "title": "A Phase 2 Clinical Study of ABSK061 and ABSK043",
      "brief_title": "A Phase 2 Clinical Study of ABSK061 and ABSK043",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "HER2-Gastric/Gastroesophageal Junction Cancer",
        "Urothelial Carcinoma",
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "ABSK061 + ABSK043",
        "ABSK061+ABSK043 in combination with CAPOX"
      ],
      "sponsor": "Abbisko Therapeutics Co, Ltd",
      "enrollment": 202,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06667622",
      "title": "Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy",
      "brief_title": "Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Chemoradiotherapy"
      ],
      "interventions": [
        "sodium glycididazole"
      ],
      "sponsor": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences",
      "enrollment": 40,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06667908",
      "title": "A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)",
      "brief_title": "A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Carcinoma, Non-Small-Cell Lung"
      ],
      "interventions": [
        "JNJ-90301900",
        "Durvalumab",
        "Concurrent Chemo/Radiation Therapy (cCRT)",
        "Concurrent Chemo/Radiation Therapy (cCRT): Carboplatin"
      ],
      "sponsor": "Johnson & Johnson Enterprise Innovation Inc.",
      "enrollment": 130,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06698965",
      "title": "Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin",
      "brief_title": "Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Lung Cancer, Small Cell"
      ],
      "interventions": [
        "Chemotherapy （Etoposide and Carboplatin）",
        "Immunotherapy （Envafolimab）",
        "Trilaciclib"
      ],
      "sponsor": "Shanghai Chest Hospital",
      "enrollment": 52,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06702826",
      "title": "Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases",
      "brief_title": "Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer",
        "Brain Metastases",
        "Stereotactic Radiation"
      ],
      "interventions": [
        "Cadonilimab combined with SRS"
      ],
      "sponsor": "Rongrong Zhou",
      "enrollment": 20,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06712316",
      "title": "Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer",
      "brief_title": "Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2",
        "PHASE3"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Pumitamig",
        "Pembrolizumab",
        "Carboplatin",
        "Pemetrexed"
      ],
      "sponsor": "BioNTech SE",
      "enrollment": 1260,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06712680",
      "title": "A Phase I/II Study of HYP-6589 Monotherapy in Treating Advanced Solid Tumors and in Combination With Tyrosine Kinase Inhibitors in Treating Patients With Advanced NSCLC Positive for Driver Genes",
      "brief_title": "A Phase I/II Study of HYP-6589 Monotherapy in Treating Advanced Solid Tumors and in Combination With Tyrosine Kinase Inhibitors in Treating Patients With Advanced NSCLC Positive for Driver Genes",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Solid Tumor"
      ],
      "interventions": [
        "Test Product HYP-6589"
      ],
      "sponsor": "Sichuan Huiyu Pharmaceutical Co., Ltd",
      "enrollment": 115,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06714708",
      "title": "Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC",
      "brief_title": "Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "NSCLC",
        "Neoadjuvant Immunotherapy",
        "Low Dose Radiotherapy"
      ],
      "interventions": [
        "Experimental",
        "Active comparator"
      ],
      "sponsor": "Anhui Provincial Cancer Hospital",
      "enrollment": 86,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06734702",
      "title": "Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer",
      "brief_title": "Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Neoadjuvant Therapy",
        "Concurrent Chemoradiotherapy",
        "Immunotherapy"
      ],
      "interventions": [
        "Neoadjuvant therapy",
        "Hypo-RT and concurrent chemotherapy",
        "CFRT and concurrent chemotherapy",
        "Consolidative immunotherapy"
      ],
      "sponsor": "Sun Yat-sen University",
      "enrollment": 497,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06775678",
      "title": "Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer",
      "brief_title": "Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Lung Cancers",
        "Radiation Treatment for Tumors"
      ],
      "interventions": [
        "Spatially Fractionated Radiation Therapy Combined With Low-dose Radiotherapy",
        "Conventional fractionated radiotherapy"
      ],
      "sponsor": "Tianjin Medical University Cancer Institute and Hospital",
      "enrollment": 84,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06792435",
      "title": "XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.",
      "brief_title": "XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Pancreatic Adenocarcinoma Metastatic",
        "Lung Cancer (NSCLC)",
        "Ovarian Cancer"
      ],
      "interventions": [
        "XNW27011",
        "XNW27011"
      ],
      "sponsor": "Evopoint Biosciences Inc.",
      "enrollment": 240,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06840782",
      "title": "First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.",
      "brief_title": "First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Oligometastatic Non-small Cell Lung Cancer (NSCLC)"
      ],
      "interventions": [
        "Radical local treatment",
        "SoC-based immunotherapy (+/- chemotherapy)"
      ],
      "sponsor": "Gustave Roussy, Cancer Campus, Grand Paris",
      "enrollment": 124,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06840834",
      "title": "Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy",
      "brief_title": "Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Pleural Mesotheliomas"
      ],
      "interventions": [
        "Ivonescimab"
      ],
      "sponsor": "Intergroupe Francophone de Cancerologie Thoracique",
      "enrollment": 38,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06841055",
      "title": "Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy Following Chemoimmunotherapy",
      "brief_title": "Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy Following Chemoimmunotherapy",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Pumitamig",
        "Docetaxel"
      ],
      "sponsor": "BioNTech SE",
      "enrollment": 60,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06851663",
      "title": "Trop2-targeted immunoPET Imaging of Solid Tumors",
      "brief_title": "Trop2-targeted immunoPET Imaging of Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE2",
        "PHASE3"
      ],
      "conditions": [
        "Solid Tumor",
        "Solid Carcinoma",
        "Uroepithelial Carcinoma"
      ],
      "interventions": [
        "[68Ga]Ga-NOTA-T4",
        "[68Ga]Ga-NOTA-RT4",
        "[18F]F-RESCA-T4",
        "[18F]F-RESCA-RT4"
      ],
      "sponsor": "RenJi Hospital",
      "enrollment": 400,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06861088",
      "title": "The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer",
      "brief_title": "The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Venous Thromboembolism",
        "Metastatic Pancreatic Cancer",
        "Locally Advanced Pancreatic Adenocarcinoma"
      ],
      "interventions": [
        "Kinisoquin™",
        "Placebo"
      ],
      "sponsor": "Quercis Pharma AG",
      "enrollment": 480,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06868277",
      "title": "A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer",
      "brief_title": "A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Carcinoma, Non-Small Cell Lung"
      ],
      "interventions": [
        "Rilvegostomig",
        "Pembrolizumab"
      ],
      "sponsor": "AstraZeneca",
      "enrollment": 830,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 High Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06888063",
      "title": "Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery",
      "brief_title": "Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside the Liver Treatable by Surgery",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Intrahepatic Bile Duct Cancer",
        "Intrahepatic Cholangiocarcinoma (Icc)",
        "Intrahepatic Bile Duct Carcinoma"
      ],
      "interventions": [
        "Hepatic Arterial Infusion Pump chemotherapy with floxuridin"
      ],
      "sponsor": "Erasmus Medical Center",
      "enrollment": 40,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06925516",
      "title": "A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC",
      "brief_title": "A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Intrahepatic Cholangiocarcinoma (Icc)"
      ],
      "interventions": [
        "Apatinib and Adebrelimab in Combination With chemotherapy"
      ],
      "sponsor": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University",
      "enrollment": 38,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT06938880",
      "title": "Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors",
      "brief_title": "Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Advanced Solid Tumor"
      ],
      "interventions": [
        "ZGGS18 for Injection",
        "ZG005 for Injection"
      ],
      "sponsor": "Suzhou Zelgen Biopharmaceuticals Co.,Ltd",
      "enrollment": 60,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06980272",
      "title": "SSGJ-707 in Advanced Non-Small Cell Lung Cancer",
      "brief_title": "SSGJ-707 in Advanced Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Advanced Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "SSGJ-707",
        "Pembrolizumab"
      ],
      "sponsor": "Shenyang Sunshine Pharmaceutical Co., LTD.",
      "enrollment": 420,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 Positive Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07003321",
      "title": "A Trial of HRS-4508 in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer",
      "brief_title": "A Trial of HRS-4508 in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Solid Tumor"
      ],
      "interventions": [
        "HRS-4508 tablet"
      ],
      "sponsor": "Jiangsu HengRui Medicine Co., Ltd.",
      "enrollment": 120,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07010419",
      "title": "A Study to Assess the Efficacy and Safety of Firmonertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB - IIIB NSCLC With Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations, Following Complete Surgical Resection With or Without Adjuvant Chemotherapy（FIRMOST）",
      "brief_title": "A Study to Assess the Efficacy and Safety of Firmonertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB - IIIB NSCLC With Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations, Following Complete Surgical Resection With or Without Adjuvant Chemotherapy（FIRMOST）",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "NSCLC",
        "Adjuvant Treatment"
      ],
      "interventions": [
        "Firmonertinib",
        "Placebo"
      ],
      "sponsor": "Allist Pharmaceuticals, Inc.",
      "enrollment": 338,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07058948",
      "title": "Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors",
      "brief_title": "Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Solid Cancers",
        "Radiotherapy",
        "Immune Checkpoint Inhibitor"
      ],
      "interventions": [
        "lattice radiation therapy"
      ],
      "sponsor": "Tianjin Medical University Cancer Institute and Hospital",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07070700",
      "title": "Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma",
      "brief_title": "Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Intrahepatic Cholangiocarcinoma (Icc)"
      ],
      "interventions": [
        "QL1706 (bispecific antibody targeting PD-1 and CLTA-4)",
        "Lenvatinib",
        "cryoablation"
      ],
      "sponsor": "Fudan University",
      "enrollment": 56,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT07071103",
      "title": "Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors",
      "brief_title": "Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Radiotherapy",
        "Metastatic Solid Cancers",
        "Immune Checkpoint Blockade"
      ],
      "interventions": [
        "Low-dose radiotherapy to the intestine (ILDR)",
        "PD-1/PD-L1 monoclonal antibodies"
      ],
      "sponsor": "Chuangzhen Chen",
      "enrollment": 48,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07082179",
      "title": "A Prospective Phase II Clinical Study of Immunotherapy Combined With Chemotherapy for Stage III Unresectable Non-small Cell Lung Cancer",
      "brief_title": "A Prospective Phase II Clinical Study of Immunotherapy Combined With Chemotherapy for Stage III Unresectable Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "NSCLC"
      ],
      "interventions": [
        "Iparomlimab and Tuvonralimab combined with paclitaxel polymer micelles and Platinum (cisplatin/carboplatin)"
      ],
      "sponsor": "Jiangsu Cancer Institute & Hospital",
      "enrollment": 33,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07104630",
      "title": "Pulmonary Rehabilitation in Advanced Lung Cancer Survivors",
      "brief_title": "Pulmonary Rehabilitation in Advanced Lung Cancer Survivors",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer Stage III",
        "Non-small Cell Lung Cancer Stage IV",
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Pulmonary Rehabilitation (PR)",
        "No intervention: Usual care"
      ],
      "sponsor": "Case Comprehensive Cancer Center",
      "enrollment": 85,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07109401",
      "title": "Perioperative Immunotherapy for Resectable Limited-Stage SCLC",
      "brief_title": "Perioperative Immunotherapy for Resectable Limited-Stage SCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Perioperative Immunotherapy",
        "Limited Stage Lung Small Cell Carcinoma",
        "Resectable Small Cell Lung Cancer"
      ],
      "interventions": [
        "Tislelizumab (BGB-A317) Plus Chemotherapy (Cisplatin/Carboplatin and Etoposide)"
      ],
      "sponsor": "Fudan University",
      "enrollment": 37,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07111520",
      "title": "A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)",
      "brief_title": "A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "BNT326",
        "BNT327",
        "Pembrolizumab",
        "SoC"
      ],
      "sponsor": "BioNTech SE",
      "enrollment": 420,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07144280",
      "title": "A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)",
      "brief_title": "A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Non-small Cell Carcinoma",
        "Non-Small Cell Lung Cancer Metastatic",
        "Non-Small Cell Lung Carcinoma"
      ],
      "interventions": [
        "PF-08046054",
        "Docetaxel monotherapy"
      ],
      "sponsor": "Pfizer",
      "enrollment": 680,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 Positive Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07145255",
      "title": "Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors",
      "brief_title": "Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Prostate Cancer Castration-resistant Prostate Cancer",
        "Breast Cancer",
        "Colo-rectal Cancer"
      ],
      "interventions": [
        "ADC"
      ],
      "sponsor": "MBrace Therapeutics",
      "enrollment": 150,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT07169552",
      "title": "HC010 in First-line PD-L1 Positive Advanced NSCLC Patients",
      "brief_title": "HC010 in First-line PD-L1 Positive Advanced NSCLC Patients",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "NSCLC"
      ],
      "interventions": [
        "HC010"
      ],
      "sponsor": "HC Biopharma Inc.",
      "enrollment": 50,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 Positive Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07190248",
      "title": "A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)",
      "brief_title": "A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)",
      "status": "RECRUITING",
      "phase": [
        "PHASE3"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Calderasib",
        "Pembrolizumab (+) Berahyaluronidase alfa",
        "Pemetrexed",
        "Cisplatin"
      ],
      "sponsor": "Merck Sharp & Dohme LLC",
      "enrollment": 675,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07232849",
      "title": "A Trial of HRS-4508 Combined With Other Antitumor Therapies in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer",
      "brief_title": "A Trial of HRS-4508 Combined With Other Antitumor Therapies in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Lung Cancer"
      ],
      "interventions": [
        "HRS-4508 tablet"
      ],
      "sponsor": "Jiangsu HengRui Medicine Co., Ltd.",
      "enrollment": 100,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07242547",
      "title": "Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients",
      "brief_title": "Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Limited-stage Small-cell Lung Cancer",
        "Carcinoma, Small Cell Lung",
        "Respiratory Tract Neoplasms"
      ],
      "interventions": [
        "Tarlatamab"
      ],
      "sponsor": "Fundación GECP",
      "enrollment": 37,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07330596",
      "title": "QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLC",
      "brief_title": "QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "NSCLC (Advanced Non-small Cell Lung Cancer)"
      ],
      "interventions": [
        "QL1706 combined with Chemotherapy",
        "Chemotherapy"
      ],
      "sponsor": "Anhui Provincial Cancer Hospital",
      "enrollment": 96,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='ALK Negative NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07339059",
      "title": "SG and Immunotherapy as Maintenance Therapy for Extensive-stage Small-cell Lung Cancer",
      "brief_title": "SG and Immunotherapy as Maintenance Therapy for Extensive-stage Small-cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Small Cell Lung Cancer ( SCLC )",
        "Extensive Stage Small Cell Lung Cancer (ES-SCLC)"
      ],
      "interventions": [
        "Sacituzumab govitecan",
        "Atezolizumab",
        "Durvalumab"
      ],
      "sponsor": "Bindu R Potugari",
      "enrollment": 35,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07392658",
      "title": "Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With EGFR exon20 Insertion Mutations.",
      "brief_title": "Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With EGFR exon20 Insertion Mutations.",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Metastatic NSCLC - Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "Amivantamab"
      ],
      "sponsor": "Fondazione Ricerca Traslazionale",
      "enrollment": 33,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT07398937",
      "title": "Comparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-IIIA Squamous NSCLC",
      "brief_title": "Comparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-IIIA Squamous NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE2"
      ],
      "conditions": [
        "Resectable Stage II-IIIa Squamous NSCLC"
      ],
      "interventions": [
        "Serplulimab + chemotherapy",
        "Nivolumab + chemotherapy"
      ],
      "sponsor": "Fudan University",
      "enrollment": 116,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT03198052",
      "title": "GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers",
      "brief_title": "GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Lung Cancer",
        "Cancer",
        "Immunotherapy"
      ],
      "interventions": [
        "CAR-T cells targeting GPC3, Mesothelin, Claudin18.2, GUCY2C, B7-H3, PSCA, PSMA, MUC1, TGFβ, HER2, Lewis-Y, AXL, or EGFR"
      ],
      "sponsor": "Second Affiliated Hospital of Guangzhou Medical University",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT03778814",
      "title": "TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors",
      "brief_title": "TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Nonsmall Cell Lung Cancer",
        "Solid Tumor, Adult"
      ],
      "interventions": [
        "TCR-T cells"
      ],
      "sponsor": "Second Affiliated Hospital of Guangzhou Medical University",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT03819296",
      "title": "Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer",
      "brief_title": "Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Clinical Stage 0 Cutaneous Melanoma AJCC v8",
        "Clinical Stage I Cutaneous Melanoma AJCC v8",
        "Clinical Stage IA Cutaneous Melanoma AJCC v8"
      ],
      "interventions": [
        "Best Practice",
        "Biospecimen Collection",
        "Endoscopic Procedure",
        "Fecal Microbiota Transplantation"
      ],
      "sponsor": "M.D. Anderson Cancer Center",
      "enrollment": 800,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Stage IVA Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04038619",
      "title": "Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients",
      "brief_title": "Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Colitis",
        "Diarrhea",
        "Malignant Genitourinary System Neoplasm"
      ],
      "interventions": [
        "Fecal Microbiota Transplantation",
        "Loperamide"
      ],
      "sponsor": "M.D. Anderson Cancer Center",
      "enrollment": 40,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04137900",
      "title": "Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies",
      "brief_title": "Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced Unresectable Solid Tumor",
        "Metastatic Solid Tumor"
      ],
      "interventions": [
        "TAB004",
        "Toripalimab"
      ],
      "sponsor": "TopAlliance Biosciences",
      "enrollment": 499,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04147078",
      "title": "Personalized DC Vaccine for Postoperative Cancer",
      "brief_title": "Personalized DC Vaccine for Postoperative Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Gastric Cancer",
        "Hepatocellular Carcinoma",
        "Non-Small-Cell Lung Cancer"
      ],
      "interventions": [
        "DC vaccine subcutaneous administration"
      ],
      "sponsor": "Sichuan University",
      "enrollment": 80,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT04423029",
      "title": "A Study of DF6002 Alone and in Combination With Nivolumab",
      "brief_title": "A Study of DF6002 Alone and in Combination With Nivolumab",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Solid Tumors"
      ],
      "interventions": [
        "DF6002",
        "Nivolumab"
      ],
      "sponsor": "Dragonfly Therapeutics",
      "enrollment": 438,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04429087",
      "title": "A Study to Test Different Doses of BI 764532 in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3",
      "brief_title": "A Study to Test Different Doses of BI 764532 in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Patients With Small Cell Lung Carcinoma and Other Neoplasms"
      ],
      "interventions": [
        "BI 764532 - parenteral 1",
        "BI 764532 - parenteral 2"
      ],
      "sponsor": "Boehringer Ingelheim",
      "enrollment": 300,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Non-Small Cell Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04780568",
      "title": "Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer",
      "brief_title": "Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Metastatic Lung Non-Small Cell Carcinoma",
        "Stage IV Lung Cancer AJCC v8",
        "Stage IVA Lung Cancer AJCC v8"
      ],
      "interventions": [
        "Osimertinib",
        "Tegavivint",
        "Echocardiography Test",
        "Multigated Acquisition Scan"
      ],
      "sponsor": "Ohio State University Comprehensive Cancer Center",
      "enrollment": 24,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Stage IVA Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04952272",
      "title": "Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors",
      "brief_title": "Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Lung Cancer",
        "Hepatocellular Carcinoma",
        "Solid Tumor"
      ],
      "interventions": [
        "CpG-ODN"
      ],
      "sponsor": "Second Affiliated Hospital of Guangzhou Medical University",
      "enrollment": 50,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05098210",
      "title": "Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer",
      "brief_title": "Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Anatomic Stage IV Breast Cancer AJCC v8",
        "Clinical Stage IV Cutaneous Melanoma AJCC v8",
        "Locally Advanced Cutaneous Melanoma"
      ],
      "interventions": [
        "Neoantigen Peptide Vaccine",
        "Nivolumab",
        "Poly ICLC",
        "Echocardiography"
      ],
      "sponsor": "Fred Hutchinson Cancer Center",
      "enrollment": 25,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='PD-L1 Positive Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05166616",
      "title": "Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer",
      "brief_title": "Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced Lung Non-Small Cell Carcinoma",
        "Locally Advanced Lung Non-Small Cell Carcinoma",
        "Stage III Lung Cancer AJCC v8"
      ],
      "interventions": [
        "Biopsy",
        "Osimertinib",
        "Triptolide Analog"
      ],
      "sponsor": "City of Hope Medical Center",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Stage IVA Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05234307",
      "title": "PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer",
      "brief_title": "PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Metastatic Lung Non-Small Cell Carcinoma",
        "Recurrent Lung Non-Small Cell Carcinoma",
        "Stage IV Lung Cancer AJCC v8"
      ],
      "interventions": [
        "Adenosine A2B Receptor Antagonist PBF-1129",
        "Biospecimen Collection",
        "Nivolumab"
      ],
      "sponsor": "Dwight Owen",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Stage IVA Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05254184",
      "title": "KRAS-Targeted Vaccine With Nivolumab and Ipilimumab for Patients With NSCLC",
      "brief_title": "KRAS-Targeted Vaccine With Nivolumab and Ipilimumab for Patients With NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "Pooled Mutant KRAS-Targeted Long Peptide Vaccine 0.3mg each; 1.8mg total peptides"
      ],
      "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
      "enrollment": 12,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05283330",
      "title": "Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors",
      "brief_title": "Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Cervical Cancer",
        "Breast Cancer",
        "Colon Cancer"
      ],
      "interventions": [
        "²¹²Pb-DOTAM-GRPR1"
      ],
      "sponsor": "Orano Med LLC",
      "enrollment": 48,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05366478",
      "title": "A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors",
      "brief_title": "A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Melanoma",
        "Non Small Cell Lung Cancer",
        "Cervical Carcinoma"
      ],
      "interventions": [
        "Autologous tumor infiltrating lymphocytes (TILs)"
      ],
      "sponsor": "Suzhou BlueHorse Therapeutics Co., Ltd.",
      "enrollment": 15,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05430009",
      "title": "Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer",
      "brief_title": "Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Liver Metastases",
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Liver SBRT",
        "Pembrolizumab"
      ],
      "sponsor": "VA Ann Arbor Healthcare System",
      "enrollment": 12,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05544240",
      "title": "Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors",
      "brief_title": "Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Metastatic Cancer",
        "Metastatic Breast Cancer",
        "Metastatic Lung Cancer"
      ],
      "interventions": [
        "SV-101"
      ],
      "sponsor": "Williams Cancer Foundation",
      "enrollment": 20,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05856981",
      "title": "Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors",
      "brief_title": "Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Solid Tumor, Adult",
        "Metastatic Solid Tumor",
        "Refractory Cancer"
      ],
      "interventions": [
        "ADU-1805",
        "Pembrolizumab"
      ],
      "sponsor": "Sairopa B.V.",
      "enrollment": 130,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05865002",
      "title": "A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)",
      "brief_title": "A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Relapsed Malignant Solid Neoplasm"
      ],
      "interventions": [
        "AUR107"
      ],
      "sponsor": "Aurigene Discovery Technologies Limited",
      "enrollment": 50,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05967533",
      "title": "The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors",
      "brief_title": "The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced Colorectal Carcinoma",
        "Advanced Lung Non-Small Cell Carcinoma",
        "Advanced Malignant Solid Neoplasm"
      ],
      "interventions": [
        "Fermented Wheat Germ Extract"
      ],
      "sponsor": "University of California, Davis",
      "enrollment": 100,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT05969041",
      "title": "Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors",
      "brief_title": "Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Epithelial Tumors, Malignant"
      ],
      "interventions": [
        "MT-302 (A)"
      ],
      "sponsor": "Myeloid Therapeutics",
      "enrollment": 48,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05983432",
      "title": "Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors",
      "brief_title": "Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer",
        "Lung Cancer",
        "Breast Cancer"
      ],
      "interventions": [
        "BL-B01D1"
      ],
      "sponsor": "SystImmune Inc.",
      "enrollment": 470,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06196294",
      "title": "GPC3/Mesothelin-CAR-γδT Cells Against Cancers",
      "brief_title": "GPC3/Mesothelin-CAR-γδT Cells Against Cancers",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Pancreas Cancer",
        "Lung Cancer",
        "Liver Cancer"
      ],
      "interventions": [
        "Cell therapy for solid tumors"
      ],
      "sponsor": "Second Affiliated Hospital of Guangzhou Medical University",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06270706",
      "title": "A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors",
      "brief_title": "A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Metastatic Solid Tumor"
      ],
      "interventions": [
        "PLN-101095",
        "Pembrolizumab"
      ],
      "sponsor": "Pliant Therapeutics, Inc.",
      "enrollment": 77,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06332755",
      "title": "Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC",
      "brief_title": "Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer(NSCLC)",
        "Head and Neck Squamous Cell Carcinoma(HNSCC)",
        "Renal Cell Carcinoma(RCC)"
      ],
      "interventions": [
        "Phase 1a: LB-LR1109",
        "Phase 1b: LB-LR1109 and Atezolizumab"
      ],
      "sponsor": "LG Chem",
      "enrollment": 76,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06362980",
      "title": "A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations",
      "brief_title": "A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "NSCLC"
      ],
      "interventions": [
        "BPI-1178",
        "Osimertinib"
      ],
      "sponsor": "National Cancer Center, China",
      "enrollment": 20,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06431685",
      "title": "Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer",
      "brief_title": "Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "NSCLC",
        "Low Dose Radiotherapy",
        "PD-1 Inhibitor"
      ],
      "interventions": [
        "Whole Brain Low Dose Radiotherapy",
        "Pemetrexed",
        "Sintilimab",
        "Chemotherapy"
      ],
      "sponsor": "Sichuan University",
      "enrollment": 10,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06561685",
      "title": "A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors",
      "brief_title": "A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Metastatic Solid Tumor",
        "Advanced Solid Tumor",
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "LY4050784",
        "Pembrolizumab",
        "Cisplatin",
        "Carboplatin"
      ],
      "sponsor": "Eli Lilly and Company",
      "enrollment": 340,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06566079",
      "title": "Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors",
      "brief_title": "Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Malignant Mesothelioma",
        "Metastatic Malignant Solid Tumor",
        "Advanced Solid Tumor"
      ],
      "interventions": [
        "ISM6331"
      ],
      "sponsor": "InSilico Medicine Hong Kong Limited",
      "enrollment": 100,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06607185",
      "title": "A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors",
      "brief_title": "A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Pancreatic Ductal Adenocarcinoma",
        "Non-small Cell Lung Cancer",
        "Colorectal Cancer"
      ],
      "interventions": [
        "LY4066434.",
        "Cetuximab",
        "Nab paclitaxel",
        "Gemcitabine"
      ],
      "sponsor": "Eli Lilly and Company",
      "enrollment": 750,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06673329",
      "title": "Brodalumab in the Treatment of Immune-Related Adverse Events",
      "brief_title": "Brodalumab in the Treatment of Immune-Related Adverse Events",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Breast Cancer",
        "Esophageal Cancer",
        "Kidney Cancer"
      ],
      "interventions": [
        "Brodalumab",
        "CT scan"
      ],
      "sponsor": "Brian Henick, MD",
      "enrollment": 11,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06723236",
      "title": "A Study of MGC028 in Participants With Advanced Solid Tumors",
      "brief_title": "A Study of MGC028 in Participants With Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced Solid Tumors",
        "NSCLC Adenocarcinoma",
        "Cholangiocarcinoma"
      ],
      "interventions": [
        "MGC028"
      ],
      "sponsor": "MacroGenics",
      "enrollment": 124,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06756035",
      "title": "CT-95 in Advanced Cancers Associated With Mesothelin Expression",
      "brief_title": "CT-95 in Advanced Cancers Associated With Mesothelin Expression",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Mesothelin-Expressing Tumors",
        "Epithelial Ovarian Cancer",
        "Malignant Pleural Mesothelioma, Advanced"
      ],
      "interventions": [
        "CT-95"
      ],
      "sponsor": "Context Therapeutics Inc.",
      "enrollment": 70,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06773507",
      "title": "Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors",
      "brief_title": "Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced Esophageal Cancers",
        "Advanced Non-small Cell Lung Cancer (NSCLC)"
      ],
      "interventions": [
        "BC008-1A 900mg",
        "BC008-1A 1200mg"
      ],
      "sponsor": "Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.",
      "enrollment": 80,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06789172",
      "title": "A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors",
      "brief_title": "A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Solid Tumours",
        "Sarcoma",
        "HNSCC"
      ],
      "interventions": [
        "OKN4395",
        "Pembrolizumab",
        "Fasting",
        "Fed"
      ],
      "sponsor": "Epkin",
      "enrollment": 166,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06835569",
      "title": "A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations",
      "brief_title": "A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Cancer",
        "PDAC - Pancreatic Ductal Adenocarcinoma",
        "NSCLC (Non-small Cell Lung Cancer)"
      ],
      "interventions": [
        "ALTA3263",
        "cetuximab"
      ],
      "sponsor": "Alterome Therapeutics, Inc.",
      "enrollment": 188,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06945523",
      "title": "Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer",
      "brief_title": "Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced Lung Cancer"
      ],
      "interventions": [
        "Targeted CEA CAR-T",
        "Targeted CEA CAR-T"
      ],
      "sponsor": "Chongqing Precision Biotech Co., Ltd",
      "enrollment": 60,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06992583",
      "title": "Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer",
      "brief_title": "Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Advanced Lung Cancer"
      ],
      "interventions": [
        "Targeted CEA CAR-T",
        "Targeted CEA CAR-T"
      ],
      "sponsor": "Chongqing Precision Biotech Co., Ltd",
      "enrollment": 60,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06999187",
      "title": "A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas",
      "brief_title": "A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Triple Negative Breast Cancer",
        "HER2-negative Breast Cancer",
        "Non Small Cell Lung Cancer"
      ],
      "interventions": [
        "DR-0202"
      ],
      "sponsor": "Dren Bio",
      "enrollment": 96,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT07006727",
      "title": "Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors",
      "brief_title": "Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Small Cell Lung Carcinoma",
        "Large Cell Neuroendocrine Carcinoma of the Lung",
        "Neuroendocrine Prostate Cancer"
      ],
      "interventions": [
        "225Ac-ETN029",
        "111In-ETN029"
      ],
      "sponsor": "Novartis Pharmaceuticals",
      "enrollment": 116,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07080242",
      "title": "Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors",
      "brief_title": "Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Small Cell Lung Cancer Metastatic or Locally Advanced",
        "Neuroendocrine Cancer",
        "Metastatic or Locally Advanced Neuroendocrine Prostate Cancer"
      ],
      "interventions": [
        "BL-M14D1"
      ],
      "sponsor": "SystImmune Inc.",
      "enrollment": 120,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT07094113",
      "title": "AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors",
      "brief_title": "AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "KRAS Altered Advanced or Metastatic Solid Tumors"
      ],
      "interventions": [
        "AMG 410",
        "Pembrolizumab",
        "Panitumumab"
      ],
      "sponsor": "Amgen",
      "enrollment": 434,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT07116057",
      "title": "MOv19-BBz CAR T Cells in FRa+ Cancers",
      "brief_title": "MOv19-BBz CAR T Cells in FRa+ Cancers",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Metastatic Non Small Cell Lung Cancer",
        "Recurrent Lung Non-Small Cell Carcinoma"
      ],
      "interventions": [
        "MOv19-BBz CAR T cells",
        "Cyclophosphamide/Fludarabine",
        "FRa Expression Testing"
      ],
      "sponsor": "University of Pennsylvania",
      "enrollment": 10,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT07118176",
      "title": "Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers",
      "brief_title": "Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Anal Carcinoma",
        "Bladder Carcinoma",
        "Breast Carcinoma"
      ],
      "interventions": [
        "Computed Tomography",
        "Fludeoxyglucose F-18",
        "Gallium Ga 68 FAPi-46",
        "Positron Emission Tomography"
      ],
      "sponsor": "Jonsson Comprehensive Cancer Center",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT07139990",
      "title": "Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)",
      "brief_title": "Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Small Cell Lung Cancer Extensive Stage",
        "Brain Metastases",
        "Solid Tumor, Adult"
      ],
      "interventions": [
        "Cohort A: Extensive Stage Small Cell Lung Cancer (ES-SCLC) Thoracic Tumor PULSAR (Personalized ultrahypofractionated stereotactic ablative radiotherapy)",
        "Cohort B: Brain metastasis PULSAR (Personalized ultrahypofractionated stereotactic ablative radiotherapy)"
      ],
      "sponsor": "University of Texas Southwestern Medical Center",
      "enrollment": 45,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT07227168",
      "title": "A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer",
      "brief_title": "A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "Head and Neck Squamous Cell Carcinoma HNSCC",
        "Non-Small Cell Lung Cancer NSCLC",
        "Esophageal Cancer"
      ],
      "interventions": [
        "STRO-004",
        "Pembrolizumab"
      ],
      "sponsor": "Sutro Biopharma, Inc.",
      "enrollment": 200,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT07277413",
      "title": "A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors",
      "brief_title": "A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "PHASE1"
      ],
      "conditions": [
        "NSCLC Adenocarcinoma",
        "Gastroesophageal Cancer (GC)",
        "Gastric Adenocarcinoma"
      ],
      "interventions": [
        "IDE892",
        "IDE397"
      ],
      "sponsor": "IDEAYA Biosciences",
      "enrollment": 260,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT00001823",
      "title": "Evaluation for NCI Surgery Branch Clinical Research Protocols",
      "brief_title": "Evaluation for NCI Surgery Branch Clinical Research Protocols",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Synovial Cell Cancer",
        "Melanoma",
        "Colorectal Cancer"
      ],
      "interventions": [],
      "sponsor": "National Cancer Institute (NCI)",
      "enrollment": 7000,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT02682667",
      "title": "Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols",
      "brief_title": "Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Multiple Myeloma",
        "Lymphoma, Non-Hodgkin",
        "Leukemia-Lymphoma, Adult T-Cell"
      ],
      "interventions": [],
      "sponsor": "National Cancer Institute (NCI)",
      "enrollment": 500,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT03225586",
      "title": "Prospective Urban Rural Epidemiology Study",
      "brief_title": "Prospective Urban Rural Epidemiology Study",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Cardiovascular Diseases",
        "Risk Factor, Cardiovascular",
        "Health Behavior"
      ],
      "interventions": [],
      "sponsor": "Population Health Research Institute",
      "enrollment": 200000,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT03452774",
      "title": "SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry",
      "brief_title": "SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Cancer, Metastatic",
        "Cancer",
        "Cancer of Pancreas"
      ],
      "interventions": [
        "Clinical Trial Matching"
      ],
      "sponsor": "Massive Bio, Inc.",
      "enrollment": 50000,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT03647098",
      "title": "Survival Outcomes of Lung Cancer",
      "brief_title": "Survival Outcomes of Lung Cancer",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Cancer"
      ],
      "interventions": [
        "Treatment"
      ],
      "sponsor": "Hunan Province Tumor Hospital",
      "enrollment": 20000,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT03948100",
      "title": "Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers",
      "brief_title": "Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Esophageal Carcinoma",
        "Lung Non-Small Cell Carcinoma",
        "Stage I Lung Cancer AJCC v8"
      ],
      "interventions": [
        "Educational Intervention",
        "Quality-of-Life Assessment",
        "Questionnaire Administration",
        "Yoga"
      ],
      "sponsor": "M.D. Anderson Cancer Center",
      "enrollment": 400,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Stage IVA Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT03987555",
      "title": "Paclitaxel Therapeutic Drug Monitoring in Cancer Patients",
      "brief_title": "Paclitaxel Therapeutic Drug Monitoring in Cancer Patients",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Solid Tumor, Adult",
        "Metastatic Nonsmall Cell Lung Cancer",
        "Anatomic Stage IV Breast Cancer AJCC v8"
      ],
      "interventions": [
        "Blood draws",
        "QLQ-CIPN20 Survey",
        "PR-CTCAE Survey"
      ],
      "sponsor": "Wake Forest University Health Sciences",
      "enrollment": 20,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Stage IVA Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04063501",
      "title": "Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer",
      "brief_title": "Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Cancer"
      ],
      "interventions": [
        "Bronchoscopy",
        "Research Procedures"
      ],
      "sponsor": "NYU Langone Health",
      "enrollment": 48,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04169542",
      "title": "Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery",
      "brief_title": "Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Breast Ductal Carcinoma In Situ",
        "COVID-19 Infection",
        "Hereditary Breast Carcinoma"
      ],
      "interventions": [
        "Questionnaire Administration"
      ],
      "sponsor": "M.D. Anderson Cancer Center",
      "enrollment": 600,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT04258137",
      "title": "Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study",
      "brief_title": "Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Colorectal Cancer",
        "Non Small Cell Lung Cancer"
      ],
      "interventions": [
        "Liquid biopsy"
      ],
      "sponsor": "Institut Bergonié",
      "enrollment": 332,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04291755",
      "title": "Development and Analysis of a Stool Bank for Cancer Patients",
      "brief_title": "Development and Analysis of a Stool Bank for Cancer Patients",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Carcinoma, Non-Small-Cell Lung",
        "Carcinoma, Colorectal"
      ],
      "interventions": [
        "Pembrolizumab Injection"
      ],
      "sponsor": "Persephone Biosciences",
      "enrollment": 100,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04451473",
      "title": "Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery",
      "brief_title": "Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Cancer",
        "Surgery",
        "ERAS"
      ],
      "interventions": [
        "Enhanced Recovery After Surgery (ERAS )",
        "Traditional perioperative management without Enhanced Recovery After Surgery (ERAS )"
      ],
      "sponsor": "The Second Hospital of Shandong University",
      "enrollment": 350,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04510129",
      "title": "A Multicenter Cancer Biospecimen Collection Study",
      "brief_title": "A Multicenter Cancer Biospecimen Collection Study",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Cancer of Head and Neck",
        "Lung Cancer, Nonsmall Cell",
        "Small-cell Lung Cancer"
      ],
      "interventions": [
        "OncoPrism™ assay"
      ],
      "sponsor": "Cofactor Genomics, Inc.",
      "enrollment": 1650,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT04527419",
      "title": "SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009)",
      "brief_title": "SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009)",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Carcinoma, Non-Small-Cell Lung"
      ],
      "interventions": [
        "No mediastinal lymph node dissection"
      ],
      "sponsor": "Fudan University",
      "enrollment": 545,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT04706754",
      "title": "Pan-Canadian Lung Cancer Observational Study (PALEOS)",
      "brief_title": "Pan-Canadian Lung Cancer Observational Study (PALEOS)",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Cancer"
      ],
      "interventions": [
        "Questionnaires"
      ],
      "sponsor": "William Osler Health System",
      "enrollment": 25000,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04716257",
      "title": "A Prospective, Multi-center, Real-world Study of Ovarian Metastatic Colorectal Cancer Patients",
      "brief_title": "A Prospective, Multi-center, Real-world Study of Ovarian Metastatic Colorectal Cancer Patients",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Ovarian Metastasis",
        "Colorectal Cancer"
      ],
      "interventions": [],
      "sponsor": "West China Hospital",
      "enrollment": 400,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Signet Ring Cell Carcinoma'"
      ]
    },
    {
      "nct_id": "NCT04751747",
      "title": "Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer",
      "brief_title": "Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Locally Advanced Lung Non-Small Cell Carcinoma",
        "Metastatic Lung Non-Small Cell Carcinoma",
        "Stage II Lung Cancer AJCC v8"
      ],
      "interventions": [
        "Computed Tomography",
        "Contrast Agent"
      ],
      "sponsor": "Rutgers, The State University of New Jersey",
      "enrollment": 34,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Stage IVA Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04790682",
      "title": "LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG",
      "brief_title": "LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Metastatic Lung Cancer"
      ],
      "interventions": [
        "assessment of the predictive value of ctDNA level of the prominent mutant allele variation between baseline and week 6, on response to treatment according to RECIST 1.1 criteria."
      ],
      "sponsor": "Institut Curie",
      "enrollment": 300,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT04807114",
      "title": "A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC",
      "brief_title": "A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Diseases, Interstitial",
        "NSCLC",
        "Immunotherapy"
      ],
      "interventions": [
        "Immune checkpoint inhibitor",
        "Chemotherapy + Immune checkpoint inhibitor"
      ],
      "sponsor": "Universitaire Ziekenhuizen KU Leuven",
      "enrollment": 70,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT04913311",
      "title": "Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer",
      "brief_title": "Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Non-Small Cell Carcinoma"
      ],
      "interventions": [
        "Biospecimen Collection",
        "Bronchoscopy with Bronchoalveolar Lavage",
        "Chemoradiotherapy",
        "Computed Tomography"
      ],
      "sponsor": "M.D. Anderson Cancer Center",
      "enrollment": 150,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05037825",
      "title": "The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors",
      "brief_title": "The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Non-Small-Cell Lung Carcinoma",
        "Malignant Melanoma",
        "Renal Cell Carcinoma"
      ],
      "interventions": [
        "Checkpoint Inhibitor, Immune"
      ],
      "sponsor": "VastBiome",
      "enrollment": 800,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05126290",
      "title": "CTNNA1 Familial Expansion Study",
      "brief_title": "CTNNA1 Familial Expansion Study",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Cancer Gene Mutation",
        "Gastric Cancer",
        "Breast Cancer"
      ],
      "interventions": [
        "Collection of personal and family history from CAFÉ Study participants"
      ],
      "sponsor": "Abramson Cancer Center at Penn Medicine",
      "enrollment": 100,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Signet Ring Cell Carcinoma'"
      ]
    },
    {
      "nct_id": "NCT05267041",
      "title": "Joint Thoracic Oncology Research Unit of LYon: Lung cancerS DatabaSE (ULYSSE)",
      "brief_title": "Joint Thoracic Oncology Research Unit of LYon: Lung cancerS DatabaSE (ULYSSE)",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Cancer"
      ],
      "interventions": [
        "Blood sample",
        "Questionnaire"
      ],
      "sponsor": "Hospices Civils de Lyon",
      "enrollment": 4000,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05297734",
      "title": "Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer",
      "brief_title": "Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "End of Life",
        "Cancer"
      ],
      "interventions": [
        "Receive technology-based supportive cancer care",
        "Receive redesigned team-based supportive cancer care"
      ],
      "sponsor": "Stanford University",
      "enrollment": 2996,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05384769",
      "title": "Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer",
      "brief_title": "Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Carcinoma"
      ],
      "interventions": [
        "Liquid Biopsy",
        "Low Dose Computed Tomography of the Chest",
        "Survey Administration"
      ],
      "sponsor": "City of Hope Medical Center",
      "enrollment": 108,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05384873",
      "title": "Immunonutrition for Improving the Efficacy of Immunotherapy in Patients With Metastatic Non-small Cell Lung Cancer",
      "brief_title": "Immunonutrition for Improving the Efficacy of Immunotherapy in Patients With Metastatic Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Cancer, Nonsmall Cell"
      ],
      "interventions": [
        "Immunonutrition",
        "Control dietary intervention"
      ],
      "sponsor": "Fondazione IRCCS Policlinico San Matteo di Pavia",
      "enrollment": 180,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05456841",
      "title": "Empathic Communication Skills (ECS) Training",
      "brief_title": "Empathic Communication Skills (ECS) Training",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Cancer"
      ],
      "interventions": [
        "Empathic Communication Skills (ECS) training",
        "Standard of Care participant interaction"
      ],
      "sponsor": "Memorial Sloan Kettering Cancer Center",
      "enrollment": 1232,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05456867",
      "title": "A Multi-center, Non-interventional, Prospective Study of Durvalumab in Unresectable Locally Advanced NSCLC in Routine Clinical Practice in Russia",
      "brief_title": "A Multi-center, Non-interventional, Prospective Study of Durvalumab in Unresectable Locally Advanced NSCLC in Routine Clinical Practice in Russia",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "NSCLC, Non-small-cell Lung Carcinoma"
      ],
      "interventions": [],
      "sponsor": "AstraZeneca",
      "enrollment": 250,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05463796",
      "title": "InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer",
      "brief_title": "InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Cancer Risk",
        "Cancer Predisposition Syndrome",
        "Hereditary Cancer Prediction"
      ],
      "interventions": [
        "Samples"
      ],
      "sponsor": "Dana-Farber Cancer Institute",
      "enrollment": 5000,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05475366",
      "title": "Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures",
      "brief_title": "Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Carcinoma, Pancreatic Ductal",
        "Prognosis"
      ],
      "interventions": [
        "Clinical value of 5 transcriptomic signatures to personalize the therapeutic decision for L1 in PDAC",
        "Biomarkers of tumor signatures (translational studies)"
      ],
      "sponsor": "Institut Curie",
      "enrollment": 85,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05478538",
      "title": "Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform",
      "brief_title": "Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "NSCLC (Non-small Cell Lung Cancer)",
        "Metastatic NSCLC - Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "Core Needle, Forceps, or Punch Biopsy"
      ],
      "sponsor": "Elephas",
      "enrollment": 200,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05493566",
      "title": "Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer",
      "brief_title": "Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "EARLY_PHASE1"
      ],
      "conditions": [
        "Lung Non-Small Cell Carcinoma",
        "Stage IV Lung Cancer AJCC v8",
        "Stage IVA Lung Cancer AJCC v8"
      ],
      "interventions": [
        "Aldesleukin",
        "Pembrolizumab"
      ],
      "sponsor": "Emory University",
      "enrollment": 15,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Stage IVA Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05517811",
      "title": "Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection",
      "brief_title": "Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Liver Cancer",
        "Esophageal Cancer",
        "Colorectal Cancer"
      ],
      "interventions": [
        "TEG indices"
      ],
      "sponsor": "University of Colorado, Denver",
      "enrollment": 400,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT05537922",
      "title": "I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy",
      "brief_title": "I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Non Small Cell Lung Cancer",
        "Lung Cancer Metastatic",
        "Lung Cancer, Nonsmall Cell"
      ],
      "interventions": [],
      "sponsor": "Fondazione IRCCS Istituto Nazionale dei Tumori, Milano",
      "enrollment": 2200,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05552846",
      "title": "Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy",
      "brief_title": "Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Small-cell Lung Cancer"
      ],
      "interventions": [
        "thoracic radiotherapy"
      ],
      "sponsor": "Ruijin Hospital",
      "enrollment": 104,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05557552",
      "title": "Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer",
      "brief_title": "Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer Stage III"
      ],
      "interventions": [
        "standar thoracic RT dose",
        "decreased thoracic RT dose"
      ],
      "sponsor": "Ruijin Hospital",
      "enrollment": 56,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05596578",
      "title": "Role of Intrapulmonary Lymph Nodes in Patients With NSCLC and Visceral Pleural Invasion",
      "brief_title": "Role of Intrapulmonary Lymph Nodes in Patients With NSCLC and Visceral Pleural Invasion",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Cancer",
        "Lymph Node Metastasis"
      ],
      "interventions": [],
      "sponsor": "Luzerner Kantonsspital",
      "enrollment": 958,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05665504",
      "title": "Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer",
      "brief_title": "Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung; Node",
        "Adenocarcinoma of Lung"
      ],
      "interventions": [
        "DetermaRX"
      ],
      "sponsor": "H. Lee Moffitt Cancer Center and Research Institute",
      "enrollment": 250,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT05701176",
      "title": "A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer",
      "brief_title": "A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Advanced Stage Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "[18F]F-AraG PET scan"
      ],
      "sponsor": "Amsterdam UMC, location VUmc",
      "enrollment": 15,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced NSCLC'"
      ]
    },
    {
      "nct_id": "NCT05701787",
      "title": "Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations",
      "brief_title": "Molecular Landscape Analysis and Clinical Implications for NSCLC Patients With Rare Mutations",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "NSCLC",
        "NSCLC Stage IV",
        "NSCLC, Recurrent"
      ],
      "interventions": [],
      "sponsor": "Shanghai Chest Hospital",
      "enrollment": 500,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05715255",
      "title": "Adaptive Symptom Self-Management Immunotherapy Study",
      "brief_title": "Adaptive Symptom Self-Management Immunotherapy Study",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Breast Cancer",
        "Colon Cancer",
        "Lung Cancer"
      ],
      "interventions": [
        "Automated Telephone Symptom Management (ATMS) and Telephone Interpersonal Counseling (TIP-C)",
        "Active control comparator"
      ],
      "sponsor": "University of Arizona",
      "enrollment": 400,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05755672",
      "title": "On-treatment Biomarkers in Metastatic Colorectal Cancer for Life",
      "brief_title": "On-treatment Biomarkers in Metastatic Colorectal Cancer for Life",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Metastatic Colorectal Cancer",
        "Chemotherapy Effect",
        "Peritoneal Metastases"
      ],
      "interventions": [
        "Chemotherapy",
        "Resection of the primary tumor",
        "Resection of tumour metastases",
        "Blood sampling during chemotherapy"
      ],
      "sponsor": "Region Skane",
      "enrollment": 100,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05804786",
      "title": "Prospective Cohort of Diagnostic Bronchoscopy for Peripheral Lung Lesions",
      "brief_title": "Prospective Cohort of Diagnostic Bronchoscopy for Peripheral Lung Lesions",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Cancer"
      ],
      "interventions": [
        "Guided bronchoscopy"
      ],
      "sponsor": "Seoul National University Bundang Hospital",
      "enrollment": 1240,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05837767",
      "title": "A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue",
      "brief_title": "A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Invasive Ductal Breast Carcinoma",
        "Invasive Ductal Breast Carcinoma Stage IV",
        "Lobular Breast Carcinoma"
      ],
      "interventions": [
        "Palliative radiotherapy"
      ],
      "sponsor": "Memorial Sloan Kettering Cancer Center",
      "enrollment": 26,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT05860374",
      "title": "A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors",
      "brief_title": "A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": [
        "EARLY_PHASE1"
      ],
      "conditions": [
        "Sarcoma",
        "Carcinoma",
        "Breast Cancer"
      ],
      "interventions": [
        "Recombinant oncolytic herpes simplex virus type 1 (R130)"
      ],
      "sponsor": "Shanghai Yunying Medical Technology",
      "enrollment": 20,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05888584",
      "title": "Improving Access and Recruitment to Clinical Trials for Lung Cancer Patients",
      "brief_title": "Improving Access and Recruitment to Clinical Trials for Lung Cancer Patients",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Cancer"
      ],
      "interventions": [
        "Research readiness tool"
      ],
      "sponsor": "Oxford Brookes University",
      "enrollment": 100,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05902559",
      "title": "Assessment of Novel Biomarkers in Participants Undergoing Targeted Lung Health Checks",
      "brief_title": "Assessment of Novel Biomarkers in Participants Undergoing Targeted Lung Health Checks",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Cancer"
      ],
      "interventions": [],
      "sponsor": "University College, London",
      "enrollment": 10000,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT05933876",
      "title": "The Impact of Radiotherapy on Oligometastatic Cancer",
      "brief_title": "The Impact of Radiotherapy on Oligometastatic Cancer",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Metastasis",
        "Metastatic Breast Cancer",
        "Metastatic Prostate Cancer"
      ],
      "interventions": [
        "To propose a diagnostic test to determine the viability of Stereotactic ABlative Radiotherapy (SABR).",
        "To propose a diagnostic test to determine the effectiveness of SABR.",
        "To propose a diagnostic test for Oligometastatic Cancer (OC)."
      ],
      "sponsor": "Institut Investigacio Sanitaria Pere Virgili",
      "enrollment": 2000,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06005246",
      "title": "Munich ME/CFS Cohort Study",
      "brief_title": "Munich ME/CFS Cohort Study",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3)"
      ],
      "interventions": [],
      "sponsor": "Technical University of Munich",
      "enrollment": 200,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06020430",
      "title": "Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy",
      "brief_title": "Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Non Small Cell Lung Cancer",
        "Locally Advanced",
        "Radiotherapy"
      ],
      "interventions": [
        "CTV omitted or delineated"
      ],
      "sponsor": "Hubei Cancer Hospital",
      "enrollment": 134,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06026735",
      "title": "Non-small Cell Lung Cancer With Central Nervous System Metastasis",
      "brief_title": "Non-small Cell Lung Cancer With Central Nervous System Metastasis",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Cancer With Central Nervous System Metastasis"
      ],
      "interventions": [
        "lung cancer with brain /leptomeningeal metastasis"
      ],
      "sponsor": "National Taiwan University Hospital",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06169956",
      "title": "An Observational Study to Evaluate Neoadjuvant Nivolumab (OPDIVO®) in Combination With Platinum-Based Chemotherapy in Non-Metastatic Non-Small Cell Lung Cancer Participants in Germany",
      "brief_title": "An Observational Study to Evaluate Neoadjuvant Nivolumab (OPDIVO®) in Combination With Platinum-Based Chemotherapy in Non-Metastatic Non-Small Cell Lung Cancer Participants in Germany",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Resectable Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Neoadjuvant nivolumab in combination with platinum-based chemotherapy"
      ],
      "sponsor": "Bristol-Myers Squibb",
      "enrollment": 400,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06199570",
      "title": "Support for Cancer Patients Awaiting News",
      "brief_title": "Support for Cancer Patients Awaiting News",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Cancer"
      ],
      "interventions": [
        "Adapted Stress Management Program",
        "Enhanced Usual Care"
      ],
      "sponsor": "Hackensack Meridian Health",
      "enrollment": 60,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06244355",
      "title": "Studies of Phenotypic and Functional Characteristics of Circulating Neutrophil Subpopulations in Patients With Lung Cancer",
      "brief_title": "Studies of Phenotypic and Functional Characteristics of Circulating Neutrophil Subpopulations in Patients With Lung Cancer",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Cancer"
      ],
      "interventions": [
        "Extra blood tubes"
      ],
      "sponsor": "Assistance Publique - Hôpitaux de Paris",
      "enrollment": 100,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06255197",
      "title": "Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers",
      "brief_title": "Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Cancer",
        "Lung Adenocarcinoma",
        "Lung Squamous Cell Carcinoma"
      ],
      "interventions": [],
      "sponsor": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences",
      "enrollment": 60000,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT06277388",
      "title": "Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.",
      "brief_title": "Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Non-small Cell Lung Cancer",
        "Cardiac Toxicity"
      ],
      "interventions": [
        "Impedance cardiography"
      ],
      "sponsor": "Sun Yat-sen University",
      "enrollment": 237,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06317558",
      "title": "Real-world Clinical Outcomes of NSCLC Patients Receiving Neoadjuvant Immunotherapy",
      "brief_title": "Real-world Clinical Outcomes of NSCLC Patients Receiving Neoadjuvant Immunotherapy",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "NSCLC"
      ],
      "interventions": [
        "Neoadjuvant immunotherapy",
        "Other drugs for neoadjuvant treatment"
      ],
      "sponsor": "Cancer Institute and Hospital, Chinese Academy of Medical Sciences",
      "enrollment": 4000,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06352502",
      "title": "An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis",
      "brief_title": "An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "EGF-R Positive Non-Small Cell Lung Cancer",
        "CNS Metastases"
      ],
      "interventions": [
        "Furmonertinib"
      ],
      "sponsor": "Tang-Du Hospital",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06360822",
      "title": "Increasing Equity in Lung Cancer Screening",
      "brief_title": "Increasing Equity in Lung Cancer Screening",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Cancer"
      ],
      "interventions": [
        "ED-LCS"
      ],
      "sponsor": "Indiana University",
      "enrollment": 144,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06400654",
      "title": "PrognostIc and Predictive Factors in Unresectable Locally Advanced NEC and MANEC",
      "brief_title": "PrognostIc and Predictive Factors in Unresectable Locally Advanced NEC and MANEC",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Neuroendocrine Carcinoma"
      ],
      "interventions": [],
      "sponsor": "European Institute of Oncology",
      "enrollment": 100,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Advanced Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06428422",
      "title": "The Impact of Probiotic on Survival and Treatment Response in Metastatic Non-small Cell Lung Cancer Patients",
      "brief_title": "The Impact of Probiotic on Survival and Treatment Response in Metastatic Non-small Cell Lung Cancer Patients",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Metastatic Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Bifidobacterium animalis subsp. lactis Bl-04",
        "Plasebo"
      ],
      "sponsor": "Necmettin Erbakan University",
      "enrollment": 100,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06441357",
      "title": "Differentiating the Invasiveness of Lung Adenocarcinoma by Dual Energy CT Parameter",
      "brief_title": "Differentiating the Invasiveness of Lung Adenocarcinoma by Dual Energy CT Parameter",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Adenocarcinoma of Lung"
      ],
      "interventions": [],
      "sponsor": "Tang-Du Hospital",
      "enrollment": 2000,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Adenocarcinoma of the Lung'"
      ]
    },
    {
      "nct_id": "NCT06451003",
      "title": "Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery",
      "brief_title": "Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Venous Thromboembolism",
        "Pulmonary Embolism",
        "Deep Vein Thrombosis"
      ],
      "interventions": [
        "Exposure to clinical decision support system and education"
      ],
      "sponsor": "Medical University of South Carolina",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06523582",
      "title": "Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients",
      "brief_title": "Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Neuroendocrine Neoplasm",
        "Neuroendocrine Neoplasm of Gastrointestinal Tract",
        "Neuroendocrine Neoplasm of Lung"
      ],
      "interventions": [],
      "sponsor": "Universidad Nacional Autonoma de Mexico",
      "enrollment": 750,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06529081",
      "title": "Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer",
      "brief_title": "Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Small Cell Lung Carcinoma"
      ],
      "interventions": [
        "Palliative Radiotherapy",
        "Radical/Ablative Radiotherapy"
      ],
      "sponsor": "Copernicus Memorial Hospital",
      "enrollment": 165,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06540495",
      "title": "Virtual Personalized Exercise Program for Lung Cancer Patients",
      "brief_title": "Virtual Personalized Exercise Program for Lung Cancer Patients",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Cancer"
      ],
      "interventions": [
        "Salaso Virtual Exercise Program"
      ],
      "sponsor": "Northwell Health",
      "enrollment": 60,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06567704",
      "title": "Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study",
      "brief_title": "Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Non-small Cell Lung Cancer"
      ],
      "interventions": [
        "Interviews"
      ],
      "sponsor": "Wake Forest University Health Sciences",
      "enrollment": 20,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06576635",
      "title": "LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients",
      "brief_title": "LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "NSCLC"
      ],
      "interventions": [
        "Docetaxel",
        "Paclitaxel",
        "Gemcitabine",
        "Pemetrexed"
      ],
      "sponsor": "University of Illinois at Chicago",
      "enrollment": 29,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Metastatic NSCLC'"
      ]
    },
    {
      "nct_id": "NCT06623487",
      "title": "The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung Cancer",
      "brief_title": "The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung Cancer",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Carcinoma, Non-Small-Cell Lung",
        "PET / CT",
        "Neoadjuvant Immunotherapy"
      ],
      "interventions": [],
      "sponsor": "Ruijin Hospital",
      "enrollment": 30,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06688422",
      "title": "Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy",
      "brief_title": "Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Lung Cancer",
        "Pneumonitis",
        "Radiation-Induced Lung Injury"
      ],
      "interventions": [
        "incentive spirometry"
      ],
      "sponsor": "The Cooper Health System",
      "enrollment": 100,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06703866",
      "title": "Value-Based Medicine (VBM) for Lung Cancer",
      "brief_title": "Value-Based Medicine (VBM) for Lung Cancer",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Lung Cancer"
      ],
      "interventions": [
        "Non Small Cell Lung Cancer (NSCLC)"
      ],
      "sponsor": "European Institute of Oncology",
      "enrollment": 200,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06717243",
      "title": "Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)",
      "brief_title": "Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Small Cell Lung Cancer",
        "Large Cell Neuroendocrine (NE) Tumors",
        "Treatment Failure"
      ],
      "interventions": [
        "Carboplatin/Cisplatin -Etoposide - Atezolizumab"
      ],
      "sponsor": "Oncology Center of Biochemical Education And Research",
      "enrollment": 111,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    },
    {
      "nct_id": "NCT06726642",
      "title": "CfDNA in Hereditary And High-risk Malignancies 2",
      "brief_title": "CfDNA in Hereditary And High-risk Malignancies 2",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Hereditary Cancer Syndrome"
      ],
      "interventions": [
        "Cell-free DNA analysis"
      ],
      "sponsor": "University Health Network, Toronto",
      "enrollment": 1000,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Signet Ring Cell Carcinoma'"
      ]
    },
    {
      "nct_id": "NCT06735560",
      "title": "Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, ICC or NEN",
      "brief_title": "Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, ICC or NEN",
      "status": "RECRUITING",
      "phase": [
        "NA"
      ],
      "conditions": [
        "Hepatocellular Carcinoma (HCC)",
        "Intrahepatic Cholangiocarcinoma (Icc)",
        "Neuroendocrine Tumors"
      ],
      "interventions": [
        "89Zr-TLX250 PET/CT"
      ],
      "sponsor": "Nantes University Hospital",
      "enrollment": 60,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Lung Adenocarcinoma'"
      ]
    },
    {
      "nct_id": "NCT06756217",
      "title": "68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC",
      "brief_title": "68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC",
      "status": "RECRUITING",
      "phase": [],
      "conditions": [
        "Non-Small Cell Lung Cancer"
      ],
      "interventions": [
        "68Ga-grazytracer PET/CT"
      ],
      "sponsor": "Ruijin Hospital",
      "enrollment": 40,
      "start_date": null,
      "primary_completion_date": null,
      "locations_count": null,
      "study_type": "",
      "found_by_queries": [
        "cond='Immunotherapy for Lung Cancer'"
      ]
    }
  ],
  "agent_reasoning": "Based on your patient's profile—**43-year-old female, treatment-naive Stage IVA Lung Adenocarcinoma with Signet-Ring Cell features, PD-L1 60%, and no driver mutations (EGFR/ALK/ROS1/KRAS WT)**—the following clinical trials are highly relevant.\n\nThe patient is an excellent candidate for **first-line immunotherapy-based trials** specifically designing for \"PD-L1 High\" (≥50%) patients, often comparing novel agents (bispecifics, ADCs) against standard Pembrolizumab. Additionally, a rare histology-specific trial for \"Signet Ring Cell\" lung cancer was identified.\n\n### **Top Priority: Histology-Specific**\n*   **NCT07207278** | **Multi Omics Molecular Characteristics and Immunophenotyping of Lung Signet Ring Cell Carcinoma**\n    *   **Why Relevant:** This is an exceptionally specific trial for \"Lung Signet Ring Cell Carcinoma\" (LSRCC), a rare and aggressive subtype. While the interventional arm mentions ALK fusions, the study involves multi-omics profiling which is critical for this rare histology.\n    *   **Site:** Hangzhou, China (Recruiting).\n\n### **High Priority: First-Line PD-L1 High (TPS ≥ 50%)**\nThese Phase 3 trials are the most clinically appropriate standard-of-care alternatives, offering access to novel agents (Ivonescimab, Dato-DXd, Rilvegostomig) in the first-line setting.\n\n*   **NCT06767514** | **Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1**\n    *   **Intervention:** Ivonescimab (PD-1/VEGF bispecific antibody) vs. Pembrolizumab.\n    *   **Relevance:** Perfect match for PD-L1 high, driver-negative status. Ivonescimab has shown promise in similar settings.\n*   **NCT06357533** | **First-line Dato-DXd + Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 (TC ≥ 50%)**\n    *   **Intervention:** Datopotamab Deruxtecan (TROP2-ADC) + Rilvegostomig (PD-1/TIGIT bispecific) vs. Pembrolizumab.\n    *   **Relevance:** Aims to improve on standard chemotherapy-free immunotherapy by adding an ADC and a bispecific.\n*   **NCT06758401** | **Sigvotatug Vedotin Plus Pembrolizumab in Non-small Cell Lung Cancer With High Levels of PD-L1**\n    *   **Intervention:** Sigvotatug Vedotin (Integrin beta-6 ADC) + Pembrolizumab.\n    *   **Relevance:** Investigates adding a novel ADC to standard Pembrolizumab for high PD-L1 expressors.\n*   **NCT06868277** | **Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic NSCLC**\n    *   **Intervention:** Rilvegostomig (PD-1/TIGIT) monotherapy vs. Pembrolizumab.\n\n### **Other First-Line Immunotherapy Combinations**\n*   **NCT05920356 (CodeBreaK 202):** Evaluating Sotorasib + Chemo vs Pembrolizumab + Chemo (Note: Check if KRAS WT is allowed in control/specific arms, as Sotorasib is KRAS G12C specific, but broad \"NSCLC\" trials often screen all). *Reviewing details: This is likely specific to KRAS G12C, so likely **exclude** for this patient.*\n*   **NCT06618287:** BMS-986507 (Anti-TIGIT) combinations in Advanced Solid Tumors.\n*   **NCT05503667:** Neoadjuvant/Perioperative trials (Patient is Stage IVA, but if oligometastatic, some \"Stage IV\" protocols involving radiation might apply, though systemic therapy is standard).\n\n### **Genomic/Profiling Studies**\n*   **NCT04314401:** NCI Cancer Moonshot Biobank (collects tissue/blood for longitudinal analysis).\n*   **NCT04981119:** Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis (Pre-screening for future cell therapy).\n\n**Recommendation:**\nPrioritize referral to sites conducting **NCT06767514 (Ivonescimab)** or **NCT06357533 (Dato-DXd + Rilvegostomig)** as these offer the most promising potentiation of standard immunotherapy for her high PD-L1 status. The **NCT07207278** trial is scientifically unique for her signet-ring cell histology if accessible.",
  "tool_call_trace": [
    {
      "call_index": 0,
      "tool_name": "consult_medical_expert",
      "args": {
        "question": "What condition terms and synonyms should I search on ClinicalTrials.gov for a 43-year-old female with Stage IVA lung adenocarcinoma, signet-ring cell features, PD-L1 TPS 60%, and no driver mutations (EGFR/ALK/ROS1/KRAS WT)? Include terms for the specific histology, the broader condition (NSCLC), and the high PD-L1 status."
      },
      "result_summary": "MedGemma (33892ms): 18 terms extracted",
      "result_count": 0,
      "latency_ms": 33892.98837500246,
      "error": null
    },
    {
      "call_index": 1,
      "tool_name": "search_trials",
      "args": {
        "page_size": 100,
        "condition": "Lung Adenocarcinoma"
      },
      "result_summary": "Found 100 trials (API total: 100), latency 396ms. NCT IDs: ['NCT06427941', 'NCT07359586', 'NCT05865730', 'NCT07376707', 'NCT05266846', 'NCT06056115', 'NCT04903873', 'NCT03740256', 'NCT07171190', 'NCT05550961', 'NCT06710132', 'NCT04566432', 'NCT05469022', 'NCT05245500', 'NCT06516887', 'NCT06585488', 'NCT06303505', 'NCT05652686', 'NCT05830812', 'NCT04149691', 'NCT06777316', 'NCT06444815', 'NCT06910657', 'NCT07219576', 'NCT07094204', 'NCT06066138', 'NCT06778863', 'NCT05768178', 'NCT07348211', 'NCT06796816', 'NCT06500455', 'NCT04084067', 'NCT03198546', 'NCT03175224', 'NCT04401059', 'NCT06523582', 'NCT06995898', 'NCT06508307', 'NCT07224464', 'NCT06745830', 'NCT05877599', 'NCT06943521', 'NCT04510129', 'NCT05503667', 'NCT05297734', 'NCT04314401', 'NCT04969315', 'NCT05463796', 'NCT04787042', 'NCT05764954', 'NCT06108479', 'NCT06047379', 'NCT07410494', 'NCT06687941', 'NCT06296745', 'NCT06040541', 'NCT05024214', 'NCT07349537', 'NCT07172802', 'NCT03556228', 'NCT06862934', 'NCT07225452', 'NCT06888063', 'NCT05937906', 'NCT07115043', 'NCT05037825', 'NCT06859684', 'NCT06349642', 'NCT06440057', 'NCT07148128', 'NCT05669430', 'NCT06031181', 'NCT04981119', 'NCT05838053', 'NCT04999761', 'NCT04119024', 'NCT06472388', 'NCT05208762', 'NCT07070518', 'NCT06922591', 'NCT06451497', 'NCT06555588', 'NCT05579366', 'NCT05703269', 'NCT06283719', 'NCT04895709', 'NCT05461430', 'NCT06810544', 'NCT07334119', 'NCT06015724', 'NCT06735560', 'NCT06805825', 'NCT06281678', 'NCT06851663', 'NCT06218914', 'NCT06073431', 'NCT07079150', 'NCT05208944', 'NCT06532799', 'NCT06814496']",
      "result_count": 100,
      "latency_ms": 398.1059159996221,
      "error": null
    },
    {
      "call_index": 2,
      "tool_name": "search_trials",
      "args": {
        "page_size": 100,
        "condition": "Adenocarcinoma of the Lung"
      },
      "result_summary": "Found 100 trials (API total: 100), latency 1416ms. NCT IDs: ['NCT06427941', 'NCT07376707', 'NCT05266846', 'NCT06056115', 'NCT03740256', 'NCT05550961', 'NCT04566432', 'NCT05469022', 'NCT06516887', 'NCT06585488', 'NCT06303505', 'NCT05652686', 'NCT05830812', 'NCT06910657', 'NCT06778863', 'NCT05768178', 'NCT07348211', 'NCT06796816', 'NCT06500455', 'NCT03175224', 'NCT04401059', 'NCT06508307', 'NCT07224464', 'NCT06745830', 'NCT05877599', 'NCT05503667', 'NCT04787042', 'NCT05764954', 'NCT06108479', 'NCT06687941', 'NCT06296745', 'NCT05024214', 'NCT07172802', 'NCT03556228', 'NCT05937906', 'NCT07115043', 'NCT07148128', 'NCT05669430', 'NCT06031181', 'NCT05838053', 'NCT04119024', 'NCT06472388', 'NCT05208762', 'NCT07070518', 'NCT06922591', 'NCT06555588', 'NCT05461430', 'NCT06810544', 'NCT07334119', 'NCT06015724', 'NCT06805825', 'NCT06218914', 'NCT07079150', 'NCT06814496', 'NCT07423169', 'NCT05176483', 'NCT06051695', 'NCT07118176', 'NCT07223047', 'NCT06026410', 'NCT06393400', 'NCT05288205', 'NCT06199895', 'NCT04339218', 'NCT05783622', 'NCT05456256', 'NCT06925516', 'NCT06266299', 'NCT06441357', 'NCT05558904', 'NCT06362369', 'NCT06937905', 'NCT05665504', 'NCT06577987', 'NCT05978284', 'NCT06126406', 'NCT07275073', 'NCT07161882', 'NCT06923761', 'NCT05873686', 'NCT05717803', 'NCT07038096', 'NCT04169542', 'NCT06528847', 'NCT07070362', 'NCT06917079', 'NCT04485013', 'NCT06255197', 'NCT06495125', 'NCT03351842', 'NCT05517811', 'NCT07219251', 'NCT05887492', 'NCT05078047', 'NCT06265285', 'NCT07020117', 'NCT06394674', 'NCT05967533', 'NCT05830058', 'NCT04527419']",
      "result_count": 100,
      "latency_ms": 1417.7251250002882,
      "error": null
    },
    {
      "call_index": 3,
      "tool_name": "search_trials",
      "args": {
        "page_size": 100,
        "condition": "NSCLC"
      },
      "result_summary": "Found 100 trials (API total: 100), latency 1391ms. NCT IDs: ['NCT06427941', 'NCT06716437', 'NCT05841472', 'NCT05452005', 'NCT07376707', 'NCT06940401', 'NCT06440954', 'NCT05965557', 'NCT05384626', 'NCT07133425', 'NCT07057102', 'NCT05266846', 'NCT06969027', 'NCT07397338', 'NCT06734182', 'NCT02596490', 'NCT04903873', 'NCT05473156', 'NCT07169994', 'NCT05502523', 'NCT05136846', 'NCT07188480', 'NCT07017829', 'NCT04686682', 'NCT07056556', 'NCT04853342', 'NCT06250829', 'NCT05550961', 'NCT02146170', 'NCT06671379', 'NCT07014202', 'NCT03958240', 'NCT06102057', 'NCT06232265', 'NCT06710132', 'NCT05941507', 'NCT06272864', 'NCT04566432', 'NCT05933265', 'NCT04777084', 'NCT06843707', 'NCT06122064', 'NCT04631770', 'NCT06358222', 'NCT05469022', 'NCT06924710', 'NCT07300150', 'NCT07016126', 'NCT06151574', 'NCT06492421', 'NCT05271916', 'NCT07164885', 'NCT06475300', 'NCT07222566', 'NCT06382129', 'NCT00900419', 'NCT03991819', 'NCT05172739', 'NCT05245500', 'NCT06737107', 'NCT06772623', 'NCT05382728', 'NCT05501665', 'NCT06150664', 'NCT06780098', 'NCT06585488', 'NCT06598839', 'NCT06303505', 'NCT06917573', 'NCT07039994', 'NCT06032052', 'NCT05589818', 'NCT04149691', 'NCT06618287', 'NCT06617416', 'NCT06141226', 'NCT06041776', 'NCT00471978', 'NCT06317558', 'NCT06444815', 'NCT07010419', 'NCT05765877', 'NCT03412877', 'NCT06731907', 'NCT06877299', 'NCT06646471', 'NCT07325864', 'NCT03476681', 'NCT07219576', 'NCT07098338', 'NCT06644768', 'NCT06417008', 'NCT07094204', 'NCT06066138', 'NCT07257471', 'NCT04926584', 'NCT06484816', 'NCT04886804', 'NCT06639191', 'NCT04973293']",
      "result_count": 100,
      "latency_ms": 1392.3474170005647,
      "error": null
    },
    {
      "call_index": 4,
      "tool_name": "search_trials",
      "args": {
        "page_size": 100,
        "condition": "Non-Small Cell Lung Cancer"
      },
      "result_summary": "Found 100 trials (API total: 100), latency 1662ms. NCT IDs: ['NCT06427941', 'NCT06716437', 'NCT01804686', 'NCT05865730', 'NCT05841472', 'NCT05452005', 'NCT07376707', 'NCT06940401', 'NCT06440954', 'NCT05965557', 'NCT07133425', 'NCT07057102', 'NCT06969027', 'NCT07397338', 'NCT06734182', 'NCT02596490', 'NCT04903873', 'NCT05473156', 'NCT07169994', 'NCT05502523', 'NCT05136846', 'NCT07188480', 'NCT07017829', 'NCT07056556', 'NCT04853342', 'NCT06250829', 'NCT05550961', 'NCT02146170', 'NCT06671379', 'NCT07014202', 'NCT03958240', 'NCT06102057', 'NCT06232265', 'NCT06710132', 'NCT06272864', 'NCT04566432', 'NCT04777084', 'NCT06843707', 'NCT06122064', 'NCT04631770', 'NCT06358222', 'NCT05469022', 'NCT07300150', 'NCT07046923', 'NCT07016126', 'NCT06151574', 'NCT06492421', 'NCT05271916', 'NCT07164885', 'NCT06475300', 'NCT07222566', 'NCT06382129', 'NCT00900419', 'NCT03991819', 'NCT05172739', 'NCT05245500', 'NCT06737107', 'NCT06772623', 'NCT05382728', 'NCT05501665', 'NCT06150664', 'NCT06780098', 'NCT06585488', 'NCT06598839', 'NCT06303505', 'NCT06917573', 'NCT07039994', 'NCT06032052', 'NCT05589818', 'NCT04149691', 'NCT06618287', 'NCT06617416', 'NCT06141226', 'NCT06041776', 'NCT00471978', 'NCT06444815', 'NCT05765877', 'NCT03412877', 'NCT06731907', 'NCT06877299', 'NCT06646471', 'NCT07325864', 'NCT03476681', 'NCT07219576', 'NCT07098338', 'NCT06644768', 'NCT06417008', 'NCT07094204', 'NCT06066138', 'NCT07257471', 'NCT04926584', 'NCT06484816', 'NCT04886804', 'NCT06639191', 'NCT04973293', 'NCT04429087', 'NCT05768178', 'NCT05538130', 'NCT06686771', 'NCT06513663']",
      "result_count": 100,
      "latency_ms": 1663.7000830014586,
      "error": null
    },
    {
      "call_index": 5,
      "tool_name": "search_trials",
      "args": {
        "page_size": 100,
        "condition": "Stage IVA Lung Cancer"
      },
      "result_summary": "Found 15 trials (API total: 15), latency 227ms. NCT IDs: ['NCT05503667', 'NCT05493566', 'NCT03582124', 'NCT04762199', 'NCT04919382', 'NCT05837052', 'NCT03819296', 'NCT04771520', 'NCT05269381', 'NCT05234307', 'NCT04751747', 'NCT03948100', 'NCT03987555', 'NCT04780568', 'NCT05166616']",
      "result_count": 15,
      "latency_ms": 227.66175000288058,
      "error": null
    },
    {
      "call_index": 6,
      "tool_name": "search_trials",
      "args": {
        "page_size": 100,
        "condition": "Metastatic Lung Adenocarcinoma"
      },
      "result_summary": "Found 100 trials (API total: 100), latency 1516ms. NCT IDs: ['NCT06427941', 'NCT07376707', 'NCT06056115', 'NCT04903873', 'NCT06585488', 'NCT06910657', 'NCT07094204', 'NCT06066138', 'NCT06778863', 'NCT07348211', 'NCT06500455', 'NCT04084067', 'NCT07224464', 'NCT05877599', 'NCT04314401', 'NCT06108479', 'NCT06047379', 'NCT07410494', 'NCT06687941', 'NCT06296745', 'NCT06040541', 'NCT07172802', 'NCT03556228', 'NCT05937906', 'NCT07115043', 'NCT06859684', 'NCT06349642', 'NCT07148128', 'NCT04999761', 'NCT04119024', 'NCT06922591', 'NCT05579366', 'NCT05703269', 'NCT05461430', 'NCT06805825', 'NCT06218914', 'NCT06532799', 'NCT05176483', 'NCT06051695', 'NCT05076760', 'NCT05277051', 'NCT06393400', 'NCT04339218', 'NCT05783622', 'NCT06266299', 'NCT05706129', 'NCT06010862', 'NCT06362369', 'NCT03924466', 'NCT04777994', 'NCT06147037', 'NCT06179160', 'NCT06953089', 'NCT06577987', 'NCT06126406', 'NCT06242470', 'NCT06917079', 'NCT04485013', 'NCT07229313', 'NCT05086692', 'NCT06908304', 'NCT05078047', 'NCT07218003', 'NCT06265285', 'NCT07020117', 'NCT06394674', 'NCT06792435', 'NCT03452774', 'NCT05267626', 'NCT07161713', 'NCT05856981', 'NCT04563338', 'NCT06756035', 'NCT06861088', 'NCT04771520', 'NCT06270706', 'NCT06561685', 'NCT07227168', 'NCT02133196', 'NCT04105270', 'NCT06031246', 'NCT05269381', 'NCT05837767', 'NCT05475366', 'NCT04977453', 'NCT05379985', 'NCT07277413', 'NCT05431270', 'NCT07094113', 'NCT06999187', 'NCT05592626', 'NCT07080242', 'NCT07116057', 'NCT06332755', 'NCT06607185', 'NCT05983432', 'NCT05537922', 'NCT05914116', 'NCT05969041', 'NCT06835569']",
      "result_count": 100,
      "latency_ms": 1517.3337919986807,
      "error": null
    },
    {
      "call_index": 7,
      "tool_name": "search_trials",
      "args": {
        "condition": "Advanced Lung Adenocarcinoma",
        "page_size": 100
      },
      "result_summary": "Found 100 trials (API total: 100), latency 1844ms. NCT IDs: ['NCT06427941', 'NCT05865730', 'NCT07376707', 'NCT05266846', 'NCT04903873', 'NCT03740256', 'NCT06710132', 'NCT05245500', 'NCT06516887', 'NCT06585488', 'NCT04149691', 'NCT06777316', 'NCT06444815', 'NCT06910657', 'NCT07094204', 'NCT06066138', 'NCT06778863', 'NCT07348211', 'NCT03175224', 'NCT04401059', 'NCT06508307', 'NCT07224464', 'NCT05877599', 'NCT06943521', 'NCT04969315', 'NCT04787042', 'NCT06108479', 'NCT07410494', 'NCT06687941', 'NCT06040541', 'NCT05024214', 'NCT07349537', 'NCT07172802', 'NCT03556228', 'NCT05937906', 'NCT07115043', 'NCT06859684', 'NCT06440057', 'NCT07148128', 'NCT05669430', 'NCT04999761', 'NCT06472388', 'NCT05208762', 'NCT07070518', 'NCT06451497', 'NCT06555588', 'NCT05579366', 'NCT06283719', 'NCT04895709', 'NCT07334119', 'NCT06805825', 'NCT06281678', 'NCT06218914', 'NCT06073431', 'NCT05208944', 'NCT06532799', 'NCT05176483', 'NCT06051695', 'NCT07223047', 'NCT05076760', 'NCT06026410', 'NCT05277051', 'NCT06393400', 'NCT05288205', 'NCT04952272', 'NCT05783622', 'NCT07070700', 'NCT06789172', 'NCT05456256', 'NCT06266299', 'NCT05706129', 'NCT06010862', 'NCT06362369', 'NCT06937905', 'NCT03924466', 'NCT04777994', 'NCT06147037', 'NCT06179160', 'NCT06400654', 'NCT06953089', 'NCT06577987', 'NCT06126406', 'NCT07275073', 'NCT06923761', 'NCT05873686', 'NCT07038096', 'NCT06242470', 'NCT06917079', 'NCT04485013', 'NCT07229313', 'NCT04147078', 'NCT06495125', 'NCT07145255', 'NCT05086692', 'NCT06908304', 'NCT05887492', 'NCT05078047', 'NCT07218003', 'NCT06265285', 'NCT07020117']",
      "result_count": 100,
      "latency_ms": 1845.34670899302,
      "error": null
    },
    {
      "call_index": 8,
      "tool_name": "search_trials",
      "args": {
        "condition": "Signet Ring Cell Carcinoma",
        "page_size": 100
      },
      "result_summary": "Found 6 trials (API total: 6), latency 1051ms. NCT IDs: ['NCT07207278', 'NCT04716257', 'NCT05126290', 'NCT06726642', 'NCT06487221', 'NCT06371586']",
      "result_count": 6,
      "latency_ms": 1051.4661249981145,
      "error": null
    },
    {
      "call_index": 9,
      "tool_name": "search_trials",
      "args": {
        "page_size": 100,
        "condition": "Signet Ring Cell Lung Cancer"
      },
      "result_summary": "Found 1 trials (API total: 1), latency 1501ms. NCT IDs: ['NCT07207278']",
      "result_count": 1,
      "latency_ms": 1501.5518330037594,
      "error": null
    },
    {
      "call_index": 10,
      "tool_name": "search_trials",
      "args": {
        "page_size": 100,
        "condition": "PD-L1 High Lung Cancer"
      },
      "result_summary": "Found 8 trials (API total: 8), latency 212ms. NCT IDs: ['NCT06767514', 'NCT06357533', 'NCT06758401', 'NCT06228066', 'NCT06305962', 'NCT05215340', 'NCT06869239', 'NCT06868277']",
      "result_count": 8,
      "latency_ms": 211.87150000332622,
      "error": null
    },
    {
      "call_index": 11,
      "tool_name": "search_trials",
      "args": {
        "page_size": 100,
        "condition": "PD-L1 Positive Lung Cancer"
      },
      "result_summary": "Found 16 trials (API total: 16), latency 1458ms. NCT IDs: ['NCT04585750', 'NCT07264647', 'NCT05718323', 'NCT05098210', 'NCT06579196', 'NCT07144280', 'NCT07169552', 'NCT06119581', 'NCT05669846', 'NCT06448312', 'NCT06980272', 'NCT06269211', 'NCT06305962', 'NCT05751798', 'NCT05920356', 'NCT05004974']",
      "result_count": 16,
      "latency_ms": 1459.0125830000034,
      "error": null
    },
    {
      "call_index": 12,
      "tool_name": "search_trials",
      "args": {
        "page_size": 100,
        "condition": "EGFR Wild-Type NSCLC"
      },
      "result_summary": "Found 5 trials (API total: 5), latency 1466ms. NCT IDs: ['NCT06382129', 'NCT06618287', 'NCT04928846', 'NCT06568939', 'NCT05777278']",
      "result_count": 5,
      "latency_ms": 1466.2147080016439,
      "error": null
    },
    {
      "call_index": 13,
      "tool_name": "search_trials",
      "args": {
        "page_size": 100,
        "condition": "ALK Negative NSCLC"
      },
      "result_summary": "Found 2 trials (API total: 2), latency 1496ms. NCT IDs: ['NCT06749886', 'NCT07330596']",
      "result_count": 2,
      "latency_ms": 1496.3911250015371,
      "error": null
    },
    {
      "call_index": 14,
      "tool_name": "search_trials",
      "args": {
        "page_size": 100,
        "condition": "ROS1 Negative NSCLC"
      },
      "result_summary": "Found 1 trials (API total: 1), latency 1578ms. NCT IDs: ['NCT06749886']",
      "result_count": 1,
      "latency_ms": 1577.7215839989367,
      "error": null
    },
    {
      "call_index": 15,
      "tool_name": "search_trials",
      "args": {
        "page_size": 100,
        "condition": "KRAS Wild-Type NSCLC"
      },
      "result_summary": "Found 3 trials (API total: 3), latency 276ms. NCT IDs: ['NCT06585488', 'NCT05276726', 'NCT05887492']",
      "result_count": 3,
      "latency_ms": 276.56233299785526,
      "error": null
    },
    {
      "call_index": 16,
      "tool_name": "search_trials",
      "args": {
        "condition": "Wild Type NSCLC",
        "page_size": 100
      },
      "result_summary": "Found 10 trials (API total: 10), latency 1407ms. NCT IDs: ['NCT06382129', 'NCT06585488', 'NCT06618287', 'NCT06047379', 'NCT04928846', 'NCT05276726', 'NCT06568939', 'NCT05887492', 'NCT05777278', 'NCT05431270']",
      "result_count": 10,
      "latency_ms": 1407.3305419951794,
      "error": null
    },
    {
      "call_index": 17,
      "tool_name": "search_trials",
      "args": {
        "condition": "Lung Cancer",
        "page_size": 100
      },
      "result_summary": "Found 100 trials (API total: 100), latency 1640ms. NCT IDs: ['NCT06427941', 'NCT06716437', 'NCT06540495', 'NCT07045103', 'NCT07359586', 'NCT01804686', 'NCT04400539', 'NCT05865730', 'NCT05841472', 'NCT05452005', 'NCT06673329', 'NCT07376707', 'NCT06940401', 'NCT06440954', 'NCT05755672', 'NCT05965557', 'NCT06703866', 'NCT06244355', 'NCT05456841', 'NCT05933876', 'NCT07133425', 'NCT07057102', 'NCT05902559', 'NCT05266846', 'NCT06969027', 'NCT07397338', 'NCT06734182', 'NCT06563388', 'NCT06056115', 'NCT07139990', 'NCT02596490', 'NCT04952480', 'NCT05502913', 'NCT04903873', 'NCT06566079', 'NCT05318027', 'NCT04706754', 'NCT05473156', 'NCT07169994', 'NCT05502523', 'NCT06203210', 'NCT06945523', 'NCT05136846', 'NCT07006727', 'NCT03740256', 'NCT07188480', 'NCT05384769', 'NCT07017829', 'NCT04451473', 'NCT06477523', 'NCT06005246', 'NCT06199570', 'NCT07171190', 'NCT06223711', 'NCT06360822', 'NCT07056556', 'NCT04853342', 'NCT06250829', 'NCT05550961', 'NCT02146170', 'NCT06671379', 'NCT07014202', 'NCT03958240', 'NCT06102057', 'NCT06232265', 'NCT06710132', 'NCT06923098', 'NCT05941507', 'NCT06272864', 'NCT04038619', 'NCT04566432', 'NCT03647098', 'NCT04777084', 'NCT06843707', 'NCT06122064', 'NCT04631770', 'NCT06358222', 'NCT03225586', 'NCT06451003', 'NCT05804786', 'NCT06247605', 'NCT05469022', 'NCT06095505', 'NCT07300150', 'NCT07046923', 'NCT06938880', 'NCT07016126', 'NCT06151574', 'NCT06853678', 'NCT06492421', 'NCT05888584', 'NCT05271916', 'NCT07164885', 'NCT07207278', 'NCT06475300', 'NCT07222566', 'NCT06382129', 'NCT00900419', 'NCT03991819', 'NCT05267041']",
      "result_count": 100,
      "latency_ms": 1641.4033750043018,
      "error": null
    },
    {
      "call_index": 18,
      "tool_name": "search_trials",
      "args": {
        "page_size": 100,
        "condition": "Metastatic NSCLC"
      },
      "result_summary": "Found 100 trials (API total: 100), latency 1612ms. NCT IDs: ['NCT06427941', 'NCT05841472', 'NCT05452005', 'NCT07376707', 'NCT06940401', 'NCT05384626', 'NCT07397338', 'NCT02596490', 'NCT04903873', 'NCT05473156', 'NCT07017829', 'NCT07056556', 'NCT06671379', 'NCT05933265', 'NCT06358222', 'NCT06151574', 'NCT06475300', 'NCT07222566', 'NCT06382129', 'NCT00900419', 'NCT06772623', 'NCT05382728', 'NCT06585488', 'NCT06917573', 'NCT06032052', 'NCT05589818', 'NCT03412877', 'NCT07325864', 'NCT07098338', 'NCT06644768', 'NCT07094204', 'NCT06066138', 'NCT04886804', 'NCT05538130', 'NCT06686771', 'NCT06513663', 'NCT06974604', 'NCT06576635', 'NCT07348211', 'NCT05631249', 'NCT06500455', 'NCT06026735', 'NCT07028489', 'NCT04790682', 'NCT06050980', 'NCT06632262', 'NCT07058519', 'NCT06500481', 'NCT05877599', 'NCT04370587', 'NCT07390838', 'NCT06881784', 'NCT06345729', 'NCT06343402', 'NCT06518057', 'NCT06581419', 'NCT06472245', 'NCT06899126', 'NCT05910827', 'NCT06962865', 'NCT04314401', 'NCT04410796', 'NCT06238479', 'NCT06946927', 'NCT06108479', 'NCT05283330', 'NCT06047379', 'NCT06107686', 'NCT07410494', 'NCT04585750', 'NCT06431685', 'NCT06216301', 'NCT06296745', 'NCT06169956', 'NCT04258137', 'NCT05609578', 'NCT07392658', 'NCT07190248', 'NCT05478538', 'NCT04762199', 'NCT06040541', 'NCT04665206', 'NCT06767514', 'NCT07232849', 'NCT06428422', 'NCT06352502', 'NCT07172802', 'NCT03556228', 'NCT06788366', 'NCT05937906', 'NCT06248606', 'NCT07115043', 'NCT05430009', 'NCT05344209', 'NCT05596578', 'NCT06362980', 'NCT06349642', 'NCT07003321', 'NCT04423029', 'NCT05261399']",
      "result_count": 100,
      "latency_ms": 1613.8702499956707,
      "error": null
    },
    {
      "call_index": 19,
      "tool_name": "search_trials",
      "args": {
        "page_size": 100,
        "condition": "Advanced NSCLC"
      },
      "result_summary": "Found 100 trials (API total: 100), latency 1530ms. NCT IDs: ['NCT06427941', 'NCT05841472', 'NCT07376707', 'NCT06940401', 'NCT06440954', 'NCT05384626', 'NCT05266846', 'NCT06969027', 'NCT07397338', 'NCT04903873', 'NCT05473156', 'NCT07169994', 'NCT05136846', 'NCT07017829', 'NCT04686682', 'NCT07056556', 'NCT06671379', 'NCT07014202', 'NCT06102057', 'NCT06710132', 'NCT05941507', 'NCT06272864', 'NCT05933265', 'NCT04777084', 'NCT07300150', 'NCT06151574', 'NCT05271916', 'NCT07164885', 'NCT06475300', 'NCT07222566', 'NCT06382129', 'NCT03991819', 'NCT05245500', 'NCT06772623', 'NCT05382728', 'NCT06150664', 'NCT06585488', 'NCT06917573', 'NCT07039994', 'NCT05589818', 'NCT04149691', 'NCT06618287', 'NCT06617416', 'NCT06141226', 'NCT06444815', 'NCT06731907', 'NCT07098338', 'NCT06644768', 'NCT06417008', 'NCT07094204', 'NCT06066138', 'NCT04926584', 'NCT06484816', 'NCT04886804', 'NCT04973293', 'NCT05538130', 'NCT06513663', 'NCT05456867', 'NCT06974604', 'NCT05701176', 'NCT07348211', 'NCT06412471', 'NCT05631249', 'NCT06582771', 'NCT05416775', 'NCT07028489', 'NCT03175224', 'NCT04401059', 'NCT06050980', 'NCT07058519', 'NCT06718309', 'NCT06773507', 'NCT06723236', 'NCT05877599', 'NCT04370587', 'NCT07390838', 'NCT06943521', 'NCT07104630', 'NCT06881784', 'NCT06345729', 'NCT06343402', 'NCT06581419', 'NCT06899126', 'NCT05910827', 'NCT06712680', 'NCT05334277', 'NCT06962865', 'NCT06667622', 'NCT05254184', 'NCT04969315', 'NCT06238479', 'NCT04787042', 'NCT06946927', 'NCT06108479', 'NCT05642572', 'NCT06107686', 'NCT07410494', 'NCT04585750', 'NCT05366478', 'NCT05865002']",
      "result_count": 100,
      "latency_ms": 1532.1926249962416,
      "error": null
    },
    {
      "call_index": 20,
      "tool_name": "search_trials",
      "args": {
        "page_size": 100,
        "condition": "Immunotherapy for Lung Cancer"
      },
      "result_summary": "Found 100 trials (API total: 100), latency 1526ms. NCT IDs: ['NCT05965557', 'NCT05266846', 'NCT07014202', 'NCT06232265', 'NCT06853678', 'NCT06492421', 'NCT05501665', 'NCT07109401', 'NCT06910657', 'NCT06527898', 'NCT04973293', 'NCT06840834', 'NCT06717243', 'NCT05358548', 'NCT05715255', 'NCT06712316', 'NCT03198546', 'NCT00001823', 'NCT03778814', 'NCT06718309', 'NCT05726383', 'NCT02682667', 'NCT06498635', 'NCT07264647', 'NCT06734702', 'NCT06714708', 'NCT07086300', 'NCT04807114', 'NCT06277388', 'NCT04981119', 'NCT06698965', 'NCT06667908', 'NCT06483347', 'NCT06567704', 'NCT06623487', 'NCT07242547', 'NCT05552846', 'NCT05703269', 'NCT06241807', 'NCT03851445', 'NCT05825443', 'NCT07320105', 'NCT05701787', 'NCT06532799', 'NCT07423169', 'NCT04137900', 'NCT06448572', 'NCT06983899', 'NCT06841055', 'NCT06562920', 'NCT05255302', 'NCT05765084', 'NCT07082179', 'NCT04273061', 'NCT04728724', 'NCT06807307', 'NCT04913311', 'NCT05085028', 'NCT05384873', 'NCT05684276', 'NCT07047573', 'NCT04339218', 'NCT07239661', 'NCT04402788', 'NCT07071103', 'NCT05798845', 'NCT04322617', 'NCT04996017', 'NCT07058948', 'NCT06702826', 'NCT05557552', 'NCT05522660', 'NCT07339059', 'NCT06528847', 'NCT06586697', 'NCT04291755', 'NCT04267848', 'NCT03394365', 'NCT06840782', 'NCT07111520', 'NCT06992583', 'NCT06926140', 'NCT05544240', 'NCT06775678', 'NCT05860374', 'NCT06196294', 'NCT06020430', 'NCT06545747', 'NCT02133196', 'NCT06529081', 'NCT03755739', 'NCT04063501', 'NCT06121505', 'NCT06688422', 'NCT03198052', 'NCT06096844', 'NCT05431270', 'NCT07398937', 'NCT06756217', 'NCT06478108']",
      "result_count": 100,
      "latency_ms": 1527.5214580033207,
      "error": null
    },
    {
      "call_index": 21,
      "tool_name": "get_trial_details",
      "args": {
        "nct_id": "NCT07207278"
      },
      "result_summary": "Fetched details for NCT07207278 (Multi Omics Molecular Characteristics and Immunophenotyping of Lung Signet Ring Cell Carcinoma), latency 171ms",
      "result_count": 0,
      "latency_ms": 171.65587499766843,
      "error": null
    },
    {
      "call_index": 22,
      "tool_name": "get_trial_details",
      "args": {
        "nct_id": "NCT06767514"
      },
      "result_summary": "Fetched details for NCT06767514 (Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1), latency 1450ms",
      "result_count": 0,
      "latency_ms": 1450.5415000021458,
      "error": null
    },
    {
      "call_index": 23,
      "tool_name": "get_trial_details",
      "args": {
        "nct_id": "NCT06758401"
      },
      "result_summary": "Fetched details for NCT06758401 (This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.), latency 1509ms",
      "result_count": 0,
      "latency_ms": 1509.0529169974616,
      "error": null
    },
    {
      "call_index": 24,
      "tool_name": "get_trial_details",
      "args": {
        "nct_id": "NCT06357533"
      },
      "result_summary": "Fetched details for NCT06357533 (Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations), latency 183ms",
      "result_count": 0,
      "latency_ms": 183.79312500474043,
      "error": null
    }
  ],
  "total_api_calls": 25,
  "total_unique_nct_ids": 519,
  "gemini_input_tokens": 676910,
  "gemini_output_tokens": 1908,
  "gemini_estimated_cost": 0.8652175,
  "medgemma_calls": 1,
  "medgemma_estimated_cost": 0.0216531450233613,
  "latency_ms": 149148.48420800263,
  "medgemma_guidance_raw": "",
  "medgemma_condition_terms": [],
  "medgemma_eligibility_keywords": [],
  "condition_terms_searched": [
    "Lung Adenocarcinoma",
    "Adenocarcinoma of the Lung",
    "NSCLC",
    "Non-Small Cell Lung Cancer",
    "Stage IVA Lung Cancer",
    "Metastatic Lung Adenocarcinoma",
    "Advanced Lung Adenocarcinoma",
    "Signet Ring Cell Carcinoma",
    "Signet Ring Cell Lung Cancer",
    "PD-L1 High Lung Cancer",
    "PD-L1 Positive Lung Cancer",
    "EGFR Wild-Type NSCLC",
    "ALK Negative NSCLC",
    "ROS1 Negative NSCLC",
    "KRAS Wild-Type NSCLC",
    "Wild Type NSCLC",
    "Lung Cancer",
    "Metastatic NSCLC",
    "Advanced NSCLC",
    "Immunotherapy for Lung Cancer"
  ]
}